<accesscontrol>审核人:代谢紊乱/稳态失衡,审核人:所有成员(ro),编辑人:普通用户(ro)</accesscontrol>
=代谢紊乱/稳态失衡(804条目)=


==[[HP:0000093]]==
{{Infobox HPO
| hpoId = HP:0000093
| 名称 = Proteinuria
| 定义 = Increased levels of protein in the urine.
| 中文译名 = 蛋白尿
| 中文定义 = 尿液中蛋白质水平增加。
}}


==[[HP:0000117]]==
{{Infobox HPO
| hpoId = HP:0000117
| 名称 = Renal phosphate wasting
| 定义 = High urine phosphate in the presence of hypophosphatemia.
| 中文译名 = 肾源性磷酸盐流失
| 中文定义 = 尿液中高磷酸盐，发生低磷血症。
}}


==[[HP:0000127]]==
{{Infobox HPO
| hpoId = HP:0000127
| 名称 = Renal salt wasting
| 定义 = A high concentration of one or more electrolytes in the urine in the presence of low serum concentrations of the electrolyte(s).
| 中文译名 = 肾源性盐流失
| 中文定义 = 尿液中一种或多种电解质浓度高，而血清中这些电解质浓度低。
}}


==[[HP:0000128]]==
{{Infobox HPO
| hpoId = HP:0000128
| 名称 = Renal potassium wasting
| 定义 = High urine potassium in the presence of hypokalemia.
| 中文译名 = 肾源性钾流失
| 中文定义 = 尿液高钾，发生低钾血症。
}}


==[[HP:0000282]]==
{{Infobox HPO
| hpoId = HP:0000282
| 名称 = Facial edema
| 定义 = #####
| 中文译名 = 面部水肿
| 中文定义 = #####
}}


==[[HP:0000790]]==
{{Infobox HPO
| hpoId = HP:0000790
| 名称 = Hematuria
| 定义 = The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).
| 中文译名 = 血尿
| 中文定义 = 尿液中存在血液，血尿可为肉眼血尿（肉眼可见）或镜下血尿（由试纸或显微镜尿检）。
}}


==[[HP:0000816]]==
{{Infobox HPO
| hpoId = HP:0000816
| 名称 = Abnormality of Krebs cycle metabolism
| 定义 = An abnormality of the `tricarboxylic acid cycle` (GO:0006099).
| 中文译名 = Krebs循环代谢异常
| 中文定义 = 在&#39;三羧酸循环`（GO:0006099）的异常。
}}

==[[HP:0000819]]==
{{Infobox HPO
| hpoId = HP:0000819
| 名称 = Diabetes mellitus
| 定义 = A group of abnormalities characterized by hyperglycemia and glucose intolerance.
| 中文译名 = 糖尿病
| 中文定义 = 一组以高血糖和葡萄糖不耐受为特征的病症。
}}


==[[HP:0000825]]==
{{Infobox HPO
| hpoId = HP:0000825
| 名称 = Hyperinsulinemic hypoglycemia
| 定义 = An `increased concentration` (PATO:0001162) of `insulin` (PRO:000009054) combined with a `decreased concentration` (PATO:0001163) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670).
| 中文译名 = 高胰岛素性低血糖
| 中文定义 = 血中胰岛素浓度异常升高的同时伴有血葡萄糖浓度的减低。
}}


==[[HP:0000831]]==
{{Infobox HPO
| hpoId = HP:0000831
| 名称 = Insulin-resistant diabetes mellitus
| 定义 = A type of diabetes mellitus related not to lack of insulin but rather to lack of response to insulin on the part of the target tissues of insulin such as muscle, fat, and liver cells. This type of diabetes is typically associated with increases both in blood glucose concentrations as will as in fasting and postprandial serum insulin levels.
| 中文译名 = 胰岛素抵抗性糖尿病
| 中文定义 = 糖尿病的一种，其致病原因不是由于缺乏胰岛素，而是由于胰岛素的靶组织如肌肉，脂肪和肝细胞等丧失对胰岛素的反应。这种类型的糖尿病中通常血中葡萄糖浓度，及空腹和餐后血清胰岛素水平都升高。
}}

==[[HP:0000833]]==
{{Infobox HPO
| hpoId = HP:0000833
| 名称 = Glucose intolerance
| 定义 = #####
| 中文译名 = 葡萄糖不耐受
| 中文定义 = #####
}}


==[[HP:0000842]]==
{{Infobox HPO
| hpoId = HP:0000842
| 名称 = Hyperinsulinemia
| 定义 = An `increased concentration` (PATO:0001162) of `insulin` (PRO:000009054) in the `blood` (FMA:9670).
| 中文译名 = 高胰岛素血症
| 中文定义 = 血中胰岛素浓度异常升高
}}


==[[HP:0000855]]==
{{Infobox HPO
| hpoId = HP:0000855
| 名称 = Insulin resistance
| 定义 = `Increased resistance` (PATO:0001650) towards `insulin` (PRO:000009054), that is, diminished effectiveness of insulin in reducing blood glucose levels.
| 中文译名 = 胰岛素抵抗
| 中文定义 = `增加resistance`（PATO:0001650）朝向`insulin`（PRO:000009054），即，胰岛素在降低血糖水平减少的效果。
}}


==[[HP:0000857]]==
{{Infobox HPO
| hpoId = HP:0000857
| 名称 = Neonatal insulin-dependent diabetes mellitus
| 定义 = #####
| 中文译名 = 新生儿胰岛素依赖性糖尿病
| 中文定义 = #####
}}

==[[HP:0000877]]==
{{Infobox HPO
| hpoId = HP:0000877
| 名称 = Insulin-resistant diabetes mellitus at puberty
| 定义 = #####
| 中文译名 = 青春期胰岛素抵抗性糖尿病
| 中文定义 = #####
}}


==[[HP:0000969]]==
{{Infobox HPO
| hpoId = HP:0000969
| 名称 = Edema
| 定义 = An abnormal accumulation of fluid beneath the skin, or in one or more cavities of the body.
| 中文译名 = 水肿
| 中文定义 = 流体的皮肤，或者在身体的一个或多个腔的下方的异常积累。
}}


==[[HP:0001004]]==
{{Infobox HPO
| hpoId = HP:0001004
| 名称 = Lymphedema
| 定义 = Localized fluid retention and tissue swelling caused by a compromised `lymphatic system` (FMA:7162).
| 中文译名 = 淋巴水肿
| 中文定义 = 局部水肿和组织肿胀引起的受损`淋巴system`（FMA:7162）。
}}


==[[HP:0001386]]==
{{Infobox HPO
| hpoId = HP:0001386
| 名称 = Joint swelling
| 定义 = #####
| 中文译名 = 关节肿胀
| 中文定义 = #####
}}


==[[HP:0001789]]==
{{Infobox HPO
| hpoId = HP:0001789
| 名称 = Hydrops fetalis
| 定义 = The abnormal accumulation of fluid in two or more fetal compartments, including ascites, pleural effusion, pericardial effusion, and skin edema.
| 中文译名 = 胎儿水肿
| 中文定义 = 两个或以上的胎儿腔隙出现异常液体积聚，包括腹水，胸水，心包积液和皮肤水肿。
}}


==[[HP:0001790]]==
{{Infobox HPO
| hpoId = HP:0001790
| 名称 = Nonimmune hydrops fetalis
| 定义 = Nonimmune hydrops fetalis is a serious fetal condition in which abnormal fluid accumulates in at least two different compartments ,and in which ciruulating antibodies against red cell antigens are absent in the mother.
| 中文译名 = 非免疫性胎儿水肿
| 中文定义 = 非免疫性胎儿水肿是指胎儿出现两处或以上不同部位的体液异常聚积；但母血中没有抗胎儿红细胞抗体
}}


==[[HP:0001854]]==
{{Infobox HPO
| hpoId = HP:0001854
| 名称 = Gout (feet)
| 定义 = `Gout` (HP:0001997) affecting the `Metatarsophalangeal joint of big toe`.
| 中文译名 = 痛风（脚）
| 中文定义 = `Gout`（HP:0001997）影响大toe`的`跖趾关节。
}}


==[[HP:0001917]]==
{{Infobox HPO
| hpoId = HP:0001917
| 名称 = Renal amyloidosis
| 定义 = A form of `amyloidosis` (HP:0011034) that affects the `kidney` (FMA:7203).
| 中文译名 = 肾淀粉样病变
| 中文定义 = 淀粉样病变累及到肾。
}}


==[[HP:0001939]]==
{{Infobox HPO
| hpoId = HP:0001939
| 名称 = Abnormality of metabolism/homeostasis
| 定义 = #####
| 中文译名 = 代谢紊乱/稳态失衡
| 中文定义 = #####
}}


==[[HP:0001941]]==
{{Infobox HPO
| hpoId = HP:0001941
| 名称 = Acidosis
| 定义 = Abnormal acid accumulation or depletion of base.
| 中文译名 = 酸中毒
| 中文定义 = 酸堆积或碱消耗的异常。
}}


==[[HP:0001942]]==
{{Infobox HPO
| hpoId = HP:0001942
| 名称 = Metabolic acidosis
| 定义 = Acid accumulation or depletion of base in the body due to buildup of metabolic acids.
| 中文译名 = 代谢性酸中毒
| 中文定义 = 酸积累或碱在身体的消耗由于代谢酸堆积。
}}


==[[HP:0001943]]==
{{Infobox HPO
| hpoId = HP:0001943
| 名称 = Hypoglycemia
| 定义 = A `decreased concentration` (PATO:0001163) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670).
| 中文译名 = 低血糖
| 中文定义 = 在`blood`（FMA:9670）一个`下降concentration`（PATO:0001163）的`glucose`（17234 CHEBI）。
}}


==[[HP:0001944]]==
{{Infobox HPO
| hpoId = HP:0001944
| 名称 = Dehydration
| 定义 = #####
| 中文译名 = 脱水
| 中文定义 = #####
}}


==[[HP:0001945]]==
{{Infobox HPO
| hpoId = HP:0001945
| 名称 = Fever
| 定义 = Elevated body temperature due to failed thermoregulation.
| 中文译名 = 发热
| 中文定义 = 体温升高，由于没有体温。
}}


==[[HP:0001946]]==
{{Infobox HPO
| hpoId = HP:0001946
| 名称 = Ketosis
| 定义 = Presence of elevated levels of ketone bodies in the body.
| 中文译名 = 酮症
| 中文定义 = 存在在体内酮体水平升高。
}}


==[[HP:0001947]]==
{{Infobox HPO
| hpoId = HP:0001947
| 名称 = Renal tubular acidosis
| 定义 = Acidosis owing to malfunction of the kidney tubules with accumulation of metabolic acids and hyperchloremia, potentially leading to complications including hypokalemia, hypercalcinuria, nephrolithiasis and nephrocalcinosis.
| 中文译名 = 肾小管性酸中毒
| 中文定义 = 由于肾小管功能异常造成代谢酸累积和高氯血症，可能导致的并发症包括低钾血症、高钙血症、肾结石和肾钙质沉着。
}}


==[[HP:0001948]]==
{{Infobox HPO
| hpoId = HP:0001948
| 名称 = Alkalosis
| 定义 = Depletion of acid or accumulation base in the body fluids.
| 中文译名 = 碱中毒
| 中文定义 = 体液内的酸消耗或碱堆积。
}}


==[[HP:0001949]]==
{{Infobox HPO
| hpoId = HP:0001949
| 名称 = Hypokalemic alkalosis
| 定义 = #####
| 中文译名 = 低钾性碱中毒
| 中文定义 = #####
}}


==[[HP:0001950]]==
{{Infobox HPO
| hpoId = HP:0001950
| 名称 = Respiratory alkalosis
| 定义 = Alkalosis due to excess loss of carbon dioxide from the body.
| 中文译名 = 呼吸性碱中毒
| 中文定义 = 性碱中毒由于二氧化碳从身体过剩损耗。
}}


==[[HP:0001951]]==
{{Infobox HPO
| hpoId = HP:0001951
| 名称 = Episodic ammonia intoxication
| 定义 = #####
| 中文译名 = 阵发性氨中毒
| 中文定义 = #####
}}


==[[HP:0001952]]==
{{Infobox HPO
| hpoId = HP:0001952
| 名称 = Abnormal glucose tolerance
| 定义 = An `abnormal` (PATO:0000460) `resistance to` (PATO:0001046) `glucose`(CHEBI:17234), i.e., a reduction in the ability to maintain glucose levels in the blood stream within normal limits following oral or intravenous administration of glucose.
| 中文译名 = 糖耐量异常
| 中文定义 = 对抗（PATO:0000460）`葡萄糖`（CHEBI:17234），的`异常`（PATO:0001046）即口服或静脉内注射葡萄糖后，维持血流中的葡萄糖水平在正常范围内的能力降低。
}}


==[[HP:0001953]]==
{{Infobox HPO
| hpoId = HP:0001953
| 名称 = Diabetic ketoacidosis
| 定义 = A type of diabetic metabolic abnormality with an accumulation of ketone bodies.
| 中文译名 = 糖尿病酮症酸中毒
| 中文定义 = 一种伴有酮体累积的糖尿病代谢异常。
}}


==[[HP:0001954]]==
{{Infobox HPO
| hpoId = HP:0001954
| 名称 = Episodic fever
| 定义 = Periodic (episodic or recurrent) bouts of fever.
| 中文译名 = 阵发性发热
| 中文定义 = 发热周期性（发作或复发）发作。
}}


==[[HP:0001955]]==
{{Infobox HPO
| hpoId = HP:0001955
| 名称 = Unexplained fevers
| 定义 = Episodes of fever for which no infectious cause can be identified.
| 中文译名 = 不明原因的发热
| 中文定义 = 发热的发作的量没有感染原因可被识别。
}}


==[[HP:0001958]]==
{{Infobox HPO
| hpoId = HP:0001958
| 名称 = Nonketotic hypoglycemia
| 定义 = #####
| 中文译名 = 非酮症性低血糖
| 中文定义 = #####
}}


==[[HP:0001960]]==
{{Infobox HPO
| hpoId = HP:0001960
| 名称 = Hypokalemic metabolic alkalosis
| 定义 = #####
| 中文译名 = 低钾性代谢性碱中毒
| 中文定义 = #####
}}


==[[HP:0001984]]==
{{Infobox HPO
| hpoId = HP:0001984
| 名称 = Intolerance to protein
| 定义 = #####
| 中文译名 = 蛋白质不耐受
| 中文定义 = #####
}}


==[[HP:0001985]]==
{{Infobox HPO
| hpoId = HP:0001985
| 名称 = Hypoketotic hypoglycemia
| 定义 = A `decreased concentration` (PATO:0001163) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670) associated with a reduced concentration of ketone bodies.
| 中文译名 = 低酮性低血糖
| 中文定义 = 在`blood`（FMA:9670）与酮体浓度降低相关联的`减少concentration`（PATO:0001163）的`glucose`（17234 CHEBI）。
}}


==[[HP:0001986]]==
{{Infobox HPO
| hpoId = HP:0001986
| 名称 = Hypertonic dehydration
| 定义 = #####
| 中文译名 = 高渗性脱水
| 中文定义 = #####
}}


==[[HP:0001987]]==
{{Infobox HPO
| hpoId = HP:0001987
| 名称 = Hyperammonemia
| 定义 = An increased concentration of `ammonia` (CHEBI:16134) in the `blood` (FMA:9670).
| 中文译名 = 高氨血症
| 中文定义 = 在`blood`:`ammonia`（16134 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0001988]]==
{{Infobox HPO
| hpoId = HP:0001988
| 名称 = Recurrent hypoglycemia
| 定义 = `Recurrent` (PATO:0000427) episodes of `decreased concentration` (PATO:0001163) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670).
| 中文译名 = 反复发作性低血糖
| 中文定义 = `Recurrent`（PATO:0000427）在`blood`（FMA:9670）:对`glucose`（17234 CHEBI）发作`下降concentration`（0001163 PATO）。
}}


==[[HP:0001992]]==
{{Infobox HPO
| hpoId = HP:0001992
| 名称 = Organic aciduria
| 定义 = Excretion of  non-amino organic acids in urine.
| 中文译名 = 有机酸尿症
| 中文定义 = 尿液中非氨基有机酸排泄增加。
}}


==[[HP:0001993]]==
{{Infobox HPO
| hpoId = HP:0001993
| 名称 = Ketoacidosis
| 定义 = Acidosis resulting from accumulation of ketone bodies.
| 中文译名 = 酮症酸中毒
| 中文定义 = 酸中毒从酮体蓄积造成。
}}


==[[HP:0001995]]==
{{Infobox HPO
| hpoId = HP:0001995
| 名称 = Hyperchloremic acidosis
| 定义 = #####
| 中文译名 = 高氯性酸中毒
| 中文定义 = #####
}}


==[[HP:0001996]]==
{{Infobox HPO
| hpoId = HP:0001996
| 名称 = Chronic metabolic acidosis
| 定义 = Longstanding metabolic acidosis.
| 中文译名 = 慢性代谢性酸中毒
| 中文定义 = 长期代谢性酸中毒。
}}


==[[HP:0001997]]==
{{Infobox HPO
| hpoId = HP:0001997
| 名称 = Gout
| 定义 = Recurrent attacks of acute inflammatory arthritis of a `joint ` (FMA:7490) or `set of joints` (FMA:73023) caused by elevated levels of `uric acid` (CHEBI:27226) in the `blood` (FMA:9670) which crystallize and are deposited in joints, tendons, and surrounding tissues.
| 中文译名 = 痛风
| 中文定义 = 的一个`关节急性炎性关节炎反复发作`（FMA:7490）或`设置joints`的（FMA:73023）:在`blood`（FMA引起的`尿酸acid`水平升高（27226 CHEBI）:9670 ），该结晶并沉积在关节，腱和周围组织。
}}


==[[HP:0001998]]==
{{Infobox HPO
| hpoId = HP:0001998
| 名称 = Neonatal hypoglycemia
| 定义 = #####
| 中文译名 = 新生儿低血糖
| 中文定义 = #####
}}


==[[HP:0002045]]==
{{Infobox HPO
| hpoId = HP:0002045
| 名称 = Hypothermia
| 定义 = Reduced body temperature due to failed thermoregulation.
| 中文译名 = 低体温
| 中文定义 = 体温降低因失败体温调节。
}}


==[[HP:0002046]]==
{{Infobox HPO
| hpoId = HP:0002046
| 名称 = Heat intolerance
| 定义 = The inability to maintain a comfortably body temperature in warm or hot weather.
| 中文译名 = 不耐热
| 中文定义 = 无法维持一个舒适体温在温或热的天气。
}}


==[[HP:0002047]]==
{{Infobox HPO
| hpoId = HP:0002047
| 名称 = Malignant hyperthermia
| 定义 = Malignant hyperthermia is characterized by a rapid increase in temperature to 39-42 degrees C in response to inhalational anesthetics such as halothane or to muscle relaxants such as succinylcholine.
| 中文译名 = 恶性高热
| 中文定义 = 恶性高热的特征在于，以39-42℃的快速温度增加响应于吸入麻醉药如氟烷或肌肉松弛剂，如琥珀酰胆碱。
}}


==[[HP:0002049]]==
{{Infobox HPO
| hpoId = HP:0002049
| 名称 = Proximal renal tubular acidosis
| 定义 = A type of renal tubular acidosis characterized by a  failure of the proximal tubular cells to reabsorb bicarbonate, leading to urinary bicarbonate wasting and subsequent acidemia.
| 中文译名 = 近端肾小管酸中毒
| 中文定义 = 一种肾小管酸中毒，其特征是由于近端肾小管上皮细胞重吸收碳酸氢盐障碍，导致尿碳酸氢盐消耗及继发性酸血症。
}}


==[[HP:0002148]]==
{{Infobox HPO
| hpoId = HP:0002148
| 名称 = Hypophosphatemia
| 定义 = An abnormally decreased `phosphate` (CHEBI:18367) concentration in the `blood` (FMA:9670).
| 中文译名 = 低磷血症
| 中文定义 = 一个异常降低`phosphate`（CHEBI:18367）的浓度在`blood`（FMA:9670）。
}}


==[[HP:0002149]]==
{{Infobox HPO
| hpoId = HP:0002149
| 名称 = Hyperuricemia
| 定义 = An abnormally high level of `uric acid` (CHEBI:27226) in the `blood` (FMA:9670).
| 中文译名 = 高尿酸血症
| 中文定义 = 在`blood`（FMA:9670）:一个异常高的水平`尿酸acid`（27226 CHEBI）的。
}}


==[[HP:0002150]]==
{{Infobox HPO
| hpoId = HP:0002150
| 名称 = Hypercalciuria
| 定义 = #####
| 中文译名 = 高钙尿症
| 中文定义 = #####
}}


==[[HP:0002151]]==
{{Infobox HPO
| hpoId = HP:0002151
| 名称 = Increased serum lactate
| 定义 = Abnormally increased level of blood `lactate` (CHEBI:24996)  (2-hydroxypropanoic acid). Lactate is produced from pyruvate by lactate dehydrogenase during normal metabolism.
| 中文译名 = 血清乳酸增高
| 中文定义 = 异常增加的血液`lactate`（CHEBI:24996）级（2-羟基丙酸）。乳酸是从丙酮酸由乳酸脱氢酶正常代谢过程中产生的。
}}


==[[HP:0002152]]==
{{Infobox HPO
| hpoId = HP:0002152
| 名称 = Hyperproteinemia
| 定义 = An `increased concentration` (PATO:0001162) of `proteins` (CHEBI:36080) in the `blood` (FMA:9670).
| 中文译名 = 高蛋白血症
| 中文定义 = 的`proteins`（CHEBI:36080）:一个`增加concentration`（0001162 PATO）在`blood`（FMA:9670）。
}}


==[[HP:0002153]]==
{{Infobox HPO
| hpoId = HP:0002153
| 名称 = Hyperkalemia
| 定义 = An abnormally increased `potassium` (CHEBI:29103) concentration in the blood.
| 中文译名 = 高钾血症
| 中文定义 = 异常增加`potassium`（CHEBI:29103）的浓度在血液中。
}}


==[[HP:0002154]]==
{{Infobox HPO
| hpoId = HP:0002154
| 名称 = Hyperglycinemia
| 定义 = An elevated concentration of `glycine` (CHEBI:15428) in the `blood` (FMA:9670).
| 中文译名 = 高甘氨酸血症
| 中文定义 = 浓度升高`glycine`（CHEBI:15428）在`blood`（FMA:9670）。
}}


==[[HP:0002155]]==
{{Infobox HPO
| hpoId = HP:0002155
| 名称 = Hypertriglyceridemia
| 定义 = An abnormal increase in the level of `triglycerides` (CHEBI:17855) in the `blood` (FMA:9670).
| 中文译名 = 高甘油三酯血症
| 中文定义 = 在`blood`（FMA:9670）:在&#39;triglycerides`（17855 CHEBI）水平的异常增加。
}}


==[[HP:0002156]]==
{{Infobox HPO
| hpoId = HP:0002156
| 名称 = Homocystinuria
| 定义 = An increased concentration of `homocystine` (CHEBI:17485) in the `urine` (FMA:12274).
| 中文译名 = 高胱氨酸尿症
| 中文定义 = 尿也中胱氨酸浓度增加。
}}


==[[HP:0002157]]==
{{Infobox HPO
| hpoId = HP:0002157
| 名称 = Azotemia
| 定义 = An increased concentration of `nitrogen compounds` (CHEBI:51143) in the `blood` (FMA:9670).
| 中文译名 = 氮质血症
| 中文定义 = `血液`（FMA:9670）中&#39;氮化合物`(CHEBI:51143)的浓度增加。
}}


==[[HP:0002159]]==
{{Infobox HPO
| hpoId = HP:0002159
| 名称 = Heparan sulfate excretion in urine
| 定义 = An `increased concentration` (PATO:0001162) of `heparan sulfates` (CHEBI:35721) in the `urine` (FMA:12274).
| 中文译名 = 尿中硫酸乙酰肝素排泄
| 中文定义 = 尿液中硫酸乙酰肝素浓度增加。
}}


==[[HP:0002160]]==
{{Infobox HPO
| hpoId = HP:0002160
| 名称 = Hyperhomocystinemia
| 定义 = An increased concentration of `homocystine` (CHEBI:17485) in the `blood` (FMA:9670).
| 中文译名 = 高同型半胱氨酸血症
| 中文定义 = 在`blood`:`homocystine`（17485 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0002161]]==
{{Infobox HPO
| hpoId = HP:0002161
| 名称 = Hyperlysinemia
| 定义 = An increased concentration of `lysine` (CHEBI:25094) in the `blood` (FMA:9670).
| 中文译名 = 高赖氨酸血症
| 中文定义 = 在`blood`:`lysine`（25094 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0002173]]==
{{Infobox HPO
| hpoId = HP:0002173
| 名称 = Hypoglycemic seizures
| 定义 = #####
| 中文译名 = 低血糖发作
| 中文定义 = #####
}}


==[[HP:0002181]]==
{{Infobox HPO
| hpoId = HP:0002181
| 名称 = Cerebral edema
| 定义 = Abnormal accumulation of fluid in the brain.
| 中文译名 = 脑水肿
| 中文定义 = 大脑内液体异常蓄积。
}}


==[[HP:0002199]]==
{{Infobox HPO
| hpoId = HP:0002199
| 名称 = Hypocalcemic seizures
| 定义 = #####
| 中文译名 = 低钙发作
| 中文定义 = #####
}}


==[[HP:0002202]]==
{{Infobox HPO
| hpoId = HP:0002202
| 名称 = Pleural effusion
| 定义 = The presence of an excessive amount of fluid in the `pleural cavity` (FMA:9740).
| 中文译名 = 胸腔积液
| 中文定义 = 胸腔内存在过多的液体（FMA:9740）。
}}


==[[HP:0002720]]==
{{Infobox HPO
| hpoId = HP:0002720
| 名称 = IgA deficiency
| 定义 = Decreased levels of immunoglobulin IgA.
| 中文译名 = IgA缺乏
| 中文定义 = 免疫球蛋白的IgA水平降低。
}}


==[[HP:0002847]]==
{{Infobox HPO
| hpoId = HP:0002847
| 名称 = Impaired memory B-cell generation
| 定义 = Impaired production of memory cells, the B-cells that persist for years or an entire lifetime and which confer rapid and enhanced response to secondary challenge.
| 中文译名 = 记忆B细胞生成障碍
| 中文定义 = 记忆细胞生成受损，具有记忆功能的B细胞可以在体内持续存在数年或整个寿命，当第二次遇到相同抗原时，可以快速和增效反应。
}}


==[[HP:0002850]]==
{{Infobox HPO
| hpoId = HP:0002850
| 名称 = IgM deficiency
| 定义 = An abnormally decreased level of immunoglobulin IgM in blood.
| 中文译名 = IgM抗体缺乏症
| 中文定义 = 免疫球蛋白的IgM在血液异常降低。
}}


==[[HP:0002900]]==
{{Infobox HPO
| hpoId = HP:0002900
| 名称 = Hypokalemia
| 定义 = An abnormally decreased `potassium` (CHEBI:29103) concentration in the blood.
| 中文译名 = 低钾血症
| 中文定义 = 一个异常降低`potassium`（CHEBI:29103）的浓度在血液中。
}}


==[[HP:0002901]]==
{{Infobox HPO
| hpoId = HP:0002901
| 名称 = Hypocalcemia
| 定义 = An abnormally decreased `calcium` (CHEBI:29108) concentration in the blood.
| 中文译名 = 低钙血症
| 中文定义 = 一个异常降低`calcium`（CHEBI:29108）的浓度在血液中。
}}


==[[HP:0002902]]==
{{Infobox HPO
| hpoId = HP:0002902
| 名称 = Hyponatremia
| 定义 = An abnormally decreased `sodium` (CHEBI:29101) concentration in the blood.
| 中文译名 = 低钠血症
| 中文定义 = 一个异常降低`sodium`（CHEBI:29101）的浓度在血液中。
}}


==[[HP:0002904]]==
{{Infobox HPO
| hpoId = HP:0002904
| 名称 = Hyperbilirubinemia
| 定义 = An increased amount of `bilirubin` (CHEBI:16990) in the `blood` (FMA:9670).
| 中文译名 = 高胆红素血症
| 中文定义 = 在`blood`（FMA:9670）:`bilirubin`（16990 CHEBI）的量增加。
}}


==[[HP:0002905]]==
{{Infobox HPO
| hpoId = HP:0002905
| 名称 = Hyperphosphatemia
| 定义 = An abnormally increased `phosphate` (CHEBI:18367) concentration in the `blood` (FMA:9670).
| 中文译名 = 高磷血症
| 中文定义 = 一个异常升高`phosphate`（CHEBI:18367）的浓度在`blood`（FMA:9670）。
}}


==[[HP:0002907]]==
{{Infobox HPO
| hpoId = HP:0002907
| 名称 = Microscopic hematuria
| 定义 = Microscopic hematuria detected by dipstick or microscopic examination of the urine.
| 中文译名 = 镜下血尿症
| 中文定义 = 通过试纸或显微镜检查可发现的血尿。
}}


==[[HP:0002908]]==
{{Infobox HPO
| hpoId = HP:0002908
| 名称 = Conjugated hyperbilirubinemia
| 定义 = #####
| 中文译名 = 高结合胆红素血症
| 中文定义 = #####
}}

==[[HP:0002909]]==
{{Infobox HPO
| hpoId = HP:0002909
| 名称 = Generalized aminoaciduria
| 定义 = An increased concentration of all types of `amino acid` (CHEBI:33709 ) in the `urine` (FMA:12274).
| 中文译名 = 全谱氨基酸尿
| 中文定义 = 尿中出现各种氨基酸的浓度增加。
}}


==[[HP:0002912]]==
{{Infobox HPO
| hpoId = HP:0002912
| 名称 = Methylmalonic acidemia
| 定义 = Increased concentration of `methylmalonic acid` (CHEBI:30860) in the blood.
| 中文译名 = 甲基丙二酸血症
| 中文定义 = 血液中的:增加`甲基丙acid`（30860 CHEBI）的浓度。
}}


==[[HP:0002913]]==
{{Infobox HPO
| hpoId = HP:0002913
| 名称 = Myoglobinuria
| 定义 = Presence of `myoglobin` (CHEBI:7044)  in the urine.
| 中文译名 = 肌红蛋白尿
| 中文定义 = 尿中存在肌红蛋白。
}}


==[[HP:0002914]]==
{{Infobox HPO
| hpoId = HP:0002914
| 名称 = Hyperchloridura
| 定义 = An increased concentration of `chloride` (CHEBI:17996) in the `urine` (FMA:12274).
| 中文译名 = 高氯尿症
| 中文定义 = 尿液中氯化物浓度增加。
}}


==[[HP:0002916]]==
{{Infobox HPO
| hpoId = HP:0002916
| 名称 = Abnormality of chromosome segregation
| 定义 = An abnormality of `chromosome segregation` (GO:0007059).
| 中文译名 = 染色体分离异常
| 中文定义 = `染色体分离`（GO:0007059）的异常
}}


==[[HP:0002917]]==
{{Infobox HPO
| hpoId = HP:0002917
| 名称 = Hypomagnesemia
| 定义 = An abnormally decreased `magnesium` (CHEBI:18420) concentration in the blood.
| 中文译名 = 低镁血症
| 中文定义 = 一个异常降低`magnesium`（CHEBI:18420）的浓度在血液中。
}}


==[[HP:0002918]]==
{{Infobox HPO
| hpoId = HP:0002918
| 名称 = Hypermagnesemia
| 定义 = An abnormally increased `magnesium` (CHEBI:18420) concentration in the blood.
| 中文译名 = 高镁血症
| 中文定义 = 异常增加`magnesium`（CHEBI:18420）的浓度在血液中。
}}


==[[HP:0002919]]==
{{Infobox HPO
| hpoId = HP:0002919
| 名称 = Ketonuria
| 定义 = High levels of ketone bodies in the urine.
| 中文译名 = 酮尿
| 中文定义 = 尿中出现酮体。
}}


==[[HP:0002927]]==
{{Infobox HPO
| hpoId = HP:0002927
| 名称 = Histidinuria
| 定义 = An increased concentration of `histidine` (CHEBI:27570) in the `urine` (FMA:12274).
| 中文译名 = 组氨酸尿
| 中文定义 = 尿液中组氨酸浓度增加。
}}


==[[HP:0002928]]==
{{Infobox HPO
| hpoId = HP:0002928
| 名称 = Decreased activity of the pyruvate dehydrogenase (PDH) complex
| 定义 = #####
| 中文译名 = 丙酮酸脱氢酶（PDH）复合物活性降低
| 中文定义 = #####
}}


==[[HP:0002932]]==
{{Infobox HPO
| hpoId = HP:0002932
| 名称 = Aldehyde oxidase deficiency
| 定义 = A reduction in `aldehyde oxidase activity` (GO:0004031).
| 中文译名 = 醛氧化酶缺乏症
| 中文定义 = `醛氧化酶活性`（GO:0004031）的降低。
}}


==[[HP:0002959]]==
{{Infobox HPO
| hpoId = HP:0002959
| 名称 = Impaired Ig class switch recombination
| 定义 = An impairment of the class-switch recombination process that normally leads B lymphocytes to produce IgG, IgA, or IgE.
| 中文译名 = 免疫球蛋白类别转换重组障碍
| 中文定义 = 在B淋巴细胞产生IgG，IgA或IgE的类转换重组过程中受损。
}}


==[[HP:0002961]]==
{{Infobox HPO
| hpoId = HP:0002961
| 名称 = Dysgammaglobulinemia
| 定义 = Selective deficiency of one or more, but not all, classes of immunoglobulins.
| 中文译名 = 异常丙种球蛋白血症
| 中文定义 = 免疫球蛋白一种或多种减少，但不是所有种类不足。
}}


==[[HP:0002963]]==
{{Infobox HPO
| hpoId = HP:0002963
| 名称 = Abnormal delayed hypersensitivity skin test
| 定义 = Delay in cutaneous immune reaction to specific antigens mediated not by antibodies but by cells. The delayed hypersensitivity test is an immune function test measuring the presence of activated T cells that recognize a specific antigen and is performed by injecting a small amount of the antigen into the skin. The area of the injection is examined 48-72 hours thereafter.
| 中文译名 = 皮肤过敏试验反应延迟
| 中文定义 = 皮肤由抗体或细胞介导的对特异性抗原的迟发免疫应答。迟发型超敏反应试验是测量活化的T细胞识别特定抗原的一种免疫功能测试，通过注入少量的抗原进入皮肤，48-72小时之后观察注射的区域的变化。
}}


==[[HP:0002965]]==
{{Infobox HPO
| hpoId = HP:0002965
| 名称 = Cutaneous anergy
| 定义 = Inability to react to a delayed hypersensitivity skin test.
| 中文译名 = 皮肤反应不能
| 中文定义 = 对迟发性超敏反应皮肤试验无反应。
}}

==[[HP:0002972]]==
{{Infobox HPO
| hpoId = HP:0002972
| 名称 = Reduced delayed hypersensitivity
| 定义 = Decreased ability to react to a delayed hypersensitivity skin test.
| 中文译名 = 迟发型超敏反应降低
| 中文定义 = 迟发性超敏反应皮肤试验反应能力降低。
}}


==[[HP:0003072]]==
{{Infobox HPO
| hpoId = HP:0003072
| 名称 = Hypercalcemia
| 定义 = An abnormally increased `calcium` (CHEBI:29108) concentration in the blood.
| 中文译名 = 高钙血症
| 中文定义 = 异常增加`calcium`（CHEBI:29108）的浓度在血液中。
}}


==[[HP:0003073]]==
{{Infobox HPO
| hpoId = HP:0003073
| 名称 = Hypoalbuminemia
| 定义 = Reduction in the concentration of `albumin` (PR:000003918) in the `blood` (FMA:9670).
| 中文译名 = 低蛋白血症
| 中文定义 = 减少`albumin`（PR:000003918）的浓度在`blood`（FMA:9670）。
}}


==[[HP:0003074]]==
{{Infobox HPO
| hpoId = HP:0003074
| 名称 = Hyperglycemia
| 定义 = An `increased concentration` (PATO:0001162) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670).
| 中文译名 = 高血糖
| 中文定义 = 的`glucose`（CHEBI:17234）:一个`增加concentration`（0001162 PATO）在`blood`（FMA:9670）。
}}


==[[HP:0003075]]==
{{Infobox HPO
| hpoId = HP:0003075
| 名称 = Hypoproteinemia
| 定义 = A `decreased concentration` (PATO:0001163) of `protein` (CHEBI:36080) in the `blood` (FMA:9670).
| 中文译名 = 低蛋白血症
| 中文定义 = 在`blood`（FMA:9670）一个`下降concentration`（PATO:0001163）的`protein`（36080 CHEBI）。
}}


==[[HP:0003076]]==
{{Infobox HPO
| hpoId = HP:0003076
| 名称 = Glycosuria
| 定义 = An `increased concentration` (PATO:0001162) of `glucose` (CHEBI:17234) in the `urine` (FMA:12274).
| 中文译名 = 糖尿
| 中文定义 = 尿液中葡萄糖的浓度增加。
}}


==[[HP:0003077]]==
{{Infobox HPO
| hpoId = HP:0003077
| 名称 = Hyperlipidemia
| 定义 = An elevated `lipid` (CHEBI:18059) concentration in the `blood` (FMA:9670).
| 中文译名 = 高脂血症
| 中文定义 = 高架`lipid`（CHEBI:18059）在`blood`（FMA:9670）的浓度。
}}


==[[HP:0003079]]==
{{Infobox HPO
| hpoId = HP:0003079
| 名称 = Defective DNA repair after ultraviolet radiation damage
| 定义 = #####
| 中文译名 = 紫外线辐射后DNA损伤修复缺陷
| 中文定义 = #####
}}

==[[HP:0003080]]==
{{Infobox HPO
| hpoId = HP:0003080
| 名称 = Hydroxyprolinuria
| 定义 = An increased concentration of `4-hydroxy-L-proline` (CHEBI:18240) the `urine` (FMA:12274).
| 中文译名 = 羟脯氨酸尿症
| 中文定义 = 尿中4-羟基-L-脯氨酸的浓度增加。
}}


==[[HP:0003081]]==
{{Infobox HPO
| hpoId = HP:0003081
| 名称 = Increased urinary potassium
| 定义 = An increased concentration of `potassium(1+)` (CHEBI:29103) in the `urine` (FMA:12274).
| 中文译名 = 尿钾增加
| 中文定义 = 尿液中钾离子(1+)的浓度增加。
}}


==[[HP:0003107]]==
{{Infobox HPO
| hpoId = HP:0003107
| 名称 = Abnormality of cholesterol metabolism
| 定义 = #####
| 中文译名 = 胆固醇代谢异常
| 中文定义 = #####
}}


==[[HP:0003108]]==
{{Infobox HPO
| hpoId = HP:0003108
| 名称 = Hyperglycinuria
| 定义 = An increased concentration of `glycine` (CHEBI:15428 ) in the `urine` (FMA:12274).
| 中文译名 = 高甘氨酸尿症
| 中文定义 = 尿液中甘氨酸浓度增加。
}}


==[[HP:0003109]]==
{{Infobox HPO
| hpoId = HP:0003109
| 名称 = Hyperphosphaturia
| 定义 = An increased excretion of phosphates in the urine.
| 中文译名 = 高磷酸盐尿症
| 中文定义 = 尿液中磷酸盐的排泄增加。
}}


==[[HP:0003110]]==
{{Infobox HPO
| hpoId = HP:0003110
| 名称 = Abnormality of urine homeostasis
| 定义 = An abnormality of the composition of urine or the levels of its components.
| 中文译名 = 尿稳态平衡异常
| 中文定义 = 尿液中各组分构成或各自水平的异常。
}}

==[[HP:0003111]]==
{{Infobox HPO
| hpoId = HP:0003111
| 名称 = Abnormality of ion homeostasis
| 定义 = Abnormality of the homeostasis (concentration) of a `monoatomic ion` (CHEBI:24867).
| 中文译名 = 离子稳态平衡异常
| 中文定义 = `单原子离子`（CHEBI:24867）的内稳态平衡（浓度）异常。
}}


==[[HP:0003112]]==
{{Infobox HPO
| hpoId = HP:0003112
| 名称 = Abnormality of serum amino acid levels
| 定义 = The presence of an abnormal decrease or increase of one or more amino acids in the blood circulation.
| 中文译名 = 血清氨基酸水平异常
| 中文定义 = 血液循环中出现一个或多个氨基酸的升高或降低。
}}


==[[HP:0003113]]==
{{Infobox HPO
| hpoId = HP:0003113
| 名称 = Hypochloremia
| 定义 = An abnormally decreased `chloride` (CHEBI:17996) concentration in the blood.
| 中文译名 = 低氯血症
| 中文定义 = 一个异常降低`chloride`（CHEBI:17996）的浓度在血液中。
}}


==[[HP:0003119]]==
{{Infobox HPO
| hpoId = HP:0003119
| 名称 = Abnormality of lipid metabolism
| 定义 = An abnormality in the of `lipid` (CHEBI:18059) metabolism.
| 中文译名 = 脂代谢异常
| 中文定义 = `脂质`（CHEBI:18059）的代谢异常。
}}


==[[HP:0003124]]==
{{Infobox HPO
| hpoId = HP:0003124
| 名称 = Hypercholesterolemia
| 定义 = An increased concentration of `cholesterol` (CHEBI:16113) in the `blood` (FMA:9670).
| 中文译名 = 高胆固醇血症
| 中文定义 = 在`blood`:`cholesterol`（16113 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003126]]==
{{Infobox HPO
| hpoId = HP:0003126
| 名称 = Low-molecular-weight proteinuria
| 定义 = Excretion in urine of proteins of a size smaller than albumin (molecular weight 69 kD).
| 中文译名 = 低分子量蛋白尿
| 中文定义 = 从尿中排出分子量小于白蛋白（分子量为69 KD）的低分子蛋白。
}}


==[[HP:0003127]]==
{{Infobox HPO
| hpoId = HP:0003127
| 名称 = Hypocalciuria
| 定义 = An abnormally decreased `calcium` (CHEBI:29108) concentration in the urine (FMA:12274).
| 中文译名 = 低钙尿症
| 中文定义 = 尿液中的钙离子浓度异常降低。
}}


==[[HP:0003128]]==
{{Infobox HPO
| hpoId = HP:0003128
| 名称 = Lactic acidosis
| 定义 = An abnormal buildup of `lactic acid` (CHEBI:28358) in the body, leading to `acidification` (GO:0045851) of the blood and other bodily fluids.
| 中文译名 = 乳酸酸中毒
| 中文定义 = `乳酸acid`（CHEBI:28358）的异常积聚在体内，导致`acidification`（GO:0045851）的血液和其他体液。
}}


==[[HP:0003131]]==
{{Infobox HPO
| hpoId = HP:0003131
| 名称 = Cystinuria
| 定义 = An increased concentration of `cystine` (CHEBI:17376) in the `urine` (FMA:12274).
| 中文译名 = 胱氨酸尿
| 中文定义 = 尿中胱氨酸浓度增加。
}}


==[[HP:0003137]]==
{{Infobox HPO
| hpoId = HP:0003137
| 名称 = Prolinuria
| 定义 = An increased concentration of `proline` (CHEBI:26271) in the `urine` (FMA:12274).
| 中文译名 = 脯氨酸尿
| 中文定义 = 尿液中脯氨酸浓度增加。
}}


==[[HP:0003138]]==
{{Infobox HPO
| hpoId = HP:0003138
| 名称 = Increased blood urea nitrogen (BUN)
| 定义 = An increased amount of nitrogen in the form of `urea` (CHEBI:16199) in the `blood` (FMA:9670).
| 中文译名 = 血液尿素氮（BUN）升高
| 中文定义 = 在`blood`（FMA:9670）:氮在`urea`形式（16199 CHEBI）量增加。
}}


==[[HP:0003139]]==
{{Infobox HPO
| hpoId = HP:0003139
| 名称 = Panhypogammaglobulinemia
| 定义 = #####
| 中文译名 = 全丙种球蛋白减少血症
| 中文定义 = #####
}}


==[[HP:0003141]]==
{{Infobox HPO
| hpoId = HP:0003141
| 名称 = Hyperbetalipoproteinemia
| 定义 = An elevated concentration of `low-density lipoprotein cholesterol` (CHEBI:47774) in the `blood` (FMA:9670).
| 中文译名 = 高β-脂蛋白血症
| 中文定义 = 浓度升高`低密度脂蛋白cholesterol`（CHEBI:47774）在`blood`（FMA:9670）。
}}


==[[HP:0003142]]==
{{Infobox HPO
| hpoId = HP:0003142
| 名称 = Excessive purine production
| 定义 = #####
| 中文译名 = 嘌呤产生过量
| 中文定义 = #####
}}


==[[HP:0003145]]==
{{Infobox HPO
| hpoId = HP:0003145
| 名称 = Decreased adenosylcobalamin
| 定义 = Decreased concentration of `adenosylcobalamin` (CHEBI:18408). Adenosylcobalamin is one of the active forms of vitamin B12.
| 中文译名 = 腺苷钴胺素减少
| 中文定义 = 下降`adenosylcobalamin`浓度（CHEBI:18408）。腺苷钴胺是维生素B12的活性形式之一。
}}


==[[HP:0003146]]==
{{Infobox HPO
| hpoId = HP:0003146
| 名称 = Hypocholesterolemia
| 定义 = An decreased concentration of `cholesterol` (CHEBI:16113) in the `blood` (FMA:9670).
| 中文译名 = 低胆固醇血症
| 中文定义 = 在`blood`:`cholesterol`（16113 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0003148]]==
{{Infobox HPO
| hpoId = HP:0003148
| 名称 = Elevated serum acid phosphatase
| 定义 = #####
| 中文译名 = 血清酸性磷酸酶升高
| 中文定义 = #####
}}


==[[HP:0003149]]==
{{Infobox HPO
| hpoId = HP:0003149
| 名称 = Hyperuricosuria
| 定义 = An abnormally high level of `uric acid` (CHEBI:27226) in the `urine` (FMA:12274).
| 中文译名 = 高尿酸尿症
| 中文定义 = 尿液中尿酸水平异常增高。
}}


==[[HP:0003150]]==
{{Infobox HPO
| hpoId = HP:0003150
| 名称 = Glutaric aciduria
| 定义 = An increased concentration of `glutaric acid` (CHEBI:17859) in the `urine` (FMA:12274).
| 中文译名 = 戊二酸尿症
| 中文定义 = 尿液中戊二酸的浓度增加。
}}


==[[HP:0003153]]==
{{Infobox HPO
| hpoId = HP:0003153
| 名称 = Cystathioninuria
| 定义 = An elevated urinary concentration of `cystathionine` (CHEBI:17755).
| 中文译名 = 胱硫醚尿症
| 中文定义 = 尿中胱硫醚浓度升高。
}}


==[[HP:0003155]]==
{{Infobox HPO
| hpoId = HP:0003155
| 名称 = Elevated alkaline phosphatase
| 定义 = Abnormally increased serum levels of `alkaline phosphatase activity` (GO:0004035).
| 中文译名 = 碱性磷酸酶升高
| 中文定义 = 异常上升`碱性磷酸酶activity`的血清水平（GO:0004035）。
}}


==[[HP:0003158]]==
{{Infobox HPO
| hpoId = HP:0003158
| 名称 = Hyposthenuria
| 定义 = An abnormally low urinary specific gravity, i.e., reduced concentration of solutes in the urine.
| 中文译名 = 低渗尿
| 中文定义 = 异常低的尿比重，即尿中溶质的浓度降低。
}}


==[[HP:0003159]]==
{{Infobox HPO
| hpoId = HP:0003159
| 名称 = Hyperoxaluria
| 定义 = Increased excretion of  oxalates in the urine.
| 中文译名 = 高草酸尿症
| 中文定义 = 尿液中草酸盐的排泄增加。
}}


==[[HP:0003160]]==
{{Infobox HPO
| hpoId = HP:0003160
| 名称 = Abnormal isoelectric focusing of serum transferrin
| 定义 = Glycosylated transferrin concentrations can be measured in serum as a marker of N-linked glycosylation fidelity. In the traditional nomenclature for congenital disorders of glycosylation, absence of entire glycans was designated type I, and loss of one or more monosaccharides as type II. These terms are retained for historical reasons but for new annotations the precise glycosylation defect should be recorded.
| 中文译名 = 血清转铁蛋白的等电位聚焦异常
| 中文定义 = 糖基化转铁蛋白的浓度可作为N联糖基化保真度的标记物在血清中检测。在先天性糖基化缺陷病的传统命名法中，整个聚糖的缺失被命名为I型，一个或多个单糖的缺失被命名为II型。这些术语因历史原因被保留，但应记录新的注释作为对糖基化缺陷的精确注解。
}}


==[[HP:0003161]]==
{{Infobox HPO
| hpoId = HP:0003161
| 名称 = 4-Hydroxyphenylpyruvic aciduria
| 定义 = Increased concentration of `(4-hydroxyphenyl)pyruvic acid` (CHEBI:15999) in the urine.
| 中文译名 = 4-羟基苯丙酮酸尿症
| 中文定义 = 尿中4-羟基苯丙酮酸(CHEBI:15999)浓度升高。
}}


==[[HP:0003163]]==
{{Infobox HPO
| hpoId = HP:0003163
| 名称 = Elevated urinary delta-aminolevulinic acid
| 定义 = An increased concentration of 5-aminolevulinic acid (CHEBI:17549) in the `urine` (FMA:12274).
| 中文译名 = 尿δ-氨基乙酰丙酸水平升高
| 中文定义 = 在`urine`（FMA:12274）:将5-氨基乙酰丙酸（17549 CHEBI）的浓度增加。
}}


==[[HP:0003165]]==
{{Infobox HPO
| hpoId = HP:0003165
| 名称 = Elevated circulating parathyroid hormone (PTH) level
| 定义 = An abnormal increased concentration of parathyroid hormone.
| 中文译名 = 血甲状旁腺激素（PTH）水平升高
| 中文定义 = 血循环中甲状旁腺激素的浓度异常增加。
}}


==[[HP:0003166]]==
{{Infobox HPO
| hpoId = HP:0003166
| 名称 = Increased urinary taurine
| 定义 = Increased concentration of `taurine` (CHEBI:15891) in the `urine` (FMA:12274).
| 中文译名 = 尿牛磺酸增加
| 中文定义 = 尿液中牛磺酸浓度增加。
}}


==[[HP:0003167]]==
{{Infobox HPO
| hpoId = HP:0003167
| 名称 = Carnosinuria
| 定义 = An increased concentration of `carnosine` (CHEBI:15727) in the `urine` (FMA:12274).
| 中文译名 = 肌肽尿
| 中文定义 = 尿内肌肽浓度增加。
}}


==[[HP:0003168]]==
{{Infobox HPO
| hpoId = HP:0003168
| 名称 = Dibasicaminoaciduria
| 定义 = #####
| 中文译名 = 双碱基氨基酸尿
| 中文定义 = #####
}}


==[[HP:0003204]]==
{{Infobox HPO
| hpoId = HP:0003204
| 名称 = Intracellular accumulation of autofluorescent lipopigment storage material
| 定义 = The intracellular accumulation of autofluorescent storage material.
| 中文译名 = 自体荧光脂色素存物质的胞内堆积增加
| 中文定义 = 自发荧光存储材料的胞内积累。
}}

==[[HP:0003205]]==
{{Infobox HPO
| hpoId = HP:0003205
| 名称 = Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
| 定义 = An `intracellular accumulation of autofluorescent lipopigment storage material` (HP:0003204) in a `curved` (PATO:0000406) pattern.
| 中文译名 = 自体萤光脂色素存储物质的胞内曲线堆积
| 中文定义 = `自体荧光脂褐素存储物质的细胞内堆积`(HP:0003204)&#39;以一种`曲线`（PATO:0000406）模式。
}}


==[[HP:0003206]]==
{{Infobox HPO
| hpoId = HP:0003206
| 名称 = Decreased activity of NADPH oxidase
| 定义 = #####
| 中文译名 = NADPH氧化酶活性降低
| 中文定义 = #####
}}


==[[HP:0003208]]==
{{Infobox HPO
| hpoId = HP:0003208
| 名称 = Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
| 定义 = An `intracellular accumulation of autofluorescent lipopigment storage material` (HP:0003204) in a `trabecular` (PATO:0002121) or fingerprint-like pattern.
| 中文译名 = 自体萤光脂色素存储物质的细胞内堆积指纹谱
| 中文定义 = 在`trabecular`:萤光lipopigment存储material`（0003204 HP）的&#39;细胞内积累（PATO:0002121）或指纹状花纹。
}}


==[[HP:0003209]]==
{{Infobox HPO
| hpoId = HP:0003209
| 名称 = Decreased pyruvate carboxylase activity
| 定义 = A `decreased rate` (PATO:0000911) of `pyruvate carboxylase activity` (GO:0004736).
| 中文译名 = 丙酮酸羧化酶活性降低
| 中文定义 = 一个`下降rate`（PATO:0000911）`丙酮酸羧化酶activity`（:0004736 GO）的。
}}


==[[HP:0003210]]==
{{Infobox HPO
| hpoId = HP:0003210
| 名称 = Decreased methylmalonyl-CoA mutase activity
| 定义 = An `abnormality of Krebs cycle metabolism` (HP:0000816) that is characterized by a `decreased rate` (PATO:0000911) of `methylmalonyl-CoA mutase activity` (GO:0004494).
| 中文译名 = 甲基丙二酰辅酶A变位酶活性降低
| 中文定义 = 异常克雷布斯的`周期metabolism`（HP:0000816），其特征在于一个`降低rate`（PATO:0000911）`甲基丙二酰-CoA变位酶的activity`（GO:0004494）。
}}


==[[HP:0003212]]==
{{Infobox HPO
| hpoId = HP:0003212
| 名称 = Increased IgE level
| 定义 = An abnormally increased level of immunoglobulin E in blood.
| 中文译名 = IgE水平增加
| 中文定义 = 免疫球蛋白E在血液中异常。
}}


==[[HP:0003213]]==
{{Infobox HPO
| hpoId = HP:0003213
| 名称 = Deficient excision of UV-induced pyrimidine dimers in DNA
| 定义 = #####
| 中文译名 = 紫外线引起的DNA分子中嘧啶二聚体的切除缺陷
| 中文定义 = #####
}}


==[[HP:0003214]]==
{{Infobox HPO
| hpoId = HP:0003214
| 名称 = Prolonged G2 phase of cell cycle
| 定义 = #####
| 中文译名 = 细胞周期中G2期延长
| 中文定义 = #####
}}


==[[HP:0003215]]==
{{Infobox HPO
| hpoId = HP:0003215
| 名称 = Dicarboxylic aciduria
| 定义 = An increased concentration of `dicarboxylic acid` (CHEBI:35692) in the `urine` (FMA:12274).
| 中文译名 = 二羧酸尿症
| 中文定义 = 尿液中二羧酸浓度增加。
}}


==[[HP:0003216]]==
{{Infobox HPO
| hpoId = HP:0003216
| 名称 = Generalized amyloid deposition
| 定义 = A `diffuse` (PATO:0001513) form of `amyloidosis` (HP:0011034).
| 中文译名 = 淀粉样物质的广泛沉积
| 中文定义 = 一个`diffuse`（PATO:0001513）的`amyloidosis`形式（HP:0011034）。
}}


==[[HP:0003217]]==
{{Infobox HPO
| hpoId = HP:0003217
| 名称 = Hyperglutaminemia
| 定义 = An increased concentration of `glutamine` (CHEBI:28300) in the `blood` (FMA:9670).
| 中文译名 = 高谷氨酰胺血症
| 中文定义 = 在`blood`:`glutamine`（28300 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003218]]==
{{Infobox HPO
| hpoId = HP:0003218
| 名称 = Oroticaciduria
| 定义 = An increased concentration of `orotic acid` (CHEBI:16742) in the urine (FMA:12274).
| 中文译名 = 乳清酸尿症
| 中文定义 = 尿液中（FMA:12274）:`乳清acid`（16742 CHEBI）的浓度增加。
}}


==[[HP:0003219]]==
{{Infobox HPO
| hpoId = HP:0003219
| 名称 = Ethylmalonic aciduria
| 定义 = An increased concentration of `ethylmalonic acid` (CHEBI:741548) in the `urine` (FMA:12274).
| 中文译名 = 乙基丙二酸尿症
| 中文定义 = 尿液中乙基丙二酸浓度增加。
}}


==[[HP:0003220]]==
{{Infobox HPO
| hpoId = HP:0003220
| 名称 = Abnormality of chromosome stability
| 定义 = A type of chromosomal aberration characterized by an increased susceptibility to chromosomal breakage induced by treatment of cultured lymphocytes with agents such as chemical mutagens, irradiation, and alkylating agents.
| 中文译名 = 染色体稳定性异常
| 中文定义 = 染色体畸变的一种类型，其特征为，当使用如化学诱变剂，辐射，和烷基化剂来处理淋巴细胞培养液时诱导产生染色体断裂十，易感性增加。
}}


==[[HP:0003221]]==
{{Infobox HPO
| hpoId = HP:0003221
| 名称 = Chromosomal breakage induced by crosslinking agents
| 定义 = Increased amount of chromosomal breaks in cultured blood lymphocytes or other cells induced by treatment with DNA cross-linking agents such as diepoxybutane and mitomycin C.
| 中文译名 = 交联剂诱发的染色体断裂
| 中文定义 = 用DNA交联剂如二环氧丁烷和丝裂霉素C处理培养的血淋巴细胞或其它细胞时，染色体断裂的数量增加。
}}


==[[HP:0003223]]==
{{Infobox HPO
| hpoId = HP:0003223
| 名称 = Decreased methylcobalamin
| 定义 = Decreased concentration of `methylcobalamin` (CHEBI:28115). Methylcobalamin is a form of vitamin B12.
| 中文译名 = 甲基钴胺素减少
| 中文定义 = 下降`methylcobalamin`浓度（CHEBI:28115）。甲钴是维生素B12的一种形式。
}}


==[[HP:0003224]]==
{{Infobox HPO
| hpoId = HP:0003224
| 名称 = Increased cellular sensitivity to UV light
| 定义 = #####
| 中文译名 = 对紫外光的细胞敏感度增强
| 中文定义 = #####
}}


==[[HP:0003226]]==
{{Infobox HPO
| hpoId = HP:0003226
| 名称 = Rectilinear intracellular accumulation of autofluorescent lipopigment storage material
| 定义 = An `intracellular accumulation of autofluorescent lipopigment storage material` (HP:0003204) in a `straight` (PATO:0002180) or rectilinear pattern.
| 中文译名 = 自体萤光脂色素存储物质的直线性胞内堆积
| 中文定义 = 在`straight`（PATO:0002180）或直线图案:萤光lipopigment存储material`的&#39;细胞内积累（0003204 HP）。
}}

==[[HP:0003228]]==
{{Infobox HPO
| hpoId = HP:0003228
| 名称 = Hypernatremia
| 定义 = An abnormally increased `sodium` (CHEBI:29101) concentration in the blood.
| 中文译名 = 高钠血症
| 中文定义 = 异常增加`sodium`（CHEBI:29101）的浓度在血液中。
}}


==[[HP:0003231]]==
{{Infobox HPO
| hpoId = HP:0003231
| 名称 = Hypertyrosinemia
| 定义 = An increased concentration of `tyrosine` (CHEBI:18186) in the blood.
| 中文译名 = 高酪氨酸血症
| 中文定义 = 血液中的:`tyrosine`（18186 CHEBI）的浓度增加。
}}


==[[HP:0003232]]==
{{Infobox HPO
| hpoId = HP:0003232
| 名称 = Mitochondrial malic enzyme reduced
| 定义 = #####
| 中文译名 = 线粒体苹果酸酶减少
| 中文定义 = #####
}}


==[[HP:0003233]]==
{{Infobox HPO
| hpoId = HP:0003233
| 名称 = Hypoalphalipoproteinemia
| 定义 = An decreased concentration of `high-density lipoprotein cholesterol` (CHEBI:47775) in the `blood` (FMA:9670).
| 中文译名 = 低α-脂蛋白血症
| 中文定义 = 在`blood`（FMA:9670）:&#39;高密度脂蛋白cholesterol`（47775 CHEBI）的浓度降低。
}}


==[[HP:0003234]]==
{{Infobox HPO
| hpoId = HP:0003234
| 名称 = Decreased plasma carnitine
| 定义 = A decreased concentration of `carnitine` (CHEBI:17126) in the `blood` (FMA:9670).
| 中文译名 = 血浆肉碱降低
| 中文定义 = 在`blood`:`carnitine`（17126 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0003235]]==
{{Infobox HPO
| hpoId = HP:0003235
| 名称 = Hypermethioninemia
| 定义 = An increased concentration of `methionine` (CHEBI:16811) in the `blood` (FMA:9670).
| 中文译名 = 高甲硫胺酸血症
| 中文定义 = 在`blood`:`methionine`（16811 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003236]]==
{{Infobox HPO
| hpoId = HP:0003236
| 名称 = Elevated serum creatine phosphokinase
| 定义 = An elevation of the level of the enzyme creatine kinase (also known as creatine phosphokinase, CPK; EC 2.7.3.2) in the blood. CPK levels can be elevated in a number of clinical disorders such as myocardial infarction, rhabdomyolysis, and muscular dystrophy.
| 中文译名 = 血清肌酸磷酸激酶升高
| 中文定义 = 在血液中;所述酶肌酸激酶水平的正视（EC 2.7.3.2也称为肌酸磷酸，CPK）。 CPK水平可以在许多临床病症的升高，如心肌梗死，横纹肌溶解，和肌营养不良症。
}}


==[[HP:0003237]]==
{{Infobox HPO
| hpoId = HP:0003237
| 名称 = Increased IgG level
| 定义 = An abnormally increased level of immunoglobulin G in blood.
| 中文译名 = IgG水平升高
| 中文定义 = 免疫球蛋白G在血液中的水平异常升高。
}}


==[[HP:0003238]]==
{{Infobox HPO
| hpoId = HP:0003238
| 名称 = Hyperpepsinogenemia I
| 定义 = #####
| 中文译名 = 高胃蛋白酶原血症
| 中文定义 = #####
}}


==[[HP:0003239]]==
{{Infobox HPO
| hpoId = HP:0003239
| 名称 = Phosphoethanolaminuria
| 定义 = An increased concentration of ` phosphoethanolamine` (CHEBI:36711) in the `urine` (FMA:12274).
| 中文译名 = 磷酸乙醇胺尿症
| 中文定义 = 尿液中磷酸乙醇胺浓度增加。
}}


==[[HP:0003240]]==
{{Infobox HPO
| hpoId = HP:0003240
| 名称 = Increased phosphoribosylpyrophosphate (PRPP) synthetase
| 定义 = #####
| 中文译名 = 磷酸核糖焦磷酸（PRPP）合成酶增高
| 中文定义 = #####
}}


==[[HP:0003254]]==
{{Infobox HPO
| hpoId = HP:0003254
| 名称 = Abnormality of DNA repair
| 定义 = An abnormality of the process of `DNA repair` (GO:0006281), that is, of the process of restoring DNA after damage.
| 中文译名 = DNA修复异常
| 中文定义 = `DNA修复`（GO:0006281）过程中的异常，也就是DNA损坏后恢复的过程。
}}


==[[HP:0003258]]==
{{Infobox HPO
| hpoId = HP:0003258
| 名称 = Glyoxalase deficiency
| 定义 = #####
| 中文译名 = 乙二醛酶缺乏症
| 中文定义 = #####
}}


==[[HP:0003259]]==
{{Infobox HPO
| hpoId = HP:0003259
| 名称 = Elevated serum creatinine
| 定义 = An increased amount of `creatinine` (CHEBI:16737) in the `blood` (FMA:9670).
| 中文译名 = 血清肌酐水平升高
| 中文定义 = 在`blood`（FMA:9670）:中`creatinine`量增加（16737 CHEBI）。
}}


==[[HP:0003260]]==
{{Infobox HPO
| hpoId = HP:0003260
| 名称 = Hydroxyprolinemia
| 定义 = An increased concentration of `hydroxyproline` (CHEBI:18095) in the `blood` (FMA:9670).
| 中文译名 = 羟脯氨酸血症
| 中文定义 = 在`blood`:`hydroxyproline`（18095 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003261]]==
{{Infobox HPO
| hpoId = HP:0003261
| 名称 = Increased IgA level
| 定义 = An abnormally increased level of immunoglobulin A in blood.
| 中文译名 = IgA水平升高
| 中文定义 = 免疫球蛋白A在血液中异常升高。
}}


==[[HP:0003264]]==
{{Infobox HPO
| hpoId = HP:0003264
| 名称 = Deficiency of N-acetylglucosamine-1-phosphotransferase
| 定义 = #####
| 中文译名 = N-乙酰氨基葡萄糖胺-1-磷酸转移酶缺陷
| 中文定义 = #####
}}


==[[HP:0003265]]==
{{Infobox HPO
| hpoId = HP:0003265
| 名称 = Neonatal hyperbilirubinemia
| 定义 = A type of `hyperbilirubinemia` (HP:0002904) with `neonatal onset` (HP:0003623).
| 中文译名 = 新生儿高胆红素血症
| 中文定义 = A型`hyperbilirubinemia`（HP:0002904）与`新生儿onset`（HP:0003623）。
}}


==[[HP:0003267]]==
{{Infobox HPO
| hpoId = HP:0003267
| 名称 = Reduced orotidine 5-prime phosphate decarboxylase activity
| 定义 = An abnormal decrease in `orotidine 5&#39;-phosphate decarboxylase activity` (GO:0004590).
| 中文译名 = 乳清苷5&#39;磷酸苷脱羧酶活性降低
| 中文定义 = 在`乳清酸核苷5&#39;-磷酸脱羧酶activity`的异常降低（GO:0004590）。
}}


==[[HP:0003268]]==
{{Infobox HPO
| hpoId = HP:0003268
| 名称 = Argininuria
| 定义 = A increased concentration of `arginine` (CHEBI:29016) in the `urine` (FMA:12274).
| 中文译名 = 精氨酸尿
| 中文定义 = 尿中精氨酸浓度升高。
}}


==[[HP:0003281]]==
{{Infobox HPO
| hpoId = HP:0003281
| 名称 = Increased serum ferritin
| 定义 = Abnormal raised concentration of ferritin, a ubiquitous intracellular protein that stores iron, in the blood.
| 中文译名 = 血清铁蛋白增高
| 中文定义 = 铁蛋白的异常升高浓度，存储铁，在血液中普遍存在的细胞内蛋白质。
}}


==[[HP:0003282]]==
{{Infobox HPO
| hpoId = HP:0003282
| 名称 = Low alkaline phosphatase
| 定义 = Abnormally reduced serum levels of `alkaline phosphatase activity` (GO:0004035).
| 中文译名 = 低碱性磷酸酶
| 中文定义 = 异常减少`碱性磷酸酶activity`的血清水平（GO:0004035）。
}}


==[[HP:0003286]]==
{{Infobox HPO
| hpoId = HP:0003286
| 名称 = Cystathioninemia
| 定义 = An increased concentration of `cystathionine` (CHEBI:17755) in the `blood` (FMA:9670).
| 中文译名 = 胱硫醚血症
| 中文定义 = `血液`（FMA:9670）中`胱硫醚`(CHEBI:17755)浓度增加。
}}


==[[HP:0003287]]==
{{Infobox HPO
| hpoId = HP:0003287
| 名称 = Abnormality of mitochondrial metabolism
| 定义 = A functional anomaly of mitochondria.
| 中文译名 = 线粒体代谢异常
| 中文定义 = 线粒体的功能异常。
}}


==[[HP:0003288]]==
{{Infobox HPO
| hpoId = HP:0003288
| 名称 = Mitochondrial propionyl-CoA carboxylase (PCC) defect
| 定义 = #####
| 中文译名 = 线粒体丙酰辅酶A羧化酶（PCC）缺陷
| 中文定义 = #####
}}


==[[HP:0003296]]==
{{Infobox HPO
| hpoId = HP:0003296
| 名称 = Hyperthreoninuria
| 定义 = An increased concentration of `threonine` (CHEBI:26986) in the `urine` (FMA:12274).
| 中文译名 = 高苏氨酸尿
| 中文定义 = 尿液中苏氨酸浓度增加。
}}


==[[HP:0003297]]==
{{Infobox HPO
| hpoId = HP:0003297
| 名称 = Hyperlysinuria
| 定义 = An increased concentration of `lysine` (CHEBI:25094) in the blood.
| 中文译名 = 高赖氨酸尿症
| 中文定义 = 血液中的赖氨酸浓度增加。
}}


==[[HP:0003333]]==
{{Infobox HPO
| hpoId = HP:0003333
| 名称 = Increased serum beta-hexosaminidase
| 定义 = #####
| 中文译名 = 血清β-氨基己糖苷酶增高
| 中文定义 = #####
}}


==[[HP:0003343]]==
{{Infobox HPO
| hpoId = HP:0003343
| 名称 = Glutathione synthetase deficiency
| 定义 = #####
| 中文译名 = 谷胱甘肽合成酶缺乏症
| 中文定义 = #####
}}


==[[HP:0003344]]==
{{Infobox HPO
| hpoId = HP:0003344
| 名称 = 3-Methylglutaric aciduria
| 定义 = #####
| 中文译名 = 3-甲基戊二酸尿症
| 中文定义 = #####
}}


==[[HP:0003345]]==
{{Infobox HPO
| hpoId = HP:0003345
| 名称 = Elevated urinary norepinephrine
| 定义 = An increased concentration of `noradrenaline` (CHEBI:33569) in the `urine` (FMA:12274).
| 中文译名 = 尿去甲肾上腺素浓度增高
| 中文定义 = 尿液中去甲肾上腺素浓度增加。
}}


==[[HP:0003348]]==
{{Infobox HPO
| hpoId = HP:0003348
| 名称 = Hyperalaninemia
| 定义 = An increased concentration of `alanine` (CHEBI:16449) in the blood.
| 中文译名 = 高丙氨酸血症
| 中文定义 = 血液中的:`alanine`（16449 CHEBI）的浓度增加。
}}


==[[HP:0003349]]==
{{Infobox HPO
| hpoId = HP:0003349
| 名称 = Low cholesterol esterification rates
| 定义 = A reduction in the rate of `cholesterol esterification` (GO:0034435).
| 中文译名 = 低胆固醇酯化率
| 中文定义 = 在`胆固醇esterification`率的降低（GO:0034435）。
}}


==[[HP:0003352]]==
{{Infobox HPO
| hpoId = HP:0003352
| 名称 = Endopolyploidy on chromosome studies of bone marrow
| 定义 = An increase in the number of chromosome sets per cell in bone marrow cells.
| 中文译名 = 骨髓染色体的核内多倍性检查
| 中文定义 = 在骨髓细胞每细胞中染色体的数目增加设置。
}}


==[[HP:0003353]]==
{{Infobox HPO
| hpoId = HP:0003353
| 名称 = Propionyl-CoA carboxylase deficiency
| 定义 = An `abnormality of amino acid metabolism` (HP:0004337) characterized by a `decreased rate` (PATO:0000911) of `propionyl-CoA carboxylase activity` (GO:0004658).
| 中文译名 = 丙酰辅酶A羧化酶缺乏
| 中文定义 = 氨基酸metabolism`（HP:0004337）的&#39;异常特征是&#39;降低rate`（PATO:0000911）`丙酰辅酶A羧化酶activity`（:0004658 GO）的。
}}


==[[HP:0003354]]==
{{Infobox HPO
| hpoId = HP:0003354
| 名称 = Hyperthreoninemia
| 定义 = An increased concentration of `threonine` (CHEBI:26986) in the `blood` (FMA:9670).
| 中文译名 = 高苏氨酸血症
| 中文定义 = 在`blood`:`threonine`（26986 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003355]]==
{{Infobox HPO
| hpoId = HP:0003355
| 名称 = Aminoaciduria
| 定义 = An increased concentration of an `amino acid` (CHEBI:33709 ) in the `urine` (FMA:12274).
| 中文译名 = 氨基酸尿
| 中文定义 = 尿中氨基酸浓度增加。
}}


==[[HP:0003358]]==
{{Infobox HPO
| hpoId = HP:0003358
| 名称 = Elevated intracellular cystine
| 定义 = An increased concentration of `cystine` (CHEBI:17376) within cells. This finding can be demonstrated on leukocytes, but is not specific to blood cells.
| 中文译名 = 胞内胱氨酸浓度升高
| 中文定义 = 细胞内的:`cystine`（17376 CHEBI）的浓度增加。这一发现可表现出对白细胞，但不是特定于血细胞。
}}


==[[HP:0003359]]==
{{Infobox HPO
| hpoId = HP:0003359
| 名称 = Decreased urinary sulfate
| 定义 = Decreased concentration of `sulfate` (CHEBI:16189) in the urine.
| 中文译名 = 尿硫酸盐减少
| 中文定义 = 尿液中硫酸盐浓度降低。
}}


==[[HP:0003361]]==
{{Infobox HPO
| hpoId = HP:0003361
| 名称 = Tryptophanuria
| 定义 = An increased concentration of `tryptophan` (CHEBI:27897) in the urine.
| 中文译名 = 色氨酸尿症
| 中文定义 = 尿液中色氨酸浓度增加。
}}


==[[HP:0003362]]==
{{Infobox HPO
| hpoId = HP:0003362
| 名称 = Increased circulating very-low-density lipoprotein cholesterol
| 定义 = An increase in the amount of `very-low-density lipoprotein cholesterol` (CHEBI:47773) in the `blood` (FMA:9670).
| 中文译名 = 循环系统内的极低密度脂蛋白胆固醇浓度增高
| 中文定义 = 在`blood`（FMA:9670）:在`非常低密度脂蛋白cholesterol`（47773 CHEBI）的量的增加。
}}

==[[HP:0003451]]==
{{Infobox HPO
| hpoId = HP:0003451
| 名称 = Increased rate of premature chromosome condensation
| 定义 = An increased rate of `premature` (PATO:0000694) `chromosome condensation` (GO:0030261).
| 中文译名 = 早熟染色体凝缩率增高
| 中文定义 = 的`premature`率增加（PATO:0000694）`染色体condensation`（GO:0030261）。
}}


==[[HP:0003452]]==
{{Infobox HPO
| hpoId = HP:0003452
| 名称 = Increased serum iron
| 定义 = #####
| 中文译名 = 血清铁离子增高
| 中文定义 = #####
}}


==[[HP:0003455]]==
{{Infobox HPO
| hpoId = HP:0003455
| 名称 = Elevated long chain fatty acids
| 定义 = Increased concentration of `long-chain fatty acid` (CHEBI:15904).
| 中文译名 = 长链脂肪酸水平升高
| 中文定义 = `增加长链脂肪酸acid`（CHEBI:15904）的浓度。
}}


==[[HP:0003456]]==
{{Infobox HPO
| hpoId = HP:0003456
| 名称 = Low urinary cyclic AMP response to PTH administration
| 定义 = #####
| 中文译名 = 尿环腺苷酸对甲状旁腺素（PTH）治疗反应低下
| 中文定义 = #####
}}


==[[HP:0003459]]==
{{Infobox HPO
| hpoId = HP:0003459
| 名称 = Polyclonal elevation of IgM
| 定义 = #####
| 中文译名 = IgM抗体多克隆升高
| 中文定义 = #####
}}


==[[HP:0003460]]==
{{Infobox HPO
| hpoId = HP:0003460
| 名称 = Total immunoglobulin A deficiency
| 定义 = Undetectable serum immunoglobulin A level at a value &lt; 5 mg/dL (0.05 g/L).
| 中文译名 = 总免疫球蛋白A缺乏症
| 中文定义 = 检测不到血清免疫球蛋白A，水平值&lt;5毫克/分升（0.05克/升）。
}}


==[[HP:0003461]]==
{{Infobox HPO
| hpoId = HP:0003461
| 名称 = Increased urinary O-linked sialopeptides
| 定义 = Excretion of peptides conjugated to `sialic acid` (CHEBI:26667) in the urine.
| 中文译名 = 尿液唾液酸肽增加
| 中文定义 = 排泄肽偶联到&#39;唾液酸acid`（CHEBI:26667）的尿液。
}}


==[[HP:0003462]]==
{{Infobox HPO
| hpoId = HP:0003462
| 名称 = Elevated 8-dehydrocholesterol
| 定义 = #####
| 中文译名 = 8-脱氢胆固醇水平升高
| 中文定义 = #####
}}


==[[HP:0003464]]==
{{Infobox HPO
| hpoId = HP:0003464
| 名称 = Abnormal cholesterol homeostasis
| 定义 = #####
| 中文译名 = 胆固醇内稳态平衡异常
| 中文定义 = #####
}}

==[[HP:0003465]]==
{{Infobox HPO
| hpoId = HP:0003465
| 名称 = Elevated 8(9)-cholestenol
| 定义 = #####
| 中文译名 = 8（9）-胆甾烯醇水平升高
| 中文定义 = #####
}}


==[[HP:0003472]]==
{{Infobox HPO
| hpoId = HP:0003472
| 名称 = Hypocalcemic tetany
| 定义 = Hyperexcitability of the neuromuscular system related to abnormally low level of calcium in the blood, resulting in carpopedal or generalized spasms.
| 中文译名 = 低钙搐搦
| 中文定义 = 血液中钙水平异常减低相关的神经肌肉系统过度兴奋，从而导致手足搐搦或广泛痉挛。
}}


==[[HP:0003490]]==
{{Infobox HPO
| hpoId = HP:0003490
| 名称 = Defective dehydrogenation of isovaleryl CoA and butyryl CoA
| 定义 = #####
| 中文译名 = 异戊酰辅酶A和丁酰辅酶A的脱氢功能缺陷
| 中文定义 = #####
}}


==[[HP:0003491]]==
{{Infobox HPO
| hpoId = HP:0003491
| 名称 = Elevated urine pyrophosphate
| 定义 = An abnormally increased `diphosphate(4-)` (CHEBI:18361)  concentration in the `urine` (FMA:12274). Diphosphate(4-), as ester with two phosphate groups, is also known as pyrophosphate.
| 中文译名 = 尿焦磷酸增高
| 中文定义 = 尿液中二磷酸盐(4-)异常升高，二磷酸盐有两个磷酸基团，又称焦磷酸盐。
}}


==[[HP:0003495]]==
{{Infobox HPO
| hpoId = HP:0003495
| 名称 = GM2-ganglioside accumulation
| 定义 = #####
| 中文译名 = GM2神经节苷脂堆积
| 中文定义 = #####
}}


==[[HP:0003496]]==
{{Infobox HPO
| hpoId = HP:0003496
| 名称 = Increased IgM level
| 定义 = An abnormally increased level of immunoglobulin M in blood.
| 中文译名 = IgM水平升高
| 中文定义 = 免疫球蛋白M在血液中的异常水平升高。
}}

==[[HP:0003513]]==
{{Infobox HPO
| hpoId = HP:0003513
| 名称 = Reduced ratio of renal calcium clearance to creatinine clearance
| 定义 = A reduction of the ratio of  renal calcium clearance to creatinine clearance to below 0.01.
| 中文译名 = 肾钙清除与肌酐清除比率降低
| 中文定义 = 肾脏对钙清除与对肌酐清除的比率减少，低于0.01。
}}


==[[HP:0003514]]==
{{Infobox HPO
| hpoId = HP:0003514
| 名称 = Deficiency or absence of cytochrome b(-245)
| 定义 = #####
| 中文译名 = 细胞色素b（-245）缺乏或缺失
| 中文定义 = #####
}}


==[[HP:0003524]]==
{{Infobox HPO
| hpoId = HP:0003524
| 名称 = Decreased methionine synthase activity
| 定义 = A reduction in `methionine synthase activity` (GO:0008705).
| 中文译名 = 甲硫氨酸合成酶活性降低
| 中文定义 = 在`蛋氨酸合酶activity`的减少（GO:0008705）。
}}


==[[HP:0003526]]==
{{Infobox HPO
| hpoId = HP:0003526
| 名称 = Orotic acid crystalluria
| 定义 = Formation of crystals owing to an increased concentration of `orotic acid` (CHEBI:16742) in the urine (FMA:12274).
| 中文译名 = 乳清酸结晶尿症
| 中文定义 = 形成原因是`乳清acid`（CHEBI:16742）的浓度增加晶体中的尿液（FMA:12274）。
}}


==[[HP:0003527]]==
{{Infobox HPO
| hpoId = HP:0003527
| 名称 = Hyperprostaglandinuria
| 定义 = An increased concentration of `prostaglandin` (CHEBI:26333) in the urine.
| 中文译名 = 高前列腺素尿症
| 中文定义 = 在尿常规:`prostaglandin`（26333 CHEBI）的浓度增加。
}}


==[[HP:0003528]]==
{{Infobox HPO
| hpoId = HP:0003528
| 名称 = Elevated calcitonin
| 定义 = #####
| 中文译名 = 降钙素升高
| 中文定义 = #####
}}


==[[HP:0003529]]==
{{Infobox HPO
| hpoId = HP:0003529
| 名称 = Parathormone-independent increased renal tubular calcium reabsorption
| 定义 = An increase in the reabsorption of calcium by the renal tubulus that is not associated with increased parathormone levels.
| 中文译名 = 甲状旁腺激素非依赖性肾小管钙重吸收的增加
| 中文定义 = 肾小管对钙重吸收的增加，与甲状旁腺激素水平增加无关。
}}


==[[HP:0003530]]==
{{Infobox HPO
| hpoId = HP:0003530
| 名称 = Glutaric acidemia
| 定义 = An increased concentration of `glutaric acid` (CHEBI:17859) in the `blood` (FMA:9670).
| 中文译名 = 戊二酸血症
| 中文定义 = 在`blood`:`戊二acid`（17859 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0003532]]==
{{Infobox HPO
| hpoId = HP:0003532
| 名称 = Ornithinuria
| 定义 = An increased concentration of `ornithine` (CHEBI:18257) in the urine.
| 中文译名 = 鸟氨酸尿症
| 中文定义 = 尿液中鸟氨酸浓度增加。
}}


==[[HP:0003533]]==
{{Infobox HPO
| hpoId = HP:0003533
| 名称 = Delayed oxidation of acetaldehyde
| 定义 = #####
| 中文译名 = 乙醛氧化延迟
| 中文定义 = #####
}}


==[[HP:0003534]]==
{{Infobox HPO
| hpoId = HP:0003534
| 名称 = Reduced xanthine dehydrogenase activity
| 定义 = An abnormal reduction in `xanthine dehydrogenase activity` (GO:0004854).
| 中文译名 = 黄嘌呤脱氢酶活性降低
| 中文定义 = 在`黄嘌呤脱氢酶activity`异常减少（GO:0004854）。
}}


==[[HP:0003535]]==
{{Infobox HPO
| hpoId = HP:0003535
| 名称 = 3-Methylglutaconic aciduria
| 定义 = #####
| 中文译名 = 3-甲基戊烯二酸尿症
| 中文定义 = #####
}}

==[[HP:0003536]]==
{{Infobox HPO
| hpoId = HP:0003536
| 名称 = Decreased fumarate hydratase activity
| 定义 = An `abnormality of Krebs cycle metabolism` (HP:0000816) that is characterized by a `decreased rate` (PATO:0000911) of `fumarate hydratase activity` (GO:0004333).
| 中文译名 = 延胡索酸水解酶活性降低
| 中文定义 = 异常克雷布斯的`周期metabolism`（HP:0000816），其特征在于一个`降低rate`（PATO:0000911）的`富马酸盐水合酶activity`（GO:0004333）。
}}


==[[HP:0003537]]==
{{Infobox HPO
| hpoId = HP:0003537
| 名称 = Hypouricemia
| 定义 = An abnormally low level of uric acid in the blood.
| 中文译名 = 低尿酸血症
| 中文定义 = 尿酸在血液异常低的水平。
}}


==[[HP:0003538]]==
{{Infobox HPO
| hpoId = HP:0003538
| 名称 = Increased serum iduronate sulfatase activity
| 定义 = An `increased rate` (PATO:0000912) of `iduronate-2-sulfatase activity`(GO:0004423) in the `blood` (FMA:9670).
| 中文译名 = 血清艾杜糖醛硫酸酯酶活性增高
| 中文定义 = 一个`增加rate`（PATO:0000912）`艾杜糖醛酸-2-硫酸酯酶activity`的（GO:0004423）在`blood`（FMA:9670）。
}}


==[[HP:0003541]]==
{{Infobox HPO
| hpoId = HP:0003541
| 名称 = Urinary glycosaminoglycan excretion
| 定义 = Excretion of `glycosaminoglycan` (CHEBI:18085) in the `urine` (FMA:12274). Glycosaminoglycans are long unbranched polysaccharides consisting of a repeating disaccharide unit.
| 中文译名 = 糖胺聚糖尿排泄
| 中文定义 = 尿液中含糖胺聚糖。糖胺聚糖是长无支链的多糖，由重复的双糖单位组成。
}}

==[[HP:0003542]]==
{{Infobox HPO
| hpoId = HP:0003542
| 名称 = Increased serum pyruvate
| 定义 = An `increased concentration` (PATO:0001162) of `pyruvate` (CHEBI:15361) in the `blood` (FMA:9670).
| 中文译名 = 血清丙酮酸增高
| 中文定义 = 的`pyruvate`（CHEBI:15361）:一个`增加concentration`（0001162 PATO）在`blood`（FMA:9670）。
}}


==[[HP:0003550]]==
{{Infobox HPO
| hpoId = HP:0003550
| 名称 = Predominantly lower limb lymphedema
| 定义 = Localized fluid retention and tissue swelling caused by a compromised `lymphatic system` (FMA:7162), affecting mainly the legs.
| 中文译名 = 主要累及下肢的淋巴水肿
| 中文定义 = 局部水肿和组织肿胀引起的受损`淋巴system`（FMA:7162），主要影响的腿。
}}


==[[HP:0003563]]==
{{Infobox HPO
| hpoId = HP:0003563
| 名称 = Hypobetalipoproteinemia
| 定义 = An decreased concentration of `low-density lipoprotein cholesterol` (CHEBI:47774) in the `blood` (FMA:9670).
| 中文译名 = 低β-脂蛋白血症​​
| 中文定义 = 在`blood`（FMA:9670）:&#39;低密度脂蛋白cholesterol`（47774 CHEBI）的浓度降低。
}}


==[[HP:0003564]]==
{{Infobox HPO
| hpoId = HP:0003564
| 名称 = Folate-dependent fragile site at Xq28
| 定义 = The presence of a folate sensitive fragile site at chromosome Xq28.
| 中文译名 = 叶酸依赖性Xq28脆性位点
| 中文定义 = 在染色体Xq28叶酸敏感脆弱点的存在。
}}

==[[HP:0003565]]==
{{Infobox HPO
| hpoId = HP:0003565
| 名称 = Elevated erythrocyte sedimentation rate
| 定义 = #####
| 中文译名 = 红细胞沉降速度升高
| 中文定义 = #####
}}


==[[HP:0003566]]==
{{Infobox HPO
| hpoId = HP:0003566
| 名称 = Increased serum prostaglandin E2
| 定义 = An increased concentration of `prostaglandin E2` (CHEBI:15551) in the blood.
| 中文译名 = 血清前列腺素E2增高
| 中文定义 = 血液中的:`前列腺素E2`（15551 CHEBI）的浓度增加。
}}


==[[HP:0003568]]==
{{Infobox HPO
| hpoId = HP:0003568
| 名称 = Decreased glucosephosphate isomerase activity
| 定义 = A `decreased rate` (PATO:0000911) of `glucose-6-phosphate isomerase activity` (GO:0004347).
| 中文译名 = 葡萄糖磷酸异构酶活性降低
| 中文定义 = 一个`下降rate`（PATO:0000911）`葡萄糖-6-磷酸异构酶activity`（:0004347 GO）的。
}}


==[[HP:0003570]]==
{{Infobox HPO
| hpoId = HP:0003570
| 名称 = Molybdenum cofactor deficiency
| 定义 = Absence of `molybdenum cofactor(2-)` (CHEBI:60525), a cofactor for enzymes including sulfite oxidase, xanthine oxidoreductase, and aldehyde oxidase.
| 中文译名 = 钼辅助因子缺乏
| 中文定义 = `钼辅（2-）`（CHEBI:60525）的缺席，辅助因子的酶包括亚硫酸氧化酶，黄嘌呤氧化还原酶，醛氧化酶。
}}


==[[HP:0003571]]==
{{Infobox HPO
| hpoId = HP:0003571
| 名称 = Propionicacidemia
| 定义 = #####
| 中文译名 = 丙酸血症
| 中文定义 = #####
}}


==[[HP:0003572]]==
{{Infobox HPO
| hpoId = HP:0003572
| 名称 = Low plasma citrulline
| 定义 = A decreased concentration of `citrulline` (CHEBI:18211) in the `blood` (FMA:9670).
| 中文译名 = 低血浆瓜氨酸
| 中文定义 = 在`blood`:`citrulline`（18211 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0003573]]==
{{Infobox HPO
| hpoId = HP:0003573
| 名称 = Increased total bilirubin
| 定义 = Increased concentration of total (conjugated and unconjugated) bilirubin in the blood.
| 中文译名 = 总胆红素增加
| 中文定义 = 血液中的总（游离态和结合）胆红素浓度增高。
}}


==[[HP:0003575]]==
{{Infobox HPO
| hpoId = HP:0003575
| 名称 = Increased intracellular sodium
| 定义 = An abnormally increased `sodium` (CHEBI:29101) concentration in the `cytosol` (FMA:66836).
| 中文译名 = 细胞内钠离子浓度增高
| 中文定义 = 一个异常升高`sodium`（CHEBI:29101）的浓度在`cytosol`（FMA:66836）。
}}


==[[HP:0003606]]==
{{Infobox HPO
| hpoId = HP:0003606
| 名称 = Absent urinary urothione
| 定义 = Lack of urothione (the urinary metabolite of molybdenum cofactor) in the urine.
| 中文译名 = 尿硫蝶呤缺乏
| 中文定义 = 尿中缺乏尿硫蝶呤（钼的辅因子的尿代谢产物）。
}}


==[[HP:0003607]]==
{{Infobox HPO
| hpoId = HP:0003607
| 名称 = 4-Hydroxyphenylacetic aciduria
| 定义 = Increased concentration of `4-hydroxyphenylacetic acid` (CHEBI:18101) in the urine.
| 中文译名 = 4-羟基苯乙酸尿症
| 中文定义 = 尿中4-羟基苯乙酸(CHEBI:18101)浓度升高。
}}


==[[HP:0003610]]==
{{Infobox HPO
| hpoId = HP:0003610
| 名称 = Fibroblast metachromasia
| 定义 = Increased cytoplasmic staining of fibroblasts with toluidine blue.
| 中文译名 = 成纤维细胞异染
| 中文定义 = 成纤维细胞用甲苯胺蓝的增加细胞质染色。
}}


==[[HP:0003612]]==
{{Infobox HPO
| hpoId = HP:0003612
| 名称 = Positive ferric chloride test
| 定义 = If positive, the ferric chloride test indicates an increased concentration of phenols in the urine or blood.
| 中文译名 = 三氯化铁试验阳性
| 中文定义 = 如果正，氯化铁测试表明在尿或血液酚的浓度增加。
}}


==[[HP:0003614]]==
{{Infobox HPO
| hpoId = HP:0003614
| 名称 = Trimethylaminuria
| 定义 = Increased concentration of `trimethylamine` (CHEBI:18139) in the urine.
| 中文译名 = 三甲胺尿症
| 中文定义 = 尿液中三甲胺浓度增加。
}}


==[[HP:0003616]]==
{{Infobox HPO
| hpoId = HP:0003616
| 名称 = Premature separation of centromeric heterochromatin
| 定义 = #####
| 中文译名 = 着丝粒异染色质的过早分离
| 中文定义 = #####
}}


==[[HP:0003637]]==
{{Infobox HPO
| hpoId = HP:0003637
| 名称 = Reduced 4-Hydroxyphenylpyruvate dioxygenase activity
| 定义 = An abnormal reduction in `4-hydroxyphenylpyruvate dioxygenase activity` (GO:0003868).
| 中文译名 = 4-羟基苯丙酮酸双加氧酶活性降低&#39;
| 中文定义 = 在`4羟基苯基双加氧酶activity`异常减少（GO:0003868）。
}}


==[[HP:0003639]]==
{{Infobox HPO
| hpoId = HP:0003639
| 名称 = Elevated urinary epinephrine
| 定义 = An increased concentration of `adrenaline` (CHEBI:33568) in the `urine` (FMA:12274).
| 中文译名 = 尿肾上腺素增高
| 中文定义 = 尿液中肾上腺素浓度增加。
}}


==[[HP:0003641]]==
{{Infobox HPO
| hpoId = HP:0003641
| 名称 = Hemoglobinuria
| 定义 = The presence of free hemoglobin in the urine.
| 中文译名 = 血红蛋白尿
| 中文定义 = 尿液中存在游离血红蛋白。
}}


==[[HP:0003642]]==
{{Infobox HPO
| hpoId = HP:0003642
| 名称 = Type I transferrin isoform profile
| 定义 = Abnormal transferrin isoform profile consistent with a type I congenital disorder of glycosylation. In the traditional nomenclature for congenital disorders of glycosylation, absence of entire glycans was designated type I, and loss of one or more monosaccharides as type II.
| 中文译名 = I型转铁蛋白异构体谱
| 中文定义 = 异常转异构体配置文件与糖基化类型的我的先天性紊乱一致。在传统的命名法为先天性糖基化障碍，缺失整个聚糖被指定的I型，和一个或多个单糖的损失为II型。
}}


==[[HP:0003643]]==
{{Infobox HPO
| hpoId = HP:0003643
| 名称 = Sulfite oxidase deficiency
| 定义 = Abnormally reduced `sulfite oxidase activity` (GO:0008482).
| 中文译名 = 亚硫酸氧化酶缺乏症
| 中文定义 = 异常减少`亚硫酸氧化酶activity`（GO:0008482）。
}}


==[[HP:0003646]]==
{{Infobox HPO
| hpoId = HP:0003646
| 名称 = Bicarbonaturia
| 定义 = Abnormally increased concentration of `hydrogencarbonate` (CHEBI:17544) in the `urine` (FMA:12274).
| 中文译名 = 尿中碳酸氢盐增多
| 中文定义 = 尿中碳酸氢盐浓度异常增高。
}}


==[[HP:0003647]]==
{{Infobox HPO
| hpoId = HP:0003647
| 名称 = Electron transfer flavoprotein-ubiquinone oxidoreductase defect
| 定义 = #####
| 中文译名 = 电子传递黄素蛋白 - 泛醌氧化还原酶缺陷
| 中文定义 = #####
}}


==[[HP:0003648]]==
{{Infobox HPO
| hpoId = HP:0003648
| 名称 = Lacticaciduria
| 定义 = An increased concentration of `lactic acid` (CHEBI:28358) in the urine.
| 中文译名 = 乳酸血症
| 中文定义 = 尿液中乳酸的浓度异常升高。
}}


==[[HP:0003649]]==
{{Infobox HPO
| hpoId = HP:0003649
| 名称 = Abnormality of glycoside metabolism
| 定义 = Abnormality of `glycoside` (CHEBI:24400) metabolism.
| 中文译名 = 糖苷代谢异常
| 中文定义 = `糖苷`（CHEBI:24400）的代谢异常。
}}


==[[HP:0003652]]==
{{Infobox HPO
| hpoId = HP:0003652
| 名称 = Recurrent myoglobinuria
| 定义 = Recurring episodes of myoglobinuria, i.e., of the presence of myoglobin in the urine. This is usually a consequence of rhabdomyolysis, i.e., of the destruction of muscle tissue.
| 中文译名 = 复发性肌红蛋白尿
| 中文定义 = 复发的肌红蛋白尿，即尿液中反复出现肌红蛋白。这通常是横纹肌溶解症的结果，即肌肉组织的破坏。
}}


==[[HP:0003653]]==
{{Infobox HPO
| hpoId = HP:0003653
| 名称 = Cellular metachromasia
| 定义 = Metachromasia (also known as metachromacy) is a characteristic color change which certain aniline dyes exhibit when bound to particular substances or when concentrated in solution. For example, the basic dye toluidine blue becomes distinctly pink when bound to cartilage matrix. In the sense used here, the metachromasia refers to a change in color not observed with normal tissues, anomalous staining with the cationic dyes toluidine blue O and Alcian blue resulting from excessive amounts of the polyanionic glycosaminoglycans.
| 中文译名 = 细胞异染
| 中文定义 = 异染（也称为异染色）是颜色发生的一种特异性改变，发生在某些苯胺染料与特定的物质结合或在液体中浓缩时。例如，当碱性染料甲苯胺蓝与软骨基质结合时，颜色变成明显的粉红色。在这里特指，异染是指在正常组织中无法观察到颜色的变化，却非常规的用阳离子染料甲苯胺蓝O和阿尔新蓝染色，由于阴离子糖胺多糖糖胺过量所致的颜色改变。
}}


==[[HP:0003654]]==
{{Infobox HPO
| hpoId = HP:0003654
| 名称 = Reduced dihydropyrimidine dehydrogenase activity
| 定义 = An abnormal reduction in `dihydropyrimidine dehydrogenase (NADP+) activity` (GO:0017113).
| 中文译名 = 双氢嘧啶脱氢酶活性降低
| 中文定义 = 在`二氢脱氢酶（NADP +）activity`异常减少（GO:0017113）。
}}


==[[HP:0003655]]==
{{Infobox HPO
| hpoId = HP:0003655
| 名称 = Reduced activity of N-acetylglucosaminyltransferase II
| 定义 = An `abnormality of glycoprotein metabolism` (HP:0004367) related to a `decreased rate` (PATO:0000911) of `alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity` (GO:0008455).
| 中文译名 = N-乙酰氨基葡萄糖转移酶II活性降低
| 中文定义 = 糖蛋白metabolism`（HP:0004367）的`异常相关的`降低rate`（PATO:0000911）的`α-1,6- mannosylglycoprotein 2-β-N-二乙酰activity`（GO:0008455）。
}}


==[[HP:0003656]]==
{{Infobox HPO
| hpoId = HP:0003656
| 名称 = Decreased beta-glucocerebrosidase protein and activity
| 定义 = #####
| 中文译名 = β-葡萄糖脑苷脂酶蛋白和活性降低
| 中文定义 = #####
}}


==[[HP:0003657]]==
{{Infobox HPO
| hpoId = HP:0003657
| 名称 = Granular osmiophilic deposits (GROD) in cells
| 定义 = #####
| 中文译名 = 胞内嗜锇颗粒沉积
| 中文定义 = #####
}}


==[[HP:0003658]]==
{{Infobox HPO
| hpoId = HP:0003658
| 名称 = Hypomethioninemia
| 定义 = A decreased concentration of `methionine` (CHEBI:16811) in the `blood` (FMA:9670).
| 中文译名 = 低甲硫氨酸血症
| 中文定义 = 在`blood`:`methionine`（16811 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0004313]]==
{{Infobox HPO
| hpoId = HP:0004313
| 名称 = Hypogammaglobulinemia
| 定义 = An abnormally decreased level of immunoglobulin in blood.
| 中文译名 = 低丙球蛋白血症
| 中文定义 = 血液中异常降低的免疫球蛋白水平。
}}


==[[HP:0004315]]==
{{Infobox HPO
| hpoId = HP:0004315
| 名称 = IgG deficiency
| 定义 = An abnormally decreased level of immunoglobulin IgG in blood.
| 中文译名 = IgG抗体缺乏症
| 中文定义 = 免疫球蛋白IgG的水平降低。
}}


==[[HP:0004337]]==
{{Infobox HPO
| hpoId = HP:0004337
| 名称 = Abnormality of amino acid metabolism
| 定义 = Abnormality of an `amino acid metabolic process` (GO:0006520).
| 中文译名 = 氨基酸代谢异常
| 中文定义 = `氨基酸代谢过程`（GO:0006520）中的异常。
}}


==[[HP:0004338]]==
{{Infobox HPO
| hpoId = HP:0004338
| 名称 = Abnormality of aromatic amino acid family metabolism
| 定义 = An abnormality of a `aromatic amino acid family metabolic process` (GO:0009072).
| 中文译名 = 芳香氨基酸族代谢异常
| 中文定义 = `芳香氨基酸家族的代谢过程`（GO:0009072）的异常。
}}

==[[HP:0004339]]==
{{Infobox HPO
| hpoId = HP:0004339
| 名称 = Abnormality of sulfur amino acid metabolism
| 定义 = An abnormality of a `sulfur amino acid metabolic process` (GO:0000096).
| 中文译名 = 含硫氨基酸代谢异常
| 中文定义 = `含硫氨基酸的代谢过程`（GO:0000096）的异常。
}}


==[[HP:0004340]]==
{{Infobox HPO
| hpoId = HP:0004340
| 名称 = Abnormality of vitamin B metabolism
| 定义 = #####
| 中文译名 = 维生素B代谢异常
| 中文定义 = #####
}}


==[[HP:0004341]]==
{{Infobox HPO
| hpoId = HP:0004341
| 名称 = Abnormality of the vitamin B12 metabolism
| 定义 = #####
| 中文译名 = 维生素B12代谢异常
| 中文定义 = #####
}}


==[[HP:0004342]]==
{{Infobox HPO
| hpoId = HP:0004342
| 名称 = Abnormality of galactoside metabolism
| 定义 = Abnormality of `galactoside` (CHEBI:24163) metabolism.
| 中文译名 = 半乳糖代谢异常
| 中文定义 = `半乳糖`（CHEBI:24163）的代谢异常。
}}


==[[HP:0004343]]==
{{Infobox HPO
| hpoId = HP:0004343
| 名称 = Abnormality of glycosphingolipid metabolism
| 定义 = An abnormality of `glycosphingolipid` (CHEBI:24402) metabolism.
| 中文译名 = 鞘糖脂代谢异常
| 中文定义 = `鞘糖脂`（CHEBI:24402）的代谢异常。
}}


==[[HP:0004344]]==
{{Infobox HPO
| hpoId = HP:0004344
| 名称 = Abnormality of cerebrosidase metabolism
| 定义 = #####
| 中文译名 = 脑苷酶代谢异常
| 中文定义 = #####
}}


==[[HP:0004345]]==
{{Infobox HPO
| hpoId = HP:0004345
| 名称 = Abnormality of ganglioside metabolism
| 定义 = Abnormality of `ganglioside` (CHEBI:28892) metabolism.
| 中文译名 = 神经节苷脂代谢异常
| 中文定义 = `神经节苷脂 `（CHEBI:28892）的代谢异常。
}}


==[[HP:0004352]]==
{{Infobox HPO
| hpoId = HP:0004352
| 名称 = Abnormality of purine metabolism
| 定义 = #####
| 中文译名 = 嘌呤代谢异常
| 中文定义 = #####
}}


==[[HP:0004353]]==
{{Infobox HPO
| hpoId = HP:0004353
| 名称 = Abnormality of pyrimidine metabolism
| 定义 = An abnormality of a `pyrimidine base metabolic process` (GO:0006206).
| 中文译名 = 嘧啶代谢异常
| 中文定义 = `嘧啶碱代谢过程`（GO:0006206）的异常。
}}


==[[HP:0004354]]==
{{Infobox HPO
| hpoId = HP:0004354
| 名称 = Abnormality of carboxylic acid metabolism
| 定义 = An abnormality of the metabolism of a `carboxylic acid` (CHEBI:33575).
| 中文译名 = 羧酸代谢异常
| 中文定义 = `羧酸`（CHEBI:33575）的代谢异常。
}}


==[[HP:0004355]]==
{{Infobox HPO
| hpoId = HP:0004355
| 名称 = Abnormality of proteoglycan metabolism
| 定义 = An abnormality of `proteoglycan` (CHEBI:37396) metabolism.
| 中文译名 = 蛋白聚糖代谢异常
| 中文定义 = `蛋白聚糖`（CHEBI:37396）的代谢异常。
}}


==[[HP:0004356]]==
{{Infobox HPO
| hpoId = HP:0004356
| 名称 = Abnormality of lysosomal metabolism
| 定义 = #####
| 中文译名 = 溶酶体代谢异常
| 中文定义 = #####
}}


==[[HP:0004357]]==
{{Infobox HPO
| hpoId = HP:0004357
| 名称 = Abnormality of leucine metabolism
| 定义 = Abnormality of a `leucine metabolic process`(GO:0006551).
| 中文译名 = 亮氨酸代谢异常
| 中文定义 = `亮氨酸代谢过程`（GO:0006551）的异常。
}}


==[[HP:0004358]]==
{{Infobox HPO
| hpoId = HP:0004358
| 名称 = Abnormality of superoxide metabolism
| 定义 = #####
| 中文译名 = 过氧化物代谢异常
| 中文定义 = #####
}}


==[[HP:0004359]]==
{{Infobox HPO
| hpoId = HP:0004359
| 名称 = Abnormality of fatty-acid metabolism
| 定义 = An abnormality of `fatty acid` (CHEBI:35366) metabolism.
| 中文译名 = 脂肪酸代谢异常
| 中文定义 = `脂肪酸`（CHEBI:35366）的代谢异常。
}}

==[[HP:0004360]]==
{{Infobox HPO
| hpoId = HP:0004360
| 名称 = Abnormality of acid-base homeostasis
| 定义 = An abnormality of the balance or maintenance of the balance of acids and bases in bodily fluids, resulting in an abnormal pH.
| 中文译名 = 酸碱平衡异常
| 中文定义 = 体液内的酸和碱平衡失常，引起pH值的异常。
}}


==[[HP:0004363]]==
{{Infobox HPO
| hpoId = HP:0004363
| 名称 = Abnormality of calcium homeostasis
| 定义 = An abnormality of `calcium ion homeostasis` (GO:0055074).
| 中文译名 = 钙稳态平衡异常
| 中文定义 = `钙离子体内稳态平衡`（GO:0055074）的异常。
}}


==[[HP:0004364]]==
{{Infobox HPO
| hpoId = HP:0004364
| 名称 = Abnormality of nitrogen compound homeostasis
| 定义 = The presence of an abnormal concentration of `nitrogen compounds` (CHEBI:51143).
| 中文译名 = 氮化合物稳态平衡异常
| 中文定义 = 出现`氮化合物`（CHEBI:51143）浓度的异常。
}}


==[[HP:0004365]]==
{{Infobox HPO
| hpoId = HP:0004365
| 名称 = Abnormality of tryptophan metabolism
| 定义 = An abnormality of `tryptophan metabolic process` (GO:0006568).
| 中文译名 = 色氨酸代谢异常
| 中文定义 = `色氨酸代谢过程`（GO:0006568）的异常。
}}


==[[HP:0004366]]==
{{Infobox HPO
| hpoId = HP:0004366
| 名称 = Abnormality of glycolysis
| 定义 = An abnormality of `glycolysis` (GO:0006096).
| 中文译名 = 糖酵解异常
| 中文定义 = `糖酵解`（GO:0006096）的异常。
}}


==[[HP:0004367]]==
{{Infobox HPO
| hpoId = HP:0004367
| 名称 = Abnormality of glycoprotein metabolism
| 定义 = An abnormality of a `glycoprotein metabolic process` (GO:0009100).
| 中文译名 = 糖代谢异常
| 中文定义 = `糖代谢过程`（GO:0009100）的异常。
}}


==[[HP:0004368]]==
{{Infobox HPO
| hpoId = HP:0004368
| 名称 = Increased purine levels
| 定义 = #####
| 中文译名 = 嘌呤含量增加
| 中文定义 = #####
}}


==[[HP:0004369]]==
{{Infobox HPO
| hpoId = HP:0004369
| 名称 = Decreased purine levels
| 定义 = #####
| 中文译名 = 嘌呤含量降低
| 中文定义 = #####
}}


==[[HP:0004370]]==
{{Infobox HPO
| hpoId = HP:0004370
| 名称 = Abnormality of temperature regulation
| 定义 = An abnormality of `temperature homeostasis` (GO:0001659).
| 中文译名 = 体温调节异常
| 中文定义 = &#39;体内温度平衡`（GO:0001659）的异常。
}}


==[[HP:0004371]]==
{{Infobox HPO
| hpoId = HP:0004371
| 名称 = Abnormality of glycosaminoglycan metabolism
| 定义 = Abnormality of `glycosaminoglycan` (CHEBI:18085) metabolism.
| 中文译名 = 粘多糖代谢异常
| 中文定义 = `粘多糖`（CHEBI:18085）的代谢异常。
}}


==[[HP:0004379]]==
{{Infobox HPO
| hpoId = HP:0004379
| 名称 = Abnormality of alkaline phosphatase activity
| 定义 = An abnormality of `alkaline phosphatase activity` (GO:0004035).
| 中文译名 = 碱性磷酸酶活性异常
| 中文定义 = `碱性磷酸酶活性`（GO:0004035）的异常。
}}

==[[HP:0004432]]==
{{Infobox HPO
| hpoId = HP:0004432
| 名称 = Agammaglobulinemia
| 定义 = Absence or extremely low level of generally all classes of gamma-globulin in the blood.
| 中文译名 = 丙种球蛋白缺乏血症
| 中文定义 = 血γ-球蛋白缺乏或极少。
}}


==[[HP:0004433]]==
{{Infobox HPO
| hpoId = HP:0004433
| 名称 = Secretory IgA deficiency
| 定义 = Deficiency of secretory IgA (polymers of 2-4 IgA monomers are linked by two additional chains) and is the  primary antibody response at the mucosal level, where it forms immune complexes with pathogens and allergens.
| 中文译名 = 分泌型IgA缺乏症
| 中文定义 = 分泌型IgA缺乏（分泌型IgA缺乏:2-4 个IgA单体的聚合物，是由两个附加的链连接的）。分泌型IgA是位于粘膜的主要抗原，在那里形成的免疫复合物，并参与病原体和过敏原的初级应答。
}}


==[[HP:0004639]]==
{{Infobox HPO
| hpoId = HP:0004639
| 名称 = Elevated amniotic fluid alpha-fetoprotein
| 定义 = An elevation of alpha-feto protein measured in the amniotic fluid.
| 中文译名 = 羊水甲胎蛋白升高
| 中文定义 = 的α-胎儿蛋白在羊水测量的海拔。
}}


==[[HP:0004788]]==
{{Infobox HPO
| hpoId = HP:0004788
| 名称 = Intestinal lymphedema
| 定义 = Fluid retention and edema in the intestine caused by a compromised lymphatic system.
| 中文译名 = 肠道淋巴水肿
| 中文定义 = 淋巴系统受损引起的肠液体潴留和水肿。
}}


==[[HP:0004818]]==
{{Infobox HPO
| hpoId = HP:0004818
| 名称 = Paroxysmal nocturnal hemoglobinuria
| 定义 = #####
| 中文译名 = 阵发性睡眠性血红蛋白尿症
| 中文定义 = #####
}}


==[[HP:0004852]]==
{{Infobox HPO
| hpoId = HP:0004852
| 名称 = Reduced leukocyte alkaline phosphatase
| 定义 = A decreased alkaline phosphatase activity measured within leukocytes.
| 中文译名 = 白细胞碱性磷酸酶减少
| 中文定义 = 白细胞内测量降低碱性磷酸酶活性。
}}


==[[HP:0004897]]==
{{Infobox HPO
| hpoId = HP:0004897
| 名称 = Stress/infection-induced lactic acidosis
| 定义 = A form of `lactic acidemia` (HP:0003128) that occurs in relation to stress or infection.
| 中文译名 = 应激/感染诱发的乳酸酸中毒
| 中文定义 = 表单`乳酸acidemia`（HP:0003128）的发生有关压力或感染。
}}


==[[HP:0004898]]==
{{Infobox HPO
| hpoId = HP:0004898
| 名称 = Persistent lactic acidosis
| 定义 = A `continuous` (PATO:0000689) form of `lactic acidemia` (HP:0003128).
| 中文译名 = 持续性乳酸酸中毒
| 中文定义 = 一个`continuous`（PATO:0000689）的`乳酸acidemia`形式（HP:0003128）。
}}


==[[HP:0004900]]==
{{Infobox HPO
| hpoId = HP:0004900
| 名称 = Severe lactic acidosis
| 定义 = A `severe` (PATO:0000396) form of `lactic acidemia` (HP:0003128).
| 中文译名 = 重度乳酸酸中毒
| 中文定义 = 一个`severe`（PATO:0000396）的`乳酸acidemia`形式（HP:0003128）。
}}


==[[HP:0004901]]==
{{Infobox HPO
| hpoId = HP:0004901
| 名称 = Exercise-induced lactic acidemia
| 定义 = A form of `lactic acidemia` (HP:0003128) that occurs following exercise or exertion.
| 中文译名 = 运动诱发的乳酸血症
| 中文定义 = 表单`乳酸acidemia`（HP:0003128）中发生下列运动或劳累。
}}


==[[HP:0004902]]==
{{Infobox HPO
| hpoId = HP:0004902
| 名称 = Congenital lactic acidosis
| 定义 = A form of `lactic acidemia` (HP:0003128) with `congenital onset` (HP:0003577).
| 中文译名 = 先天性乳酸酸中毒
| 中文定义 = 一种`先天性发作`（HP:0003577）的`乳酸酸中毒`形式（HP:0003128）。
}}


==[[HP:0004904]]==
{{Infobox HPO
| hpoId = HP:0004904
| 名称 = Maturity-onset diabetes of the young
| 定义 = The term Maturity-onset diabetes of the young (MODY) was initially used for patients diagnosed with fasting hyperglycemia that could be treated without insulin for more than two years, where the initial diagnosis was made at a young age (under 25 years). Thus, MODY combines characteristics of type 1 diabetes (young age at diagnosis) and type 2 diabetes (less insulin dependence than type 1 diabetes). The term MODY is now most often used to refer to a group of monogenic diseases with these characteristics. Here, the term is used to describe hyperglycemia diagnosed at a young age with no or minor insulin dependency, no evidence of insulin resistence, and lack of evidence of autoimmune destruction of the beta cells.
| 中文译名 = 成年发病性青少年糖尿病
| 中文定义 = 青少年的成年发病性糖尿病（MODY）最初是用于描述有空腹高血糖症，而且可以不用胰岛素治疗两年以上的病人，而对这些病人的最初诊断是在年轻的时候做的（低于25岁）。因此，MODY结合了1型糖尿病（年轻的诊断时年龄）和2型糖尿病（比1型糖尿病较少的胰岛素依赖）的特点。术语MODY现在经常用来指一组具有如下特点的单基因疾病，即在年轻时确诊的高血糖症，没有胰岛素依赖或有轻微胰岛素依赖，没有胰岛素抵抗，并且缺乏β细胞自身免疫损伤的证据。
}}

==[[HP:0004905]]==
{{Infobox HPO
| hpoId = HP:0004905
| 名称 = Vitamin A deficiency
| 定义 = #####
| 中文译名 = 维生素A缺乏症
| 中文定义 = #####
}}


==[[HP:0004906]]==
{{Infobox HPO
| hpoId = HP:0004906
| 名称 = hypernatremic dehydration
| 定义 = #####
| 中文译名 = 高钠脱水
| 中文定义 = #####
}}


==[[HP:0004909]]==
{{Infobox HPO
| hpoId = HP:0004909
| 名称 = hypokalemic hypochloremic metabolic alkalosis
| 定义 = #####
| 中文译名 = 低钾低氯性代谢性碱中毒
| 中文定义 = #####
}}

==[[HP:0004910]]==
{{Infobox HPO
| hpoId = HP:0004910
| 名称 = Bicarbonate-wasting renal tubular acidosis
| 定义 = #####
| 中文译名 = 碳酸氢盐消耗性肾小管性酸中毒
| 中文定义 = #####
}}


==[[HP:0004911]]==
{{Infobox HPO
| hpoId = HP:0004911
| 名称 = Episodic metabolic acidosis
| 定义 = Repeated transient episodes of metabolic acidosis, that is, of the buildup of acid or depletion of base due to accumulation of metabolic acids.
| 中文译名 = 阵发性代谢性酸中毒
| 中文定义 = 代谢性酸中毒的反复发作短暂，即，酸或碱的消耗的堆积因的代谢酸积累。
}}


==[[HP:0004912]]==
{{Infobox HPO
| hpoId = HP:0004912
| 名称 = Hypophosphatemic rickets
| 定义 = #####
| 中文译名 = 低磷性佝偻病
| 中文定义 = #####
}}

==[[HP:0004913]]==
{{Infobox HPO
| hpoId = HP:0004913
| 名称 = Intermittent lactic acidemia
| 定义 = An `intermittent (discontinuous)` (PATO:0000690) form of `lactic acidemia` (HP:0003128).
| 中文译名 = 间歇性乳酸血症
| 中文定义 = 一个`间歇性（非连续）`（PATO:0000690）形式的&#39;乳酸acidemia`（HP:0003128）。
}}


==[[HP:0004914]]==
{{Infobox HPO
| hpoId = HP:0004914
| 名称 = Recurrent infantile hypoglycemia
| 定义 = `Recurrent` (PATO:0000427) episodes of `decreased concentration` (PATO:0001163) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670) occurring during the infantile period.
| 中文译名 = 婴儿反复发作性低血糖
| 中文定义 = `Recurrent`（PATO:0000427）在`blood`（FMA:9670）在婴幼儿时期发生的:对`glucose`（17234 CHEBI）发作`下降concentration`（0001163 PATO）。
}}


==[[HP:0004915]]==
{{Infobox HPO
| hpoId = HP:0004915
| 名称 = Impairment of galactose metabolism
| 定义 = An impairment of `galactose metabolism` (GO:0006012).
| 中文译名 = 半乳糖代谢障碍
| 中文定义 = `半乳糖metabolism`的资产减值（GO:0006012）。
}}


==[[HP:0004916]]==
{{Infobox HPO
| hpoId = HP:0004916
| 名称 = Generalized distal tubular acidosis
| 定义 = #####
| 中文译名 = 远端肾小管性酸中毒
| 中文定义 = #####
}}


==[[HP:0004918]]==
{{Infobox HPO
| hpoId = HP:0004918
| 名称 = hyperchloremic metabolic acidosis
| 定义 = #####
| 中文译名 = 高氯性代谢性酸中毒
| 中文定义 = #####
}}


==[[HP:0004919]]==
{{Infobox HPO
| hpoId = HP:0004919
| 名称 = Galactose intolerance
| 定义 = #####
| 中文译名 = 半乳糖不耐受
| 中文定义 = #####
}}


==[[HP:0004920]]==
{{Infobox HPO
| hpoId = HP:0004920
| 名称 = Phenylpyruvic acidemia
| 定义 = #####
| 中文译名 = 苯丙酮酸血症
| 中文定义 = #####
}}


==[[HP:0004921]]==
{{Infobox HPO
| hpoId = HP:0004921
| 名称 = Abnormality of magnesium homeostasis
| 定义 = An abnormality of `magnesium ion homeostasis` (GO:0010960).
| 中文译名 = 镁离子稳态平衡异常
| 中文定义 = `镁离子稳态平衡`（GO:0010960）的异常。
}}


==[[HP:0004922]]==
{{Infobox HPO
| hpoId = HP:0004922
| 名称 = Atypical hyperphenylalaninemia
| 定义 = #####
| 中文译名 = 非典型高苯丙氨酸血症
| 中文定义 = #####
}}


==[[HP:0004923]]==
{{Infobox HPO
| hpoId = HP:0004923
| 名称 = Hyperphenylalaninemia
| 定义 = An increased concentration of `L-phenylalanine` (CHEBI:17295) in the `blood` (FMA:9670).
| 中文译名 = 高苯丙氨酸血症
| 中文定义 = 在`blood`（FMA:9670）:`L-phenylalanine`（17295 CHEBI）的浓度增加。
}}


==[[HP:0004924]]==
{{Infobox HPO
| hpoId = HP:0004924
| 名称 = Abnormal oral glucose tolerance
| 定义 = A type of `Abnormal glucose tolerance` (HP:0001952) observed following administration of an oral bolus of glucose.
| 中文译名 = 口服葡萄糖耐量异常
| 中文定义 = &#39;葡萄糖耐量`（HP:0001952）异常的一种类型，可在口服大剂量葡萄糖后观察到。
}}


==[[HP:0004925]]==
{{Infobox HPO
| hpoId = HP:0004925
| 名称 = Chronic lactic acidosis
| 定义 = A `chronic` (PATO:0001863) form of `lactic acidemia` (HP:0003128).
| 中文译名 = 慢性乳酸酸中毒
| 中文定义 = &#39;乳酸血症`（HP:0003128）的一种`慢性`（PATO:0001863）形式。
}}


==[[HP:0005099]]==
{{Infobox HPO
| hpoId = HP:0005099
| 名称 = Severe hydrops fetalis
| 定义 = #####
| 中文译名 = 严重性胎儿水肿
| 中文定义 = #####
}}

==[[HP:0005225]]==
{{Infobox HPO
| hpoId = HP:0005225
| 名称 = Intestinal edema
| 定义 = Accumulation of cell free, noninflammatony fluid within the wall of the intestinal tract producing uniform thickening of the mucosal folds.
| 中文译名 = 肠道水肿
| 中文定义 = 肠道内无细胞的、非炎症的液体积累导致粘膜皱襞均匀增厚。
}}


==[[HP:0005354]]==
{{Infobox HPO
| hpoId = HP:0005354
| 名称 = Absent cellular immunity
| 定义 = #####
| 中文译名 = 细胞免疫缺陷
| 中文定义 = #####
}}


==[[HP:0005357]]==
{{Infobox HPO
| hpoId = HP:0005357
| 名称 = Defective B cell differentiation
| 定义 = #####
| 中文译名 = B细胞分化缺陷
| 中文定义 = #####
}}


==[[HP:0005372]]==
{{Infobox HPO
| hpoId = HP:0005372
| 名称 = Abnormality of B cell physiology
| 定义 = An abnormality of the physiological functioning of `B cells` (CL:0000236).
| 中文译名 = B细胞生理异常
| 中文定义 = B细胞（:0000236 CL）的生理功能的异常。
}}


==[[HP:0005384]]==
{{Infobox HPO
| hpoId = HP:0005384
| 名称 = Defective B cell activation
| 定义 = #####
| 中文译名 = B细胞激活缺陷
| 中文定义 = #####
}}


==[[HP:0005397]]==
{{Infobox HPO
| hpoId = HP:0005397
| 名称 = Exaggerated cellular immune processes
| 定义 = #####
| 中文译名 = 细胞免疫过程过度化
| 中文定义 = #####
}}

==[[HP:0005402]]==
{{Infobox HPO
| hpoId = HP:0005402
| 名称 = Primary T-lymphocyte immune abnormalities
| 定义 = #####
| 中文译名 = 原发性T淋巴细胞免疫异常
| 中文定义 = #####
}}


==[[HP:0005409]]==
{{Infobox HPO
| hpoId = HP:0005409
| 名称 = Markedly reduced T cell function
| 定义 = #####
| 中文译名 = T细胞功能显著降低
| 中文定义 = #####
}}

==[[HP:0005413]]==
{{Infobox HPO
| hpoId = HP:0005413
| 名称 = Increased alpha-globulin
| 定义 = #####
| 中文译名 = α-球蛋白增加
| 中文定义 = #####
}}


==[[HP:0005419]]==
{{Infobox HPO
| hpoId = HP:0005419
| 名称 = Decreased T cell activation
| 定义 = #####
| 中文译名 = T细胞活化性降低
| 中文定义 = #####
}}

==[[HP:0005424]]==
{{Infobox HPO
| hpoId = HP:0005424
| 名称 = Absent specific antibody response
| 定义 = #####
| 中文译名 = 特异性抗体应答缺失
| 中文定义 = #####
}}


==[[HP:0005432]]==
{{Infobox HPO
| hpoId = HP:0005432
| 名称 = Transient hypogammaglobulinemia of infancy
| 定义 = At birth, newborns are endowed with maternal antibodies. IgG production normally begins at the age of two months. A delay in recovery from this physiological hypogammaglobulinemia between the 3rd and the 6th month of life, and of recovery period between 18 and 36 months defines transient newborn hypogammaglobulinemia.
| 中文译名 = 婴儿短暂性低丙球蛋白血症
| 中文定义 = 出生时，新生儿携带母源抗体。 IgG的产生通常开始于出生后两个月。此处指暂时性新生儿低丙球蛋白血症常见于从出生后第三和第六个月之间。这种生理低丙球蛋白血症至18至36个月恢复。
}}

==[[HP:0005435]]==
{{Infobox HPO
| hpoId = HP:0005435
| 名称 = Impaired T cell function
| 定义 = #####
| 中文译名 = T细胞功能损害
| 中文定义 = #####
}}

==[[HP:0005479]]==
{{Infobox HPO
| hpoId = HP:0005479
| 名称 = IgE deficiency
| 定义 = An abnormally decreased level of immunoglobulin IgE in blood.
| 中文译名 = IgE缺乏
| 中文定义 = 免疫球蛋白IgE缺乏。
}}


==[[HP:0005508]]==
{{Infobox HPO
| hpoId = HP:0005508
| 名称 = Waldenstrom macroglobulinemia
| 定义 = A malignant monoclonal gammopathy characterized by a high level of an IgM monoclonal protein.
| 中文译名 = 华氏巨球蛋白血症
| 中文定义 = 一种恶性单克隆丙种球蛋白病，特征为高水平的IgM 蛋白单克隆异常增高。
}}


==[[HP:0005527]]==
{{Infobox HPO
| hpoId = HP:0005527
| 名称 = Reduced kininogen activity
| 定义 = Reduction in the amount of kininogen, which functions as a cofactor in the contact phase of the intrinsic blood coagulation cascade.
| 中文译名 = 激肽原活性降低
| 中文定义 = 激肽原的量减少，是内源性血液凝固级联中的一个辅助因子。
}}


==[[HP:0005559]]==
{{Infobox HPO
| hpoId = HP:0005559
| 名称 = Abnormality of the kinin-kallikrein system
| 定义 = #####
| 中文译名 = 激肽 - 激肽释放酶系统的异常
| 中文定义 = #####
}}


==[[HP:0005567]]==
{{Infobox HPO
| hpoId = HP:0005567
| 名称 = Renal magnesium wasting
| 定义 = High urine magnesium in the presence of hypomagnesemia.
| 中文译名 = 肾脏镁消耗
| 中文定义 = 尿液镁浓度增高，出现低镁血症。
}}


==[[HP:0005833]]==
{{Infobox HPO
| hpoId = HP:0005833
| 名称 = Joint swelling onset late infancy
| 定义 = #####
| 中文译名 = 婴儿后期关节肿胀
| 中文定义 = #####
}}


==[[HP:0005959]]==
{{Infobox HPO
| hpoId = HP:0005959
| 名称 = Impaired gluconeogenesis
| 定义 = An impairment of `gluconeogenesis` (GO:0006094).
| 中文译名 = 糖异生功能障碍
| 中文定义 = 的`gluconeogenesis`的减值（GO:0006094）。
}}


==[[HP:0005961]]==
{{Infobox HPO
| hpoId = HP:0005961
| 名称 = Hypoargininemia
| 定义 = A decreased concentration of `arginine` (CHEBI:29016) in the `blood` (FMA:9670).
| 中文译名 = 低精氨酸血症
| 中文定义 = 在`blood`:`arginine`（29016 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0005964]]==
{{Infobox HPO
| hpoId = HP:0005964
| 名称 = Intermittent hypothermia
| 定义 = Episodes of reduced body termperature.
| 中文译名 = 间歇性低体温
| 中文定义 = 降低体内termperature情节。
}}


==[[HP:0005967]]==
{{Infobox HPO
| hpoId = HP:0005967
| 名称 = Mixed respiratory and metabolic acidosis
| 定义 = #####
| 中文译名 = 混合性呼吸和代谢性酸中毒
| 中文定义 = #####
}}


==[[HP:0005968]]==
{{Infobox HPO
| hpoId = HP:0005968
| 名称 = Temperature instability
| 定义 = Disordered thermoregulation characterized by an impaired ability to maintain a balance between heat production and heat loss, with resulting instability of body temperature.
| 中文译名 = 体温不稳定
| 中文定义 = 无序体温调节特征的能力受损维持产热和损失之间的平衡，以得到的体温的不稳定性。
}}


==[[HP:0005972]]==
{{Infobox HPO
| hpoId = HP:0005972
| 名称 = Respiratory acidosis
| 定义 = Acidosis because of respiratory retention of carbon dioxide.
| 中文译名 = 呼吸性酸中毒
| 中文定义 = 因为二氧化碳呼吸保留的酸中毒。
}}


==[[HP:0005973]]==
{{Infobox HPO
| hpoId = HP:0005973
| 名称 = Fructose intolerance
| 定义 = #####
| 中文译名 = 果糖不耐受
| 中文定义 = #####
}}


==[[HP:0005974]]==
{{Infobox HPO
| hpoId = HP:0005974
| 名称 = Episodic ketoacidosis
| 定义 = Intermittent episodes of ketoacidosis.
| 中文译名 = 阵发性酸中毒
| 中文定义 = 酮症酸中毒的间歇性发作。
}}


==[[HP:0005976]]==
{{Infobox HPO
| hpoId = HP:0005976
| 名称 = Hyperkalemic metabolic acidosis
| 定义 = #####
| 中文译名 = 高钾代谢性酸中毒
| 中文定义 = #####
}}


==[[HP:0005977]]==
{{Infobox HPO
| hpoId = HP:0005977
| 名称 = Hypochloremic metabolic alkalosis
| 定义 = #####
| 中文译名 = 低氯性代谢性碱中毒
| 中文定义 = #####
}}


==[[HP:0005978]]==
{{Infobox HPO
| hpoId = HP:0005978
| 名称 = Type II diabetes mellitus
| 定义 = A type of diabetes mellitus initially characterized by insulin resistance and hyperinsulinemia and subsequently by glucose interolerance and hyperglycemia.
| 中文译名 = 2型糖尿病
| 中文定义 = 2型糖尿病的特征是最开始胰岛素抵抗和高胰岛素血症，随后葡萄糖不耐受和高血糖症。
}}


==[[HP:0005979]]==
{{Infobox HPO
| hpoId = HP:0005979
| 名称 = Metabolic ketoacidosis
| 定义 = #####
| 中文译名 = 代谢酮症酸中毒
| 中文定义 = #####
}}


==[[HP:0005982]]==
{{Infobox HPO
| hpoId = HP:0005982
| 名称 = Reduced phenylalanine hydroxylase activity
| 定义 = A reduction in `phenylalanine 4-monooxygenase activity` (GO:0004505).
| 中文译名 = 苯丙氨酸羟化酶活性降低
| 中文定义 = 在&#39;苯丙氨酸4 - 单加氧酶activity`的减少（GO:0004505）。
}}


==[[HP:0005984]]==
{{Infobox HPO
| hpoId = HP:0005984
| 名称 = Elevated maternal serum alpha-fetoprotein
| 定义 = An elevation of alpha-feto protein in the maternal serum.
| 中文译名 = 孕妇血清α-甲胎蛋白水平升高
| 中文定义 = 阿尔法 - 胎儿蛋白在母体血清升高。
}}


==[[HP:0006254]]==
{{Infobox HPO
| hpoId = HP:0006254
| 名称 = Elevated alpha-fetoprotein
| 定义 = An `increased concentration` (PATO:0001162) of `alpha-fetoprotein`(PRO:000003809).
| 中文译名 = α-甲胎蛋白升高
| 中文定义 = `字母fetoprotein`的:一个`增加concentration`（0001162 PATO）（PRO:000003809）。
}}


==[[HP:0006901]]==
{{Infobox HPO
| hpoId = HP:0006901
| 名称 = Impaired thermal sensitivity
| 定义 = #####
| 中文译名 = 热敏度受损
| 中文定义 = #####
}}


==[[HP:0006916]]==
{{Infobox HPO
| hpoId = HP:0006916
| 名称 = Intraaxonal accumulation of curvilinear autofluorescent lipopigment storage material
| 定义 = `Curvilinear intracellular accumulation of autofluorescent lipopigment storage material` (HP:0003205) within `axons` (GO:0030424).
| 中文译名 = 曲线性自体荧光脂色素存储物质的轴突内堆积增加
| 中文定义 = `萤光lipopigment存储material`的曲线细胞​​内积累（HP:0003205）中`axons`（GO:0030424）。
}}

==[[HP:0007430]]==
{{Infobox HPO
| hpoId = HP:0007430
| 名称 = Generalized edema
| 定义 = Generalized abnormal accumulation of fluid beneath the skin, or in one or more cavities of the body.
| 中文译名 = 广泛水肿
| 中文定义 = 广义流体的异常积聚的皮肤下，或在身体的一个或多个空腔。
}}


==[[HP:0007448]]==
{{Infobox HPO
| hpoId = HP:0007448
| 名称 = Hyperkeratosis over edematous areas
| 定义 = #####
| 中文译名 = 水肿伴角化过度
| 中文定义 = #####
}}


==[[HP:0007514]]==
{{Infobox HPO
| hpoId = HP:0007514
| 名称 = Edema of the dorsum of hands
| 定义 = An abnormal accumulation of fluid beneath the skin on the back of the hands.
| 中文译名 = 手背水肿
| 中文定义 = 流体对手背的皮肤下的异常积累。
}}


==[[HP:0007609]]==
{{Infobox HPO
| hpoId = HP:0007609
| 名称 = Hypoproteinemic edema
| 定义 = An abnormal accumulation of fluid beneath the skin, or in one or more cavities of the body because of decreased osmotic pressure of plasma (hypoproteinemia).
| 中文译名 = 低蛋白性水肿
| 中文定义 = 流体的皮肤，或者在身体的，因为一个或多个腔的下方的异常积累降低的血浆（低蛋白血症）渗透压。
}}


==[[HP:0008155]]==
{{Infobox HPO
| hpoId = HP:0008155
| 名称 = Mucopolysacchariduria
| 定义 = Excessive amounts of `mucopolysaccharide` (CHEBI:37395) in the `urine` (FMA:12274).
| 中文译名 = 粘多糖尿症
| 中文定义 = 尿液中粘多糖量超常。
}}


==[[HP:0008158]]==
{{Infobox HPO
| hpoId = HP:0008158
| 名称 = Hyperapobetalipoproteinemia
| 定义 = Hyperapobetalipoproteinemia is defined as the combination of a normal low density lipoprotein (LDL) cholesterol in the face of an increased LDL apolipoprotein B (apoB) protein.
| 中文译名 = 高β-载脂蛋白血症
| 中文定义 = Hyperapobetalipoproteine​​mia被定义为一个正常的低密度脂蛋白（LDL）中的胆固醇增加的LDL载脂蛋白B（apoB的）蛋白质的面的组合。
}}


==[[HP:0008160]]==
{{Infobox HPO
| hpoId = HP:0008160
| 名称 = 3-hydroxydicarboxylic aciduria
| 定义 = #####
| 中文译名 = 3羟基二羧酸尿症
| 中文定义 = #####
}}


==[[HP:0008161]]==
{{Infobox HPO
| hpoId = HP:0008161
| 名称 = Absent leukocyte alkaline phosphatase
| 定义 = A decrease in alkaline phosphatase activity measured within leukocytes below detectable levels .
| 中文译名 = 白细胞碱性磷酸酶缺失
| 中文定义 = 白细胞内测量到的碱性磷酸酶活性降低至可检测范围以下。
}}


==[[HP:0008162]]==
{{Infobox HPO
| hpoId = HP:0008162
| 名称 = Asymptomatic hyperammonemia
| 定义 = An increased concentration of `ammonia` (CHEBI:16134) in the `blood` (FMA:9670) not associated with symptoms such as encephalopathy.
| 中文译名 = 无症状高氨血症
| 中文定义 = `血液 `（FMA:9670）中`氨`（16134 CHEBI）的浓度增加，没有如脑病的症状。
}}


==[[HP:0008166]]==
{{Infobox HPO
| hpoId = HP:0008166
| 名称 = Decreased beta-galactosidase activity
| 定义 = Abnormally `decreased rate` (PATO:0000911) of `beta-galactosidase activity` (GO:0004565).
| 中文译名 = β-半乳糖苷酶活性降低
| 中文定义 = 异常`下降rate`（PATO:0000911）`β-半乳糖苷activity`（:0004565 GO）的。
}}


==[[HP:0008167]]==
{{Infobox HPO
| hpoId = HP:0008167
| 名称 = Very long chain fatty acid accumulation
| 定义 = #####
| 中文译名 = 极长链脂肪酸堆积
| 中文定义 = #####
}}


==[[HP:0008176]]==
{{Infobox HPO
| hpoId = HP:0008176
| 名称 = Neonatal unconjugated hyperbilirubinemia
| 定义 = #####
| 中文译名 = 新生儿高非结合胆红素血症
| 中文定义 = #####
}}


==[[HP:0008180]]==
{{Infobox HPO
| hpoId = HP:0008180
| 名称 = Mildly elevated creatine phosphokinase
| 定义 = #####
| 中文译名 = 肌酸磷酸激酶轻度升高
| 中文定义 = #####
}}


==[[HP:0008181]]==
{{Infobox HPO
| hpoId = HP:0008181
| 名称 = Abetalipoproteinemia
| 定义 = An absence of `low-density lipoprotein cholesterol` (CHEBI:47774) in the `blood` (FMA:9670).
| 中文译名 = 无β脂蛋白血症
| 中文定义 = 血中(FMA:9670)无”低密度低密度脂蛋白胆固醇” (CHEBI:47774)。
}}


==[[HP:0008189]]==
{{Infobox HPO
| hpoId = HP:0008189
| 名称 = Insulin insensitivity
| 定义 = `Decreased sensitivity toward` (PATO:0001550) `insulin` (PRO:000009054).
| 中文译名 = 胰岛素不敏感
| 中文定义 = `灵敏度降低toward`（PATO:0001550）`insulin`（PRO:000009054）。
}}


==[[HP:0008205]]==
{{Infobox HPO
| hpoId = HP:0008205
| 名称 = Insulin-dependent but ketosis-resistant diabetes
| 定义 = Ketosis-resistant diabetes is a synonym for type II diabetes. This term thus refers to a form of type II diabetes in which patients are dependent on insulin.
| 中文译名 = 胰岛素依赖性非酮症性糖尿病
| 中文定义 = 非酮症性糖尿病是2型糖尿病的同义词。因此，该术语是指2型糖尿病的一种形式，其患者依赖胰岛素治疗​​。
}}

==[[HP:0008230]]==
{{Infobox HPO
| hpoId = HP:0008230
| 名称 = Decreased testosterone in males
| 定义 = #####
| 中文译名 = 男性睾酮水平降低
| 中文定义 = #####
}}


==[[HP:0008250]]==
{{Infobox HPO
| hpoId = HP:0008250
| 名称 = Infantile hypercalcemia
| 定义 = #####
| 中文译名 = 婴儿高钙血症
| 中文定义 = #####
}}


==[[HP:0008255]]==
{{Infobox HPO
| hpoId = HP:0008255
| 名称 = Transient neonatal diabetes mellitus
| 定义 = #####
| 中文译名 = 新生儿短暂性糖尿病
| 中文定义 = #####
}}

==[[HP:0008265]]==
{{Infobox HPO
| hpoId = HP:0008265
| 名称 = Mitochondrial lysine transport defect
| 定义 = #####
| 中文译名 = 线粒体赖氨酸转运缺陷
| 中文定义 = #####
}}


==[[HP:0008273]]==
{{Infobox HPO
| hpoId = HP:0008273
| 名称 = Transient aminoaciduria
| 定义 = #####
| 中文译名 = 短暂性氨基酸尿
| 中文定义 = #####
}}

==[[HP:0008277]]==
{{Infobox HPO
| hpoId = HP:0008277
| 名称 = Abnormality of zinc homeostasis
| 定义 = An abnormality of `zinc ion homeostasis` (GO:0055069).
| 中文译名 = 锌离子稳态平衡异常
| 中文定义 = `锌离子稳态`的异常（GO:0055069）。
}}


==[[HP:0008279]]==
{{Infobox HPO
| hpoId = HP:0008279
| 名称 = Transient hyperlipidemia
| 定义 = #####
| 中文译名 = 短暂性高脂血症
| 中文定义 = #####
}}

==[[HP:0008281]]==
{{Infobox HPO
| hpoId = HP:0008281
| 名称 = Acute hyperammonemia
| 定义 = An increased concentration of `ammonia` (CHEBI:16134) in the `blood` (FMA:9670) with sudden onset.
| 中文译名 = 急性高氨血症
| 中文定义 = 因`血液`（FMA:9670）中`氨`(CHEBI:16134)的浓度增加而突然发病。
}}


==[[HP:0008282]]==
{{Infobox HPO
| hpoId = HP:0008282
| 名称 = Unconjugated hyperbilirubinemia
| 定义 = An increased amount of unconjugated (indirect) bilurubin in the blood.
| 中文译名 = 高非结合胆红素血症
| 中文定义 = 未缀合的（间接）bilurubin的血液中的量增加。
}}


==[[HP:0008283]]==
{{Infobox HPO
| hpoId = HP:0008283
| 名称 = Fasting hyperinsulinemia
| 定义 = An `increased concentration` (PATO:0001162) of `insulin` (PRO:000009054) in the `blood` (FMA:9670) in the fasting state, i.e., not as the response to food intake.
| 中文译名 = 空腹高胰岛素血症
| 中文定义 = 空腹状态下胰岛素水平升高，即不是由于机体进食后的反应升高。
}}


==[[HP:0008285]]==
{{Infobox HPO
| hpoId = HP:0008285
| 名称 = Transient hypophosphatemia
| 定义 = #####
| 中文译名 = 短暂性低磷血症
| 中文定义 = #####
}}

==[[HP:0008288]]==
{{Infobox HPO
| hpoId = HP:0008288
| 名称 = Nonketotic hyperglycinemia
| 定义 = #####
| 中文译名 = 非酮症性高甘氨酸血症
| 中文定义 = #####
}}


==[[HP:0008293]]==
{{Infobox HPO
| hpoId = HP:0008293
| 名称 = Long-chain dicarboxylic aciduria
| 定义 = #####
| 中文译名 = 长链二羧基酸尿症
| 中文定义 = #####
}}


==[[HP:0008297]]==
{{Infobox HPO
| hpoId = HP:0008297
| 名称 = Transient hyperphenylalaninemia
| 定义 = A condition of not having consistently high levels of phenylalanine in the blood but of experiencing temporary hyperphenylalaninemia following ingestion of large quantities of phenylalanine (for instance, following an oral loading test with  phenylalanine).
| 中文译名 = 短暂性高苯丙氨酸血症
| 中文定义 = 不具有在血液中持续高水平苯丙氨酸但遇到暂时血症下列大量苯丙氨酸摄取（例如，经与苯丙氨酸口服负荷试验）的条件。
}}


==[[HP:0008301]]==
{{Infobox HPO
| hpoId = HP:0008301
| 名称 = Dermatan sulfate excretion in urine
| 定义 = An `increased concentration` (PATO:0001162) of `dermatan sulfate` (CHEBI:18376) in the `urine` (FMA:12274).
| 中文译名 = 尿液中硫酸皮肤素排泄
| 中文定义 = 尿液中硫酸皮肤素浓度增加。。
}}


==[[HP:0008305]]==
{{Infobox HPO
| hpoId = HP:0008305
| 名称 = Exercise-induced myoglobinuria
| 定义 = Presence of `myoglobin` (CHEBI:7044)  in the urine following exercise.
| 中文译名 = 运动后肌红蛋白尿
| 中文定义 = 体育锻炼后尿液中出现肌红蛋白。
}}


==[[HP:0008306]]==
{{Infobox HPO
| hpoId = HP:0008306
| 名称 = Abnormal iron deposition in mitochondria
| 定义 = #####
| 中文译名 = 线粒体内铁沉积异常
| 中文定义 = #####
}}


==[[HP:0008309]]==
{{Infobox HPO
| hpoId = HP:0008309
| 名称 = Medium chain dicarboxylic aciduria
| 定义 = #####
| 中文译名 = 中链长二羧酸尿症
| 中文定义 = #####
}}

==[[HP:0008314]]==
{{Infobox HPO
| hpoId = HP:0008314
| 名称 = Decreased activity of mitochondrial complex II
| 定义 = A reduction in the activity of the `mitochondrial respiratory chain complex II` (GO:0005749), which is part of the electron transport chain in mitochondria.
| 中文译名 = 线粒体复合物II活性降低
| 中文定义 = 在`线粒体呼吸链复合物II`的活性的降低（GO:0005749），这是在线粒体中的电子传递链的一部分。
}}


==[[HP:0008315]]==
{{Infobox HPO
| hpoId = HP:0008315
| 名称 = Decreased plasma free carnitine
| 定义 = A decreased concentration of free (unbound) `carnitine` (CHEBI:17126) in the `blood` (FMA:9670).
| 中文译名 = 血浆游离肉碱降低
| 中文定义 = 在`blood`（FMA:9670）:自由（未绑定）`carnitine`（17126 CHEBI）的浓度降低。
}}


==[[HP:0008316]]==
{{Infobox HPO
| hpoId = HP:0008316
| 名称 = Abnormal mitochondria in muscle tissue
| 定义 = An abnormality of the mitochondria in muscle tissue.
| 中文译名 = 肌肉组织中的线粒体异常
| 中文定义 = 肌肉组织中的线粒体的一种异常。
}}


==[[HP:0008318]]==
{{Infobox HPO
| hpoId = HP:0008318
| 名称 = Elevated leukocyte alkaline phosphatase
| 定义 = An increased alkaline phosphatase activity measured within leukocytes.
| 中文译名 = 白细胞碱性磷酸酶活性升高
| 中文定义 = 白细胞内测量的增加的碱性磷酸酶活性。
}}


==[[HP:0008322]]==
{{Infobox HPO
| hpoId = HP:0008322
| 名称 = Abnormal mitochondrial morphology
| 定义 = Any structural anomaly of the mitochondria.
| 中文译名 = 线粒体形态异常
| 中文定义 = 线粒体的任何结构异常。
}}


==[[HP:0008326]]==
{{Infobox HPO
| hpoId = HP:0008326
| 名称 = Vitamin B6 deficiency
| 定义 = #####
| 中文译名 = 维生素B6缺乏症
| 中文定义 = #####
}}


==[[HP:0008331]]==
{{Infobox HPO
| hpoId = HP:0008331
| 名称 = Elevated creatine kinase after exercise
| 定义 = #####
| 中文译名 = 运动后肌酸激酶升高
| 中文定义 = #####
}}


==[[HP:0008335]]==
{{Infobox HPO
| hpoId = HP:0008335
| 名称 = Renal aminoaciduria
| 定义 = An increased concentration of an `amino acid` (CHEBI:33709 ) in the urine, due to a decreased kidney functionality .
| 中文译名 = 肾性氨基酸尿
| 中文定义 = 由于肾功能降低导致尿液中氨基酸浓度增加。
}}


==[[HP:0008336]]==
{{Infobox HPO
| hpoId = HP:0008336
| 名称 = Complex organic aciduria
| 定义 = #####
| 中文译名 = 复杂有机酸尿症
| 中文定义 = #####
}}

==[[HP:0008339]]==
{{Infobox HPO
| hpoId = HP:0008339
| 名称 = Diaminoaciduria
| 定义 = #####
| 中文译名 = 双氨基酸尿
| 中文定义 = #####
}}


==[[HP:0008341]]==
{{Infobox HPO
| hpoId = HP:0008341
| 名称 = Distal renal tubular acidosis
| 定义 = A type of renal tubular acidosis characterized by a failure of acid secretion by the alpha intercalated cells of the cortical collecting duct of the distal nephron. The urine cannot be acidified below a pH of 5.3, associated with acidemia and hypokalemia.
| 中文译名 = 远端肾小管性酸中毒
| 中文定义 = 一种肾小管酸中毒，由于远端肾小管α间细胞泌氢障碍，尿不能酸化至pH 5.3以下，发生酸血症和低钾血症。
}}


==[[HP:0008344]]==
{{Infobox HPO
| hpoId = HP:0008344
| 名称 = Elevated plasma branched chain amino acids
| 定义 = An increased concentration of a `branched chain amino acid` (CHEBI:22918) in the `blood` (FMA:9670).
| 中文译名 = 血浆支链氨基酸水平升高
| 中文定义 = 在`blood`（FMA:9670）:一个`支链氨基酸acid`（22918 CHEBI）的浓度增加。
}}


==[[HP:0008347]]==
{{Infobox HPO
| hpoId = HP:0008347
| 名称 = Decreased activity of mitochondrial complex IV
| 定义 = A reduction in the activity of the `mitochondrial respiratory chain complex IV` (GO:0005751), which is part of the electron transport chain in mitochondria.
| 中文译名 = 线粒体复合物IV活性降低
| 中文定义 = 在`线粒体呼吸链复合物IV`的活性的降低（GO:0005751），这是在线粒体中的电子传递链的一部分。
}}

==[[HP:0008348]]==
{{Infobox HPO
| hpoId = HP:0008348
| 名称 = Immunoglobulin IgG2 deficiency
| 定义 = A reduction in immunoglobulin levels of the IgG2 subclass.
| 中文译名 = 免疫球蛋白IgG2缺乏
| 中文定义 = IgG2亚类的免疫球蛋白水平的降低。
}}


==[[HP:0008353]]==
{{Infobox HPO
| hpoId = HP:0008353
| 名称 = Neutral hyperaminoaciduria
| 定义 = #####
| 中文译名 = 中性高氨基酸尿
| 中文定义 = #####
}}

==[[HP:0008356]]==
{{Infobox HPO
| hpoId = HP:0008356
| 名称 = Combined hyperlipidemia
| 定义 = #####
| 中文译名 = 混合性高脂血症
| 中文定义 = #####
}}

==[[HP:0008358]]==
{{Infobox HPO
| hpoId = HP:0008358
| 名称 = Hyperprolinemia
| 定义 = An increased concentration of `proline` (CHEBI:26271) in the `blood` (FMA:9670).
| 中文译名 = 高脯氨酸血症
| 中文定义 = 在`blood`:`proline`（26271 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0008360]]==
{{Infobox HPO
| hpoId = HP:0008360
| 名称 = Neonatal hypoproteinemia
| 定义 = A `neonatal` (PATO:0002206) `decreased concentration` (PATO:0001163) of `proteins` (CHEBI:36080) in the `blood` (FMA:9670).
| 中文译名 = 新生儿低蛋白血症
| 中文定义 = 一个`neonatal`（PATO:0002206）在`blood`（FMA:9670）`下降concentration`（PATO:0001163）的`proteins`（36080 CHEBI）。
}}


==[[HP:0008372]]==
{{Infobox HPO
| hpoId = HP:0008372
| 名称 = Abnormality of vitamin A metabolism
| 定义 = #####
| 中文译名 = 维生素A代谢异常
| 中文定义 = #####
}}


==[[HP:0008732]]==
{{Infobox HPO
| hpoId = HP:0008732
| 名称 = Renal hypophosphatemia
| 定义 = #####
| 中文译名 = 肾性低磷血症
| 中文定义 = #####
}}

==[[HP:0008972]]==
{{Infobox HPO
| hpoId = HP:0008972
| 名称 = Decreased activity of mitochondrial respiratory chain
| 定义 = Decreased activity of the `mitochondrial respiratory chain` (GO:0005746).
| 中文译名 = 线粒体呼吸链活性降低
| 中文定义 = 降低了&#39;线粒体呼吸chain`活动（GO:0005746）。
}}


==[[HP:0009800]]==
{{Infobox HPO
| hpoId = HP:0009800
| 名称 = Maternal diabetes
| 定义 = Maternal diabetes can either be a gestational, mostly type 2 diabetes, or a type 1 diabetes. Essential is the resulting maternal hyperglycemia as a non-specific teratogen, imposing the same risk of congenital malformations to pregnant women with both type 1 and type2 diabetes.
| 中文译名 = 母体糖尿病
| 中文定义 = 母体糖尿病是妊娠期的1型或2型糖尿病，2型最常见。本质是母体高血糖症是一种非特异性的致畸因素，对于孕妇来说不管是1型还是2型糖尿病都产生同样的先天性畸形的风险。
}}


==[[HP:0010310]]==
{{Infobox HPO
| hpoId = HP:0010310
| 名称 = Chylothorax
| 定义 = Accumulation of excessive amounts of lymphatic fluid (chyle) in the pleural cavity.
| 中文译名 = 乳糜胸
| 中文定义 = 胸膜腔淋巴积液（乳糜）过量积累
}}


==[[HP:0010471]]==
{{Infobox HPO
| hpoId = HP:0010471
| 名称 = Oligosacchariduria
| 定义 = Increased urinary excretion of `oligosaccharides` (CHEBI:50699) (low molecular weight carbohydrate chains composed of at least three monosaccharide subunits), derived from a partial degradation of glycoproteins.
| 中文译名 = 寡糖尿症
| 中文定义 = 的`oligosaccharides`（CHEBI:50699）增加尿中排泄量（至少三个单糖亚单位组成的低分子量的碳水化合物链），从糖蛋白的部分降解衍生。
}}


==[[HP:0010472]]==
{{Infobox HPO
| hpoId = HP:0010472
| 名称 = Abnormality of the heme biosynthetic pathway
| 定义 = An abnormality in the synthesis or catabolism of heme. Heme is composed of ferrous iron and protoporphyrin IX and is an essential molecule as the prosthetic group of hemeproteins such as hemoglobin, myoglobin, mitochondrial and microsomal cytochromes.
| 中文译名 = 血红素生物合成途径异常
| 中文定义 = 血红素的合成或降解的异常。血红素是由亚铁和原卟啉IX组成的,作为血红素蛋白,例如血红蛋白，肌红蛋白，线粒体和微粒体细胞色素的辅基成分,是一个重要的组分分子。
}}

==[[HP:0010473]]==
{{Infobox HPO
| hpoId = HP:0010473
| 名称 = Porphyrinuria
| 定义 = Abnormally increased excretion of `porphyrins` (CHEBI:26214) in the urine.
| 中文译名 = 卟啉尿症
| 中文定义 = 尿液中的:异常增加`porphyrins`（26214 CHEBI）的排泄。
}}


==[[HP:0010569]]==
{{Infobox HPO
| hpoId = HP:0010569
| 名称 = Elevated 7-dehydrocholesterol
| 定义 = Elevated `7-dehydrocholesterol` (CHEBI:17759) levels.
| 中文译名 = 7-脱氢胆固醇水平升高
| 中文定义 = 高架`7 dehydrocholesterol`（CHEBI:17759）的水平。
}}


==[[HP:0010571]]==
{{Infobox HPO
| hpoId = HP:0010571
| 名称 = Elevated levels of phytanic acid
| 定义 = An abnormal elevation of `phytanic acid` (CHEBI:16285).
| 中文译名 = 植烷酸水平升高
| 中文定义 = 的&#39;植烷acid`的异常升高（CHEBI:16285）。
}}


==[[HP:0010637]]==
{{Infobox HPO
| hpoId = HP:0010637
| 名称 = Conjunctival amyloidosis
| 定义 = A form of `amyloidosis` (HP:0011034) that affects the `conjunctiva` (FMA:59011).
| 中文译名 = 结膜淀粉样变性
| 中文定义 = 结膜上发生的淀粉样变性（HP:0011034）`（FMA:59011）。
}}


==[[HP:0010638]]==
{{Infobox HPO
| hpoId = HP:0010638
| 名称 = Elevated alkaline phosphatase of hepatic origin
| 定义 = An abnormally increased level of liver isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 肝源性碱性磷酸酶升高
| 中文定义 = （:000003968 PRO）在血液的异常增加`碱性磷酸酶，组织非特异性isozyme`肝同工型的水平。
}}


==[[HP:0010639]]==
{{Infobox HPO
| hpoId = HP:0010639
| 名称 = Elevated alkaline phosphatase of bone origin
| 定义 = An abnormally increased level of bone isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 骨源性碱性磷酸酶升高
| 中文定义 = （:000003968 PRO）在血液的异常增加`碱性磷酸酶，组织非特异性isozyme`的骨同种型的水平。
}}


==[[HP:0010679]]==
{{Infobox HPO
| hpoId = HP:0010679
| 名称 = Elevated tissue non-specific alkaline phosphatase
| 定义 = An abnormally increased level of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 组织非特异性碱性磷酸酶升高
| 中文定义 = （:000003968 PRO）在血液的异常增加的`碱性磷酸酶，组织非特异性isozyme`水平。
}}


==[[HP:0010680]]==
{{Infobox HPO
| hpoId = HP:0010680
| 名称 = Elevated alkaline phosphatase of renal origin
| 定义 = An abnormally increased level of kidney isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 肾源性碱性磷酸酶升高
| 中文定义 = 血液中肾型碱性磷酸酶组织非特异性同工酶水平异常增加。
}}


==[[HP:0010681]]==
{{Infobox HPO
| hpoId = HP:0010681
| 名称 = Elevated intestinal alkaline phosphatase
| 定义 = An abnormally increased level of `alkaline phosphatase, intestinal type` (PRO:000003964) in the blood.
| 中文译名 = 肠内碱性磷酸酶升高
| 中文定义 = （:000003964 PRO）在血液的异常增加的`碱性磷酸酶，肠type`水平。
}}


==[[HP:0010682]]==
{{Infobox HPO
| hpoId = HP:0010682
| 名称 = Elevated placental alkaline phosphatase
| 定义 = An abnormally increased level of `alkaline phosphatase, placental type` (PRO:000003969) in the blood.
| 中文译名 = 胎盘内碱性磷酸酶升高
| 中文定义 = （:000003969 PRO）在血液的异常增加的`碱性磷酸酶，胎盘type`水平。
}}


==[[HP:0010683]]==
{{Infobox HPO
| hpoId = HP:0010683
| 名称 = Low tissue non-specific alkaline phosphatase
| 定义 = An abnormally reduced level of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 组织非特异性碱性磷酸酶偏低
| 中文定义 = （:000003968 PRO）在血液的`碱性磷酸酶，组织非特异性isozyme`异常降低的水平。
}}

==[[HP:0010684]]==
{{Infobox HPO
| hpoId = HP:0010684
| 名称 = Low alkaline phosphatase of bone origin
| 定义 = An abnormally reduced level of bone isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 骨源性碱性磷酸酶偏低
| 中文定义 = （:000003968 PRO）在血液`碱性磷酸酶，组织非特异性isozyme`的骨同种型的异常降低的水平。
}}

==[[HP:0010685]]==
{{Infobox HPO
| hpoId = HP:0010685
| 名称 = Low alkaline phosphatase of renal origin
| 定义 = An abnormally reduced level of kidney isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 肾源性碱性磷酸酶偏低
| 中文定义 = 由于肾功能异常，血液中非组织特异性碱性磷酸酶低于正常水平。
}}


==[[HP:0010686]]==
{{Infobox HPO
| hpoId = HP:0010686
| 名称 = Low alkaline phosphatase of hepatic origin
| 定义 = An abnormally reduced level of liver isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood.
| 中文译名 = 肝源碱性磷酸酶偏低
| 中文定义 = （:000003968 PRO）在血液`碱性磷酸酶，组织非特异性isozyme`肝同种型的异常降低的水平。
}}

==[[HP:0010687]]==
{{Infobox HPO
| hpoId = HP:0010687
| 名称 = Low intestinal alkaline phosphatase
| 定义 = An abnormally reduced level of `alkaline phosphatase, intestinal type` (PRO:000003964) in the blood.
| 中文译名 = 肠内碱性磷酸酶偏低
| 中文定义 = （:000003964 PRO）在血液的`碱性磷酸酶，肠type`异常降低的水平。
}}

==[[HP:0010688]]==
{{Infobox HPO
| hpoId = HP:0010688
| 名称 = Low placental alkaline phosphatase
| 定义 = An abnormally reduced level of `alkaline phosphatase, placental type` (PRO:000003969) in the blood.
| 中文译名 = 胎盘内碱性磷酸酶偏低
| 中文定义 = （:000003969 PRO）在血液的`碱性磷酸酶，胎盘type`异常降低的水平。
}}

==[[HP:0010701]]==
{{Infobox HPO
| hpoId = HP:0010701
| 名称 = Abnormal immunoglobulin level
| 定义 = An abnormal deviation from normal levels of immunoglobulins in blood.
| 中文译名 = 免疫球蛋白水平异常
| 中文定义 = 血液中免疫球蛋白含量异常。
}}


==[[HP:0010702]]==
{{Infobox HPO
| hpoId = HP:0010702
| 名称 = Hypergammaglobulinemia
| 定义 = An increased level of gamma globulin (immunoglobulin) in the blood.
| 中文译名 = 球蛋白血症
| 中文定义 = 丙种球蛋白（免疫球蛋白）在血液中的水平增加。
}}


==[[HP:0010741]]==
{{Infobox HPO
| hpoId = HP:0010741
| 名称 = Edema of the lower limbs
| 定义 = An abnormal accumulation of fluid beneath the skin of the legs.
| 中文译名 = 下肢水肿
| 中文定义 = 流体的腿的皮肤下的异常积累。
}}


==[[HP:0010742]]==
{{Infobox HPO
| hpoId = HP:0010742
| 名称 = Edema of the upper limbs
| 定义 = An abnormal accumulation of fluid beneath the skin of the arms.
| 中文译名 = 上肢水肿
| 中文定义 = 流体的手臂皮肤之下的异常堆积。
}}


==[[HP:0010749]]==
{{Infobox HPO
| hpoId = HP:0010749
| 名称 = Blepharochalasis
| 定义 = Blepharochalasis is characterized by recurrent, non-painful, nonerythematous episodes of eyelid edema. It has been divided into hypertrophic and atrophic forms. In the hypertrophic form recurrent edema results in orbital fat herniation through a weakened orbital septum. Most patients who have blepharochalasis present in an atrophic condition with atrophy of redundant eyelid skin and superior nasal fat pads.
| 中文译名 = 眼皮松弛
| 中文定义 = 眼皮松弛的特征是复发性、非疼痛、非红肿的眼睑水肿发作。它被分成肥厚型和萎缩型。肥厚型反复水肿导致眼眶脂肪疝压迫穿透弱化的眶隔。大多数萎缩型眼皮松弛患者有萎缩的冗余眼睑皮肤和上鼻脂肪垫。
}}


==[[HP:0010836]]==
{{Infobox HPO
| hpoId = HP:0010836
| 名称 = Abnormality of copper homeostasis
| 定义 = An `abnormal` ( PATO:0000460) `concentration` (PATO:0000033) of `copper` (CHEBI:28694).
| 中文译名 = 铜稳态平衡异常
| 中文定义 = `异常`（PATO:0000460）的`铜`（CHEBI:28694）`浓度`（0000033 PATO）。
}}


==[[HP:0010837]]==
{{Infobox HPO
| hpoId = HP:0010837
| 名称 = Decreased serum ceruloplasmin
| 定义 = A kind of `Abnormality of copper homeostasis` (HP:0010836) related to a `decreased concentration` (PATO:0001163) of `ceruloplasmin` (PR:000005794) in the `blood` (FMA:9670).
| 中文译名 = 血清铜蓝蛋白降低
| 中文定义 = 一种&#39;铜homeostasis`异常（HP:0010836）中的`blood`（FMA:9670）:对`ceruloplasmin`（000005794 PR）相关的`下降concentration`（0001163 PATO）。
}}


==[[HP:0010838]]==
{{Infobox HPO
| hpoId = HP:0010838
| 名称 = High nonceruloplasmin-bound serum copper
| 定义 = An `increased concentration` (PATO:0001162) of non `ceruloplasmin` (PR:000005794) bound `copper` (CHEBI:28694) in the `blood` (FMA:9670).
| 中文译名 = 高浓度非铜蓝蛋白结合型血清铜离子
| 中文定义 = 非`ceruloplasmin`（PR:000005794）的约束`copper`（CHEBI:28694）在`blood`（FMA:9670）:一个`增加concentration`（0001162 PATO）。
}}


==[[HP:0010839]]==
{{Infobox HPO
| hpoId = HP:0010839
| 名称 = Increased urinary copper concentration
| 定义 = An `increased concentration` (PATO:0001162) of `copper` (CHEBI:28694) in the `urine` (FMA:12274).
| 中文译名 = 尿液铜浓度增高
| 中文定义 = 的`copper`（CHEBI:28694）:一个`增加concentration`（0001162 PATO）在`urine`（FMA:12274）。
}}


==[[HP:0010876]]==
{{Infobox HPO
| hpoId = HP:0010876
| 名称 = Abnormality of circulating protein level
| 定义 = An abnormal level of a circulating `protein` (CHEBI:16541) in the `blood` (FMA:9670).
| 中文译名 = 循环系统内的蛋白水平异常
| 中文定义 = `血液 `（FMA:9670）中循环`蛋白`(CHEBI:16541)的水平异常。
}}


==[[HP:0010878]]==
{{Infobox HPO
| hpoId = HP:0010878
| 名称 = Fetal cystic hygroma
| 定义 = The presence during the prenatal period of a cystic mass with multiple septa with multiple, asymmetric, thin-walled cysts near the posterior aspect of the neck. Fetal cystic hygroma can be defined as nuchal translucency with or without septations measuring greater than 3.0 mm.
| 中文译名 = 胎儿囊状水瘤
| 中文定义 = 产前期间出现，颈部后方附近的囊性包块，由多个隔片及多个不对称的薄壁包囊组成。胎囊状水瘤可以被定义为有或没有分隔的长度大于3毫米的颈部半透明物。
}}


==[[HP:0010880]]==
{{Infobox HPO
| hpoId = HP:0010880
| 名称 = Increased nuchal translucency
| 定义 = The presence of an abnormally large hypoechoic space in the posterior fetal neck (usually detected on prenatal ultrasound examination).
| 中文译名 = 颈部透明带厚度增加
| 中文定义 = 胎儿颈后皮下组织内的低回声层异常增厚（通常为产前超声检查项目）。
}}


==[[HP:0010892]]==
{{Infobox HPO
| hpoId = HP:0010892
| 名称 = Abnormality of branched chain family amino acid metabolism
| 定义 = Abnormality of a `branched chain family amino acid metabolic process` (GO:0009081).
| 中文译名 = 支链族氨基酸代谢异常
| 中文定义 = 支链族氨基酸代谢异常。
}}


==[[HP:0010893]]==
{{Infobox HPO
| hpoId = HP:0010893
| 名称 = Abnormality of phenylalanine metabolism
| 定义 = An abnormality of `L-phenylalanine metabolic process` (GO:0006558).
| 中文译名 = 苯丙氨酸代谢异常
| 中文定义 = ``左旋-苯丙氨酸代谢过程`（GO:0006558）的异常。
}}


==[[HP:0010894]]==
{{Infobox HPO
| hpoId = HP:0010894
| 名称 = Abnormality of serine family amino acid metabolism
| 定义 = An abnormality of a `serine family amino acid metabolic process` (GO:0009069).
| 中文译名 = 丝氨酸族氨基酸代谢异常
| 中文定义 = `丝氨酸族氨基酸代谢过程`（GO:0009069）的异常。
}}


==[[HP:0010895]]==
{{Infobox HPO
| hpoId = HP:0010895
| 名称 = Abnormality of glycine metabolism
| 定义 = An abnormality of a `glycine metabolic process` (GO:0006544).
| 中文译名 = 甘氨酸代谢异常
| 中文定义 = `甘氨酸代谢过程`（GO:0006544）的异常。
}}


==[[HP:0010896]]==
{{Infobox HPO
| hpoId = HP:0010896
| 名称 = Hypersarcosinemia
| 定义 = An elevated plasma concentration of `sarcosine` (CHEBI:15611).
| 中文译名 = 高肌氨酸血症
| 中文定义 = 的`sarcosine`升高血药浓度（CHEBI:15611）。
}}


==[[HP:0010897]]==
{{Infobox HPO
| hpoId = HP:0010897
| 名称 = Hypersarcosinuria
| 定义 = An elevated urinary concentration of `sarcosine` (CHEBI:15611).
| 中文译名 = 高肌氨酸尿症
| 中文定义 = 的`sarcosine`升高尿中浓度（CHEBI:15611）。
}}


==[[HP:0010898]]==
{{Infobox HPO
| hpoId = HP:0010898
| 名称 = Abnormality of sarcosine metabolism
| 定义 = An abnormality of the metabolism of `sarcosine` (CHEBI:15611).
| 中文译名 = 肌氨酸代谢异常
| 中文定义 = `肌氨酸`（CHEBI:15611）的代谢异常。
}}


==[[HP:0010899]]==
{{Infobox HPO
| hpoId = HP:0010899
| 名称 = Abnormality of aspartate family amino acid metabolism
| 定义 = Abnormality of a `aspartate family amino acid metabolic process` (GO:0009066).
| 中文译名 = 天冬氨酸族的氨基酸代谢异常
| 中文定义 = 天冬氨酸族的氨基酸代谢异常。
}}


==[[HP:0010900]]==
{{Infobox HPO
| hpoId = HP:0010900
| 名称 = Abnormality of threonine metabolism
| 定义 = Abnormality of a `threonine metabolic process` (GO:0006566).
| 中文译名 = 苏氨酸代谢异常
| 中文定义 = `苏氨酸代谢过程`（GO:0006566）的异常。
}}


==[[HP:0010901]]==
{{Infobox HPO
| hpoId = HP:0010901
| 名称 = Abnormality of methionine metabolism
| 定义 = An abnormality of `methionine metabolic process` (GO:0006555).
| 中文译名 = 甲硫氨酸代谢异常
| 中文定义 = `甲硫氨酸代谢过程`（GO:0006555）的异常。
}}


==[[HP:0010902]]==
{{Infobox HPO
| hpoId = HP:0010902
| 名称 = Abnormality of glutamine family amino acid metabolism
| 定义 = An abnormality of a `glutamine family amino acid metabolic process` (GO:0009064).
| 中文译名 = 谷氨酰胺族氨基酸代谢异常
| 中文定义 = `谷氨酰胺族氨基酸代谢过程`（GO:0009064）的异常。
}}


==[[HP:0010903]]==
{{Infobox HPO
| hpoId = HP:0010903
| 名称 = Abnormality of glutamine metabolism
| 定义 = An abnormality of a `glutamine metabolic process` (GO:0006541).
| 中文译名 = 谷氨酰胺代谢异常
| 中文定义 = `谷氨酰胺代谢过程`（GO:0006541）的异常。
}}


==[[HP:0010904]]==
{{Infobox HPO
| hpoId = HP:0010904
| 名称 = Abnormality of histidine family amino acid metabolism
| 定义 = An abnormality of a `histidine family amino acid metabolic process` (GO:0009075).
| 中文译名 = 组氨酸族氨基酸代谢异常
| 中文定义 = &#39;组氨酸族氨基酸代谢过程`（GO:0009075）的异常。
}}


==[[HP:0010906]]==
{{Infobox HPO
| hpoId = HP:0010906
| 名称 = Hyperhistidinemia
| 定义 = An increased concentration of `histidine` (CHEBI:27570) in the `blood` (FMA:9670).
| 中文译名 = 高组氨酸血症
| 中文定义 = 在`blood`:`histidine`（27570 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0010907]]==
{{Infobox HPO
| hpoId = HP:0010907
| 名称 = Abnormality of proline metabolism
| 定义 = An abnormality of a `proline metabolic process` (GO:0006560).
| 中文译名 = 脯氨酸代谢异常
| 中文定义 = `脯氨酸代谢过程`（GO:0006560）的异常。
}}


==[[HP:0010908]]==
{{Infobox HPO
| hpoId = HP:0010908
| 名称 = Abnormality of lysine metabolism
| 定义 = An abnormality of a `lysine metabolic process` (GO:0006553).
| 中文译名 = 赖氨酸代谢异常
| 中文定义 = `赖氨酸代谢过程`（GO:0006553）的异常。
}}


==[[HP:0010909]]==
{{Infobox HPO
| hpoId = HP:0010909
| 名称 = Abnormality of arginine metabolism
| 定义 = An abnormality of a `arginine metabolic process` (GO:0006525).
| 中文译名 = 精氨酸代谢异常
| 中文定义 = `精氨酸代谢过程`（GO:0006525）中的异常。
}}


==[[HP:0010910]]==
{{Infobox HPO
| hpoId = HP:0010910
| 名称 = Hypervalinemia
| 定义 = An increased concentration of `valine` (CHEBI:27266) in the `blood` (FMA:9670).
| 中文译名 = 高缬氨酸血症
| 中文定义 = 在`blood`:`valine`（27266 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0010911]]==
{{Infobox HPO
| hpoId = HP:0010911
| 名称 = Hyperleucinemia
| 定义 = An increased concentration of `leucine` (CHEBI:25017) in the blood.
| 中文译名 = 高亮氨酸血症
| 中文定义 = 血液中的:`leucine`（25017 CHEBI）的浓度增加。
}}


==[[HP:0010912]]==
{{Infobox HPO
| hpoId = HP:0010912
| 名称 = Abnormality of isoleucine metabolism
| 定义 = An abnormality of a `isoleucine metabolic process` (GO:0006549).
| 中文译名 = 异亮氨酸代谢异常
| 中文定义 = `异亮氨酸代谢过程`（GO:0006549）的异常。
}}


==[[HP:0010913]]==
{{Infobox HPO
| hpoId = HP:0010913
| 名称 = Hyperisoleucinemia
| 定义 = An increased concentration of `isoleucine` (CHEBI:24898) in the `blood` (FMA:9670).
| 中文译名 = 高异亮氨酸血症
| 中文定义 = 在`blood`:`isoleucine`（24898 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0010914]]==
{{Infobox HPO
| hpoId = HP:0010914
| 名称 = Abnormality of valine metabolism
| 定义 = An abnormality of a `valine metabolic process` (GO:0006573).
| 中文译名 = 缬氨酸代谢异常
| 中文定义 = `缬氨酸代谢过程`（GO:0006573）的异常。
}}


==[[HP:0010915]]==
{{Infobox HPO
| hpoId = HP:0010915
| 名称 = Abnormality of pyruvate family amino acid metabolism
| 定义 = An abnormality of a `pyruvate family amino acid metabolic process` (GO:0009078).
| 中文译名 = 丙酮酸族氨基酸代谢异常
| 中文定义 = `丙酮酸族氨基酸代谢过程`（GO:0009078）的异常。
}}


==[[HP:0010916]]==
{{Infobox HPO
| hpoId = HP:0010916
| 名称 = Abnormality of alanine metabolism
| 定义 = An abnormality of an `alanine metabolic process` (GO:0006522).
| 中文译名 = 丙氨酸代谢异常
| 中文定义 = `丙氨酸代谢过程`（GO:0006522）中的异常。
}}


==[[HP:0010917]]==
{{Infobox HPO
| hpoId = HP:0010917
| 名称 = Abnormality of tyrosine metabolism
| 定义 = An abnormality of a `tyrosine metabolic process` (GO:0006570).
| 中文译名 = 酪氨酸代谢异常
| 中文定义 = `酪氨酸代谢过程`（GO:0006570）的异常。
}}


==[[HP:0010918]]==
{{Infobox HPO
| hpoId = HP:0010918
| 名称 = Abnormality of cysteine metabolism
| 定义 = An abnormality of a `cysteine metabolic process` (GO:0006534).
| 中文译名 = 半胱氨酸代谢异常
| 中文定义 = `半胱氨酸代谢过程`（GO:0006534）的异常。
}}


==[[HP:0010919]]==
{{Infobox HPO
| hpoId = HP:0010919
| 名称 = Abnormality of homocysteine metabolism
| 定义 = An abnormality of a `homocysteine metabolic process` (GO:0050667).
| 中文译名 = 同型半胱氨酸代谢异常
| 中文定义 = &#39;同型半胱氨酸的代谢过程`（GO:0050667）的异常。
}}


==[[HP:0010927]]==
{{Infobox HPO
| hpoId = HP:0010927
| 名称 = Abnormality of divalent inorganic cation homeostasis
| 定义 = An abnormality of `divalent inorganic cation homeostasis` (GO:0072507).
| 中文译名 = 二价无机阳离子稳态平衡异常
| 中文定义 = `二价无机阳离子稳态平衡`（GO:0072507）的异常。
}}


==[[HP:0010928]]==
{{Infobox HPO
| hpoId = HP:0010928
| 名称 = Abnormality of orotic acid metabolism
| 定义 = An abnormality of the metabolism of `orotic acid` (CHEBI:16742).
| 中文译名 = 乳清酸代谢异常
| 中文定义 = `乳清酸`（CHEBI:16742）的代谢异常。
}}


==[[HP:0010929]]==
{{Infobox HPO
| hpoId = HP:0010929
| 名称 = Abnormality of cation homeostasis
| 定义 = An abnormality of `cation homeostasis` (GO:0055080).
| 中文译名 = 阳离子的稳态平衡异常
| 中文定义 = `阳离子体内稳态平衡`的异常（GO:0055080）。
}}


==[[HP:0010930]]==
{{Infobox HPO
| hpoId = HP:0010930
| 名称 = Abnormality of monovalent inorganic cation homeostasis
| 定义 = An abnormality of `monovalent inorganic cation homeostasis` (GO:0055067).
| 中文译名 = 单价无机阳离子稳态平衡异常
| 中文定义 = `单价无机阳离子稳态平衡`（GO:0055067）的异常。
}}


==[[HP:0010931]]==
{{Infobox HPO
| hpoId = HP:0010931
| 名称 = Abnormality of sodium homeostasis
| 定义 = An abnormal concentration of `sodium` (CHEBI:29101).
| 中文译名 = 钠离子稳态平衡异常
| 中文定义 = `钠离子 `（CHEBI:29101）浓度的异常。
}}


==[[HP:0010932]]==
{{Infobox HPO
| hpoId = HP:0010932
| 名称 = Abnormality of nucleobase metabolism
| 定义 = An abnormality of a `nucleobase metabolic process` (GO:0009112).
| 中文译名 = 核碱基代谢异常
| 中文定义 = `核碱基代谢过程`（GO:0009112）的异常。
}}


==[[HP:0010933]]==
{{Infobox HPO
| hpoId = HP:0010933
| 名称 = Abnormality of xanthine metabolism
| 定义 = An abnormality of a `xanthine metabolic process` (GO:0046110).
| 中文译名 = 黄嘌呤代谢异常
| 中文定义 = `黄嘌呤代谢过程`（GO:0046110）的异常。
}}


==[[HP:0010934]]==
{{Infobox HPO
| hpoId = HP:0010934
| 名称 = Xanthinuria
| 定义 = An increased concentration of `xanthine` (CHEBI:15318) in the `urine` (FMA:12274).
| 中文译名 = 黄嘌呤尿症
| 中文定义 = 在`urine`:`xanthine`（15318 CHEBI）浓度增加（FMA:12274）。
}}


==[[HP:0010964]]==
{{Infobox HPO
| hpoId = HP:0010964
| 名称 = Abnormality of long-chain fatty-acid metabolism
| 定义 = An abnormality of `long-chain fatty acid` (CHEBI:15904) metabolism.
| 中文译名 = 长链脂肪酸代谢异常
| 中文定义 = `长链脂肪酸`(CHEBI:15904)的代谢异常。
}}


==[[HP:0010965]]==
{{Infobox HPO
| hpoId = HP:0010965
| 名称 = Abnormality of phytanic acid metabolism
| 定义 = An abnormality of `phytanic acid` (CHEBI:16285) metabolism.
| 中文译名 = 植烷酸代谢异常
| 中文定义 = `植烷酸`（CHEBI:16285）的代谢异常。
}}


==[[HP:0010966]]==
{{Infobox HPO
| hpoId = HP:0010966
| 名称 = Abnormality of fatty-acid anion metabolism
| 定义 = An abnormality of `fatty acid anion` (CHEBI:28868) metabolism.
| 中文译名 = 脂肪酸阴离子代谢异常
| 中文定义 = `脂肪酸阴离子`（CHEBI:28868）的代谢异常。
}}


==[[HP:0010967]]==
{{Infobox HPO
| hpoId = HP:0010967
| 名称 = Abnormality of carnitine metabolism
| 定义 = An abnormality of `carnitine` (CHEBI:17126) metabolism.
| 中文译名 = 肉碱代谢异常
| 中文定义 = `肉碱 `（CHEBI:17126）的代谢异常。
}}


==[[HP:0010968]]==
{{Infobox HPO
| hpoId = HP:0010968
| 名称 = Abnormality of liposaccharide metabolism
| 定义 = An abnormality of `liposaccharide` (CHEBI:35740) metabolism.
| 中文译名 = 脂多糖代谢异常
| 中文定义 = `脂多糖`（CHEBI:35740）的代谢异常。
}}


==[[HP:0010969]]==
{{Infobox HPO
| hpoId = HP:0010969
| 名称 = Abnormality of glycolipid metabolism
| 定义 = An abnormality of `glycolipid` (CHEBI:33563) metabolism.
| 中文译名 = 糖脂代谢异常
| 中文定义 = `糖脂`（CHEBI:33563）的的代谢异常。
}}


==[[HP:0010979]]==
{{Infobox HPO
| hpoId = HP:0010979
| 名称 = Abnormality of the level of lipoprotein cholesterol
| 定义 = An abnormal increase or decrease in the level of `lipoprotein cholesterol` (CHEBI:50404) in the `blood` (FMA:9670).
| 中文译名 = 脂蛋白胆固醇水平的异常
| 中文定义 = `血液`（FMA:9670）中&#39;脂蛋白胆固醇`(CHEBI:50404)水平的异常增加或减少。
}}


==[[HP:0010980]]==
{{Infobox HPO
| hpoId = HP:0010980
| 名称 = Hyperlipoproteinemia
| 定义 = An abnormal increase in the level of `lipoprotein cholesterol` (CHEBI:50404) in the `blood` (FMA:9670).
| 中文译名 = 高脂蛋白血症
| 中文定义 = 在`blood`（FMA:9670）:在&#39;脂蛋白cholesterol`（50404 CHEBI）水平的异常增加。
}}


==[[HP:0010981]]==
{{Infobox HPO
| hpoId = HP:0010981
| 名称 = Hypolipoproteinemia
| 定义 = An abnormal decrease in the level of `lipoprotein cholesterol` (CHEBI:50404) in the `blood` (FMA:9670).
| 中文译名 = 低脂蛋白血症​​
| 中文定义 = 在`blood`（FMA:9670）:在&#39;脂蛋白cholesterol`（50404 CHEBI）水平的异常降低。
}}


==[[HP:0010995]]==
{{Infobox HPO
| hpoId = HP:0010995
| 名称 = Abnormality of dicarboxylic acid metabolism
| 定义 = An abnormality of `dicarboxylic acid` (CHEBI:35692) metabolism.
| 中文译名 = 二羧酸代谢异常
| 中文定义 = `二羧酸 ` (CHEBI:35692) 的代谢异常。
}}


==[[HP:0010996]]==
{{Infobox HPO
| hpoId = HP:0010996
| 名称 = Abnormality of monocarboxylic acid metabolism
| 定义 = An abnormality of `monocarboxylic acid` (CHEBI:25384) metabolism.
| 中文译名 = 一元羧酸代谢异常
| 中文定义 = `一元羧酸`（CHEBI:25384）的代谢异常。
}}


==[[HP:0010997]]==
{{Infobox HPO
| hpoId = HP:0010997
| 名称 = Chromosomal breakage induced by ionizing radiation
| 定义 = Increased amount of chromosomal breaks in cultured blood lymphocytes or other cells induced by treatment with ionizing radiation.
| 中文译名 = 电离辐射诱发的染色体断裂
| 中文定义 = 用电离辐射处理培养的血淋巴细胞或其它细胞时，染色体断裂的数量增加。
}}


==[[HP:0010998]]==
{{Infobox HPO
| hpoId = HP:0010998
| 名称 = Increased susceptibility to spontaneous sister chromatid exchange
| 定义 = An increase in the number of spontaneous sister chromatid exchanges observed in cell culture of lymphocytes or other cells.
| 中文译名 = 姐妹染色单体自发性交换的易发性增高
| 中文定义 = 在自发姐妹染色单体交换的次数的增加的淋巴细胞或其它细胞的细胞培养物观察到的。
}}


==[[HP:0011012]]==
{{Infobox HPO
| hpoId = HP:0011012
| 名称 = Abnormality of polysaccharide metabolism
| 定义 = An abnormality of the metabolism of `polysaccharide` (CHEBI:18154).
| 中文译名 = 多糖代谢异常
| 中文定义 = `多糖`（CHEBI:18154）的代谢异常。
}}


==[[HP:0011013]]==
{{Infobox HPO
| hpoId = HP:0011013
| 名称 = Abnormality of carbohydrate metabolism/homeostasis
| 定义 = An abnormality of the metabolism/homeostasis of a `carbohydrate` (CHEBI:23008).
| 中文译名 = 碳水化合物代谢/体内稳态平衡异常
| 中文定义 = `碳水化合物`(CHEBI:23008)的代谢/体内稳态平衡异常。
}}


==[[HP:0011014]]==
{{Infobox HPO
| hpoId = HP:0011014
| 名称 = Abnormal glucose homeostasis
| 定义 = Abnormality of `glucose homeostasis` (GO:0042593).
| 中文译名 = 葡萄糖内稳态平衡异常
| 中文定义 = 体内葡萄糖稳态平衡的异常（GO:0042593）。
}}

==[[HP:0011015]]==
{{Infobox HPO
| hpoId = HP:0011015
| 名称 = Abnormality of blood glucose concentration
| 定义 = An abnormality of the concentration of `glucose` (CHEBI:17234) in the `blood` (FMA:9670).
| 中文译名 = 血糖浓度异常
| 中文定义 = `血液`（FMA:9670）中`葡萄糖`（17234 CHEBI）的浓度异常。
}}


==[[HP:0011016]]==
{{Infobox HPO
| hpoId = HP:0011016
| 名称 = Abnormality of urine glucose concentration
| 定义 = An abnormality of the concentration of `glucose` (CHEBI:17234) in the `urine` (FMA:12274).
| 中文译名 = 尿中葡萄糖浓度异常
| 中文定义 = 尿中葡萄糖的浓度异常。
}}


==[[HP:0011017]]==
{{Infobox HPO
| hpoId = HP:0011017
| 名称 = Abnormality of cell physiology
| 定义 = An abnormality in a `cellular process` (GO:0009987).
| 中文译名 = 细胞生理异常
| 中文定义 = `细胞化过程 `（GO:0009987）中的异常。
}}


==[[HP:0011018]]==
{{Infobox HPO
| hpoId = HP:0011018
| 名称 = Abnormality of the cell cycle
| 定义 = An abnormality of the `cell cycle` (GO:0007049).
| 中文译名 = 细胞周期异常
| 中文定义 = 细胞周期`（GO:0007049）的异常。
}}


==[[HP:0011019]]==
{{Infobox HPO
| hpoId = HP:0011019
| 名称 = Abnormality of chromosome condensation
| 定义 = An abnormality of `chromosome condensation` (GO:0030261).
| 中文译名 = 染色体凝缩异常
| 中文定义 = `染色体凝缩`（GO:0030261）的异常。
}}


==[[HP:0011020]]==
{{Infobox HPO
| hpoId = HP:0011020
| 名称 = Abnormality of mucopolysaccharide metabolism
| 定义 = An abnormality of the metabolism of `mucopolysaccharide` (CHEBI:37395).
| 中文译名 = 粘多糖代谢异常
| 中文定义 = `粘多糖`（CHEBI:37395）的代谢异常。
}}


==[[HP:0011021]]==
{{Infobox HPO
| hpoId = HP:0011021
| 名称 = Abnormality of circulating enzyme level
| 定义 = #####
| 中文译名 = 循环系统内酶浓度水平异常
| 中文定义 = #####
}}

==[[HP:0011022]]==
{{Infobox HPO
| hpoId = HP:0011022
| 名称 = Abnormality of unsaturated fatty acid metabolism
| 定义 = An abnormality of `unsaturated fatty acid` (CHEBI:27208) metabolism.
| 中文译名 = 不饱和脂肪酸代谢异常
| 中文定义 = `不饱和脂肪酸`(CHEBI:27208)的代谢异常。
}}


==[[HP:0011023]]==
{{Infobox HPO
| hpoId = HP:0011023
| 名称 = Abnormality of prostaglandin metabolism
| 定义 = An abnormality of `prostaglandin` (CHEBI:26333) metabolism.
| 中文译名 = 前列腺素代谢异常
| 中文定义 = `前列腺素`（CHEBI:26333）的代谢异常。
}}


==[[HP:0011030]]==
{{Infobox HPO
| hpoId = HP:0011030
| 名称 = Abnormality of transition element cation homeostasis
| 定义 = An abnormality of the homeostasis (concentration) of `transition element cation` (CHEBI:33515).
| 中文译名 = 过渡元素阳离子稳态平衡异常
| 中文定义 = `过渡元素的阳离子`（CHEBI:33515）的内稳态平衡（浓度）的异常。
}}

==[[HP:0011031]]==
{{Infobox HPO
| hpoId = HP:0011031
| 名称 = Abnormality of iron homeostasis
| 定义 = An abnormality of the homeostasis (concentration) of `iron cation` (CHEBI:24875).
| 中文译名 = 铁紊乱
| 中文定义 = `铁阳离子`（CHEBI:24875）的内稳态平衡（浓度）异常。
}}


==[[HP:0011032]]==
{{Infobox HPO
| hpoId = HP:0011032
| 名称 = Abnormality of fluid regulation
| 定义 = An abnormality of the `regulation of body fluids` (GO:0050878).
| 中文译名 = 体液调节异常
| 中文定义 = `体内液体的调节`（GO:0050878）异常。
}}


==[[HP:0011033]]==
{{Infobox HPO
| hpoId = HP:0011033
| 名称 = Impairment of fructose metabolism
| 定义 = An impairment of a `fructose metabolic process` (GO:0006000).
| 中文译名 = 果糖代谢障碍
| 中文定义 = 一个`果糖代谢process`的资产减值（GO:0006000）。
}}


==[[HP:0011034]]==
{{Infobox HPO
| hpoId = HP:0011034
| 名称 = Amyloidosis
| 定义 = The presence of `amyloid deposition` (MPATH:34) in one or more tissues. Amyloidosis may be defined as the extracellular deposition of amyloid in one or more sites of the body.
| 中文译名 = 淀粉样变
| 中文定义 = 一个或多个组织内出现`淀粉样沉积`(MPATH:34)。淀粉样变可定义为淀粉样物质在体内一个或多个部位的胞外沉积。
}}


==[[HP:0011042]]==
{{Infobox HPO
| hpoId = HP:0011042
| 名称 = Abnormality of potassium homeostasis
| 定义 = An abnormal concentration of `potassium` (CHEBI:29103).
| 中文译名 = 钾离子稳态平衡异常
| 中文定义 = `钾离子`（CHEBI:29103）的浓度异常。
}}


==[[HP:0011133]]==
{{Infobox HPO
| hpoId = HP:0011133
| 名称 = Increased sensitivity to ionizing radiation
| 定义 = An abnormally increased sensitivity to the effects of ionizing radiation.
| 中文译名 = 电离辐射敏感性增强
| 中文定义 = 异常敏感性增加电离辐射的影响。
}}


==[[HP:0011134]]==
{{Infobox HPO
| hpoId = HP:0011134
| 名称 = Low-grade fever
| 定义 = Mild fever that does not exceed 38.5 degree centrigrade.
| 中文译名 = 低热
| 中文定义 = 轻微的发烧不超过38.5度centrigrade。
}}


==[[HP:0011227]]==
{{Infobox HPO
| hpoId = HP:0011227
| 名称 = Elevated C-reactive protein level
| 定义 = An abnormal elevation of the C-reactive protein level in serum.
| 中文译名 = C-反应蛋白水平升高
| 中文定义 = 在血清中的C反应蛋白水平的异常升高。
}}


==[[HP:0011279]]==
{{Infobox HPO
| hpoId = HP:0011279
| 名称 = Abnormality of urine bicarbonate concentration
| 定义 = An abnormality of the concentration of `hydrogencarbonate` (CHEBI:17544) in the `urine` (FMA:12274).
| 中文译名 = 尿中碳酸氢盐浓度异常
| 中文定义 = 尿液中碳酸氢盐的浓度异常。
}}


==[[HP:0011280]]==
{{Infobox HPO
| hpoId = HP:0011280
| 名称 = Abnormality of urine calcium concentration
| 定义 = An abnormality of `calcium` (CHEBI:29108) concentration in the urine (FMA:12274).
| 中文译名 = 尿钙浓度异常
| 中文定义 = 尿中钙离子浓度的异常。
}}


==[[HP:0011281]]==
{{Infobox HPO
| hpoId = HP:0011281
| 名称 = Abnormality of urine catecholamine concentration
| 定义 = An abnormal level of urinary `catecholamine` (CHEBI:33567) concentration.
| 中文译名 = 尿儿茶酚胺浓度异常
| 中文定义 = 尿儿茶酚胺的浓度异常。
}}


==[[HP:0011422]]==
{{Infobox HPO
| hpoId = HP:0011422
| 名称 = Abnormality of chloride homeostasis
| 定义 = An abnormality of `chloride` (CHEBI:17996 homeostasis or concentration in the body.
| 中文译名 = 氯稳态平衡异常
| 中文定义 = 体内`氯`(CHEBI:17996) 平衡稳态或或浓度的异常。
}}


==[[HP:0011423]]==
{{Infobox HPO
| hpoId = HP:0011423
| 名称 = Hyperchloremia
| 定义 = An abnormally increased `chloride` (CHEBI:17996) concentration in the blood.
| 中文译名 = 高氯血症
| 中文定义 = 异常增加`chloride`（CHEBI:17996）的浓度在血液中。
}}


==[[HP:0011424]]==
{{Infobox HPO
| hpoId = HP:0011424
| 名称 = Increased serum zinc
| 定义 = An increased consentration of zinc in the `blood` (FMA:9670).
| 中文译名 = 血清锌含量增高
| 中文定义 = 锌在`blood`增加consentration（FMA:9670）。
}}


==[[HP:0011505]]==
{{Infobox HPO
| hpoId = HP:0011505
| 名称 = Cystoid macular edema
| 定义 = Cystoid macular edema (CME) is any type of macular edema that involves cyst formation.
| 中文译名 = 囊样黄斑水肿
| 中文定义 = 黄斑囊样水肿（CME）是任何类型的黄斑水肿，涉及囊肿形成。
}}


==[[HP:0011814]]==
{{Infobox HPO
| hpoId = HP:0011814
| 名称 = Increased urinary hypoxanthine
| 定义 = An increased level of `hypoxanthine` (CHEBI:17368) in the `urine` (FMA:12274).
| 中文译名 = 尿次黄嘌呤增高
| 中文定义 = 在`urine`（FMA:12274）的`hypoxanthine`水平升高（17368 CHEBI）。
}}


==[[HP:0011837]]==
{{Infobox HPO
| hpoId = HP:0011837
| 名称 = Partial IgA deficiency
| 定义 = Detectable but decreased IgA levels that are more than 2 standard deviations below normal age-adjusted means.
| 中文译名 = 部分IgA缺乏
| 中文定义 = 可低于IgA同年龄段正常值水平但超过2个标准差。
}}


==[[HP:0011840]]==
{{Infobox HPO
| hpoId = HP:0011840
| 名称 = Abnormality of T cell physiology
| 定义 = A deviation from the normal count of `T cells` (CL:0000084).
| 中文译名 = T细胞生理异常
| 中文定义 = 异常的T细胞（:0000084 CL）计数。
}}


==[[HP:0011855]]==
{{Infobox HPO
| hpoId = HP:0011855
| 名称 = Pharyngeal edema
| 定义 = Abnormal accumulation of fluid leading to swelling of the pharynx.
| 中文译名 = 咽部水肿
| 中文定义 = 液体异常积聚导致咽肿胀。
}}


==[[HP:0011864]]==
{{Infobox HPO
| hpoId = HP:0011864
| 名称 = Elevated plasma pyrophosphate
| 定义 = An abnormally increased `diphosphate(4-)` (CHEBI:18361)  concentration in the `blood` (FMA:9670). Diphosphate(4-), as ester with two phosphate groups, is also known as pyrophosphate.
| 中文译名 = 血浆焦磷酸盐升高
| 中文定义 = 一个异常升高`二磷酸（4-）`（CHEBI:18361）在`blood`浓度（FMA:9670）。二磷酸（4-），如酯具有两个磷酸基团，也被称为焦磷酸。
}}


==[[HP:0011892]]==
{{Infobox HPO
| hpoId = HP:0011892
| 名称 = Vitamin K deficiency
| 定义 = #####
| 中文译名 = 维生素K缺乏症
| 中文定义 = #####
}}


==[[HP:0011919]]==
{{Infobox HPO
| hpoId = HP:0011919
| 名称 = Pleural empyema
| 定义 = Accumulation of pus in the `pleural cavity` (FMA:9740).
| 中文译名 = 脓胸
| 中文定义 = 脓液在胸腔积聚（FMA:9740）。
}}


==[[HP:0011920]]==
{{Infobox HPO
| hpoId = HP:0011920
| 名称 = Transudative pleural effusion
| 定义 = A type of pleural effusion with a transudate (extravascular fluid with low protein content and a low specific gravity). Pleural effusions can be classified as transudates or exudates based on Light&#39;s criteria, which classify an effusion as exudate if one or more of the following are present: (1) the ratio of pleural fluid protein to serum protein is greater than 0.5, (2) the ratio of pleural fluid lactate dehydrogenase (LDH) to serum LDH is greater than 0.6, or (3) the pleural fluid LDH level is greater than two thirds of the upper limit of normal for serum LDH.
| 中文译名 = 漏出性胸腔积液
| 中文定义 = 漏出性胸腔积液（具有低蛋白含量和低比重特点）。根据light标准，可将胸腔积液分为漏出液和渗出液，符合以下一项或多项为渗出液:（1）胸水蛋白与血清蛋白的比率大于0.5，（2）胸水乳酸脱氢酶（LDH）与血清LDH比率大于0.6，或（3）胸液LDH水平大于三分之二的正常血清LDH的上限。
}}


==[[HP:0011921]]==
{{Infobox HPO
| hpoId = HP:0011921
| 名称 = Exudative pleural effusion
| 定义 = A type of pleural effusion with a exudate (extravascular fluid that has exuded out of a tissue or its capillaries due to injury or inflammation). Pleural effusions can be classified as transudates or exudates based on Light&#39;s criteria, which classify an effusion as exudate if one or more of the following are present: (1) the ratio of pleural fluid protein to serum protein is greater than 0.5, (2) the ratio of pleural fluid lactate dehydrogenase (LDH) to serum LDH is greater than 0.6, or (3) the pleural fluid LDH level is greater than two thirds of the upper limit of normal for serum LDH.
| 中文译名 = 渗出性胸腔积液
| 中文定义 = 一种具有渗出液的胸膜腔积液，渗出液为组织或其毛细血管因损伤或炎症而渗出的血管外液。胸腔积液分类基于Light标准，依据该标准，渗出液应符合以下至少一条:（1）胸水白蛋白/血清白蛋白的比值大于0.5，（2）胸水乳酸脱氢酶（LDH）/血清LDH比值大于0.6，或（3）胸液LDH水平大于正常血清LDH上的限三分之二。
}}


==[[HP:0011922]]==
{{Infobox HPO
| hpoId = HP:0011922
| 名称 = Abnormal activity of mitochondrial respiratory chain
| 定义 = An increased or decreased activity of the `mitochondrial respiratory chain` (GO:0005746).
| 中文译名 = 线粒体呼吸链活性异常
| 中文定义 = 线粒体呼吸链的活性增高或降低(GO:0005746)。
}}


==[[HP:0011923]]==
{{Infobox HPO
| hpoId = HP:0011923
| 名称 = Decreased activity of mitochondrial complex I
| 定义 = A reduction in the activity of the `mitochondrial respiratory chain complex I` (GO:0005747), which is part of the electron transport chain in mitochondria.
| 中文译名 = 线粒体复合物I活性降低
| 中文定义 = 在`线粒体呼吸链复合物I`的活性的降低（GO:0005747），这是在线粒体中的电子传递链的一部分。
}}


==[[HP:0011924]]==
{{Infobox HPO
| hpoId = HP:0011924
| 名称 = Decreased activity of mitochondrial complex III
| 定义 = A reduction in the activity of the `mitochondrial respiratory chain complex III` (GO:0005750), which is part of the electron transport chain in mitochondria.
| 中文译名 = 线粒体复合物III活性降低
| 中文定义 = 在`线粒体呼吸链复合物III`的活性的降低（GO:0005750），这是在线粒体中的电子传递链的一部分。
}}


==[[HP:0011925]]==
{{Infobox HPO
| hpoId = HP:0011925
| 名称 = Decreased activity of mitochondrial ATP synthase complex
| 定义 = A reduction in the activity of the ` mitochondrial proton-transporting ATP synthase complex` (GO:0005753), which makes ATP via oxidative phosphorylation, and is sometimes described as Complex V of the electron transport chain.
| 中文译名 = 线粒体ATP合成酶复合物活性降低
| 中文定义 = 在`线粒体质子转运ATP合酶complex`的活性的降低（GO:0005753），其通过氧化磷酸化使得ATP和有时被描述为电子传递链的复合物V。
}}


==[[HP:0011935]]==
{{Infobox HPO
| hpoId = HP:0011935
| 名称 = Decreased urinary urate
| 定义 = Decreased concentration of `urate` (CHEBI:46819) in the urine.
| 中文译名 = 尿液中尿酸盐减少
| 中文定义 = 尿液中尿酸盐浓度降低。
}}


==[[HP:0011936]]==
{{Infobox HPO
| hpoId = HP:0011936
| 名称 = Decreased plasma total carnitine
| 定义 = A decreased concentration of total `carnitine` (CHEBI:17126) in the `blood` (FMA:9670).
| 中文译名 = 血浆总肉碱降低
| 中文定义 = 在`blood`（FMA:9670）:总`carnitine`（17126 CHEBI）的浓度降低。
}}


==[[HP:0011942]]==
{{Infobox HPO
| hpoId = HP:0011942
| 名称 = Increased urinary sulfite
| 定义 = Increased concentration of `sulfate` (CHEBI:17359) in the urine.
| 中文译名 = 尿亚硫酸盐增加
| 中文定义 = 尿液中亚硫酸盐的浓度增加。
}}


==[[HP:0011943]]==
{{Infobox HPO
| hpoId = HP:0011943
| 名称 = Increased urinary thiosulfate
| 定义 = Increased concentration of `thiosulfate(2-)` (CHEBI:16094) in the urine.
| 中文译名 = 尿硫代硫酸盐增加
| 中文定义 = 尿液中硫代硫酸盐浓度增高。
}}


==[[HP:0011965]]==
{{Infobox HPO
| hpoId = HP:0011965
| 名称 = Abnormality of citrulline metabolism
| 定义 = Abnormality of a metabolism or concentration of `citrulline` (CHEBI:18211).
| 中文译名 = 瓜氨酸代谢异常
| 中文定义 = `瓜氨酸` (CHEBI:18211)的代谢或浓度异常。
}}


==[[HP:0011966]]==
{{Infobox HPO
| hpoId = HP:0011966
| 名称 = Elevated plasma citrulline
| 定义 = An increased concentration of `citrulline` (CHEBI:18211) in the `blood` (FMA:9670).
| 中文译名 = 血浆瓜氨酸升高
| 中文定义 = 在`blood`:`citrulline`（18211 CHEBI）浓度增加（FMA:9670）。
}}


==[[HP:0011967]]==
{{Infobox HPO
| hpoId = HP:0011967
| 名称 = Hypocupremia
| 定义 = A reduced concentration of `copper` (CHEBI:28694) in the `blood` (FMA:9670).
| 中文译名 = 低铜血症
| 中文定义 = 在`blood`:`copper`（28694 CHEBI）浓度降低（FMA:9670）。
}}


==[[HP:0011970]]==
{{Infobox HPO
| hpoId = HP:0011970
| 名称 = Cerebral amyloid angiopathy
| 定义 = Amyloid deposition in the walls of leptomeningeal and cortical arteries, arterioles, and less often capillaries and veins of the central nervous system.
| 中文译名 = 脑淀粉样血管病
| 中文定义 = 淀粉样物质沉积在神经系统的软脑脊膜和皮质动脉、小动脉、较少情况下毛细管的壁上。
}}


==[[HP:0011976]]==
{{Infobox HPO
| hpoId = HP:0011976
| 名称 = Elevated urinary catecholamines
| 定义 = An increased concentration of `catecholamine` (CHEBI:33567) in the urine.
| 中文译名 = 尿儿茶酚胺升高
| 中文定义 = 尿液中儿茶酚胺浓度增加。
}}


==[[HP:0011977]]==
{{Infobox HPO
| hpoId = HP:0011977
| 名称 = Elevated urinary homovanillic acid
| 定义 = An `increased concentration` (PATO:0001162) of `homovanillic acid` (CHEBI:545959)  in the `urine` (FMA:12274).
| 中文译名 = 尿高香草酸水平升高
| 中文定义 = `香草acid`（CHEBI:545959）在`urine`:一个`增加concentration`（0001162 PATO）（FMA:12274）。
}}


==[[HP:0011978]]==
{{Infobox HPO
| hpoId = HP:0011978
| 名称 = Elevated urinary vanillylmandelic acid
| 定义 = An `increased concentration` (PATO:0001162) of `vanillylmandelic acid` (CHEBI:20106)  in the `urine` (FMA:12274).
| 中文译名 = 尿香草扁桃酸水平升高
| 中文定义 = `香草acid`（CHEBI:20106）在`urine`（FMA:12274）:一个`增加concentration`（0001162 PATO）。
}}


==[[HP:0011979]]==
{{Infobox HPO
| hpoId = HP:0011979
| 名称 = Elevated urinary dopamine
| 定义 = An increased concentration of `dopamine` (CHEBI:18243) in the `urine` (FMA:12274).
| 中文译名 = 尿多巴胺增高
| 中文定义 = 尿液中多巴胺浓度增加。
}}


==[[HP:0011997]]==
{{Infobox HPO
| hpoId = HP:0011997
| 名称 = Postprandial hyperlactemia
| 定义 = Abnormally increased level of blood `lactate` (CHEBI:24996) following a meal.
| 中文译名 = 餐后高乳酸血症
| 中文定义 = 异常增高的血`lactate`（CHEBI:24996）水平以下的一顿饭。
}}


==[[HP:0011998]]==
{{Infobox HPO
| hpoId = HP:0011998
| 名称 = Postprandial hyperglycemia
| 定义 = An `increased concentration` (PATO:0001162) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670) following a meal.
| 中文译名 = 餐后高血糖
| 中文定义 = 的`glucose`（CHEBI:17234）:一个`增加concentration`（0001162 PATO）在`blood`（FMA:9670）继一顿饭。
}}


==[[HP:0012023]]==
{{Infobox HPO
| hpoId = HP:0012023
| 名称 = Galactosuria
| 定义 = Elevated concentration of `galactose` (CHEBI:28260) in the urine.
| 中文译名 = 半乳糖尿症
| 中文定义 = 在尿常规:高架`galactose`浓度（28260 CHEBI）。
}}


==[[HP:0012024]]==
{{Infobox HPO
| hpoId = HP:0012024
| 名称 = Hypergalactosemia
| 定义 = Elevated concentration of `galactose` (CHEBI:28260) in the blood.
| 中文译名 = 高半乳糖血症
| 中文定义 = 在血中升高`galactose`浓度（28260 CHEBI）。
}}


==[[HP:0012025]]==
{{Infobox HPO
| hpoId = HP:0012025
| 名称 = Abnormality of ornithine metabolism
| 定义 = Abnormality of a metabolism or concentration of `ornithine` (CHEBI:18257).
| 中文译名 = 鸟氨酸代谢异常
| 中文定义 = `鸟氨酸 `（CHEBI:18257）的代谢或浓度异常。
}}


==[[HP:0012026]]==
{{Infobox HPO
| hpoId = HP:0012026
| 名称 = Hyperornithinemia
| 定义 = Increased concentration of `ornithine` (CHEBI:18257) in the blood.
| 中文译名 = 高鸟氨酸血症
| 中文定义 = 血液中的:增加`ornithine`（18257 CHEBI）的浓度。
}}


==[[HP:0012027]]==
{{Infobox HPO
| hpoId = HP:0012027
| 名称 = Laryngeal edema
| 定义 = An abnormal accumulation of fluid and swelling in the tissues of the `larynx` (FMA:55097).
| 中文译名 = 喉头水肿
| 中文定义 = 喉部组织的异常液体积聚和肿胀。（FMA:55097）。
}}


==[[HP:0012030]]==
{{Infobox HPO
| hpoId = HP:0012030
| 名称 = Increased urinary cortisol level
| 定义 = Abnormally increased concentration of `cortisol` (CHEBI:17650) in the urine.
| 中文译名 = 尿皮质醇水平增高
| 中文定义 = 尿液中皮质醇浓度异常增加。
}}

==[[HP:0012040]]==
{{Infobox HPO
| hpoId = HP:0012040
| 名称 = Corneal stromal edema
| 定义 = Abnormal accumulation of fluid and swelling of the `stroma of cornea` (FMA:58306).
| 中文译名 = 角膜基质水肿
| 中文定义 = 角膜基质层出现的非正常的液体积聚和肿胀（FMA:58306）。
}}


==[[HP:0012050]]==
{{Infobox HPO
| hpoId = HP:0012050
| 名称 = Anasarca
| 定义 = An extreme form of generalized edema with widespread and massive edema due to effusion of fluid into the extracellular space.
| 中文译名 = 全身水肿
| 中文定义 = 由于体液渗出进入细胞外间隙，导致极端性的全身广泛大量的水肿。
}}


==[[HP:0012051]]==
{{Infobox HPO
| hpoId = HP:0012051
| 名称 = Reactive hypoglycemia
| 定义 = Hypoglycermia following a meal (or more generally, after intake of glucose).
| 中文译名 = 反应性低血糖
| 中文定义 = Hypoglycermia以下一餐（或更一般地，摄取葡萄糖后）。
}}


==[[HP:0012052]]==
{{Infobox HPO
| hpoId = HP:0012052
| 名称 = Low serum calcitriol (1,25-dihydroxycholecalciferol)
| 定义 = A reduced concentration of `calcitriol` (CHEBI:17823) in the blood. Calcitriol is also known as 1,25-dihydroxycholecalciferol or 1,25-dihydroxyvitamin D3.
| 中文译名 = 低血清骨化三醇（1,25-二羟基胆钙化醇）
| 中文定义 = 血液中的:`calcitriol`（17823 CHEBI）浓度降低。骨化三醇也被称为1,25-二羟或1,25-二羟基维生素D3。
}}


==[[HP:0012053]]==
{{Infobox HPO
| hpoId = HP:0012053
| 名称 = Low serum calcifediol (25-hydroxycholecalciferol)
| 定义 = A reduced concentration of `calcidiol` (CHEBI:17933) in the blood. Calcidiol is also known as 25-hydroxycholecalciferol or 25-Hydroxyvitamin D3.
| 中文译名 = 低血清骨化二醇（25-羟基胆钙化醇）
| 中文定义 = 血液中的:`calcidiol`（17933 CHEBI）浓度降低。骨化二醇也被称为25-羟基胆钙化醇或25-羟基维生素D3。
}}


==[[HP:0012061]]==
{{Infobox HPO
| hpoId = HP:0012061
| 名称 = Urinary excretion of sialylated oligosaccharides
| 定义 = Excretion of `oligosaccharides` (CHEBI:50699) conjugated to `sialic acid` (CHEBI:26667) in the urine.
| 中文译名 = 唾液酸化寡聚糖的尿排泄
| 中文定义 = 的`oligosaccharides`排泄（CHEBI:50699）共轭`唾液酸acid`（CHEBI:26667）在尿液中。
}}

==[[HP:0012066]]==
{{Infobox HPO
| hpoId = HP:0012066
| 名称 = Increased urinary disaccharide excretion
| 定义 = Increased concentration of `disaccharide` (CHEBI:36233) in the urine.
| 中文译名 = 尿液双糖排泄增加
| 中文定义 = 尿液中:增加`disaccharide`（36233 CHEBI）的浓度。
}}


==[[HP:0012067]]==
{{Infobox HPO
| hpoId = HP:0012067
| 名称 = Glycopeptiduria
| 定义 = Increased excretion of `glycopeptides` (CHEBI:24396) in the urine. Glycopeptides are peptides with carbohydrate moieties covalently attached to the side chains of the amino acid residues.
| 中文译名 = 糖肽尿症
| 中文定义 = 尿液中:增加`glycopeptides`（24396 CHEBI）的排泄。糖肽的肽与碳水化合物部分共价连接到氨基酸残基的侧链。
}}


==[[HP:0012068]]==
{{Infobox HPO
| hpoId = HP:0012068
| 名称 = Aspartylglucosaminuria
| 定义 = Excretion of excess amounts of aspartylglucosamine in the urine.
| 中文译名 = 天冬氨酰葡萄糖胺尿症
| 中文定义 = 尿液中排泄过量的天冬氨酰葡萄糖胺。
}}

==[[HP:0012069]]==
{{Infobox HPO
| hpoId = HP:0012069
| 名称 = Keratan sulfate excretion in urine
| 定义 = An `increased concentration` (PATO:0001162) of `keratan sulfate` (CHEBI:60924)  in the `urine` (FMA:12274).
| 中文译名 = 尿中排泄硫酸角质素
| 中文定义 = 硫酸角质素在尿中排出。
}}


==[[HP:0012070]]==
{{Infobox HPO
| hpoId = HP:0012070
| 名称 = Chondroitin sulfate excretion in urine
| 定义 = An `increased concentration` (PATO:0001162) of `chondroitin sulfate (CHEBI:37397) in the `urine` (FMA:12274).
| 中文译名 = 尿中排泄硫酸软骨素
| 中文定义 = 尿中硫酸软骨素排泄增加。
}}

==[[HP:0012071]]==
{{Infobox HPO
| hpoId = HP:0012071
| 名称 = Abnormality of acetylcarnitine metabolism
| 定义 = An abnormality of acylcarnitine, which is produced by reversible esterification of the 3-hydroxyl group of carnitine.
| 中文译名 = 乙酰肉碱代谢异常
| 中文定义 = 酰基肉碱的异常，这是由肉碱的3-羟基的可逆性酯化过程产生的。
}}


==[[HP:0012072]]==
{{Infobox HPO
| hpoId = HP:0012072
| 名称 = Aciduria
| 定义 = Secretion of urine with an acid pH.
| 中文译名 = 酸性尿
| 中文定义 = 排出的尿为酸性pH值。
}}


==[[HP:0012073]]==
{{Infobox HPO
| hpoId = HP:0012073
| 名称 = Abnormal urinary acylglycine profile
| 定义 = An abnormal distribution of `N-acylglycines (CHEBI:16180) in the urine. There are numerous different N-acylglycines, and this term refers to pathological alterations in their level or distribution.
| 中文译名 = 尿酰基甘氨酸谱异常
| 中文定义 = 尿液中N-酰基甘氨酸分布异常。有多种不同的N-酰基甘氨酸，此条目特指其含量和分布的病理性改变。
}}


==[[HP:0012085]]==
{{Infobox HPO
| hpoId = HP:0012085
| 名称 = Pyuria
| 定义 = Presence of an increased number of neutrophils in the urine.
| 中文译名 = 脓尿
| 中文定义 = 尿液中性粒细胞数量增加。
}}


==[[HP:0012086]]==
{{Infobox HPO
| hpoId = HP:0012086
| 名称 = Abnormal urinary color
| 定义 = An abnormal color of the urine, that is, the color of the urine appears different from the usual straw-yellow color.
| 中文译名 = 尿液颜色异常
| 中文定义 = 尿液的异常的颜色，正常的颜色为麦草黄色。
}}


==[[HP:0012087]]==
{{Infobox HPO
| hpoId = HP:0012087
| 名称 = Abnormal mitochondrial shape
| 定义 = An anomaly in the surface contour of mitochondria.
| 中文译名 = 线粒体形状异常
| 中文定义 = 线粒体表面轮廓的异常。
}}


==[[HP:0012088]]==
{{Infobox HPO
| hpoId = HP:0012088
| 名称 = Abnormal urinary odor
| 定义 = A deviation from the normal odor of the urine.
| 中文译名 = 尿味异常
| 中文定义 = 尿的气味与正常的不同。
}}


==[[HP:0012098]]==
{{Infobox HPO
| hpoId = HP:0012098
| 名称 = Edema of the dorsum of feet
| 定义 = An abnormal accumulation of fluid beneath the skin on the back of the feet.
| 中文译名 = 足背水肿
| 中文定义 = 流体的上脚背部的皮肤下的异常积累。
}}


==[[HP:0012100]]==
{{Infobox HPO
| hpoId = HP:0012100
| 名称 = Abnormal circulating creatinine level
| 定义 = An abnormal concentration of `creatinine` (CHEBI:16737) in the `blood` (FMA:9670).
| 中文译名 = 循环系统肌酐水平异常
| 中文定义 = 血中(FMA:9670)肌酐(CHEBI:16737)浓度的异常。
}}

==[[HP:0012101]]==
{{Infobox HPO
| hpoId = HP:0012101
| 名称 = Decreased serum creatinine
| 定义 = An abnormally reduced amount of `creatinine` (CHEBI:16737) in the `blood` (FMA:9670).
| 中文译名 = 血清肌酐降低
| 中文定义 = 在`blood`（FMA:9670）:中`creatinine`异常减少量（16737 CHEBI）。
}}


==[[HP:0012102]]==
{{Infobox HPO
| hpoId = HP:0012102
| 名称 = Abnormal mitochondrial number
| 定义 = A deviation from the normal number of mitochondria per cell.
| 中文译名 = 线粒体数目异常
| 中文定义 = 每个细胞中的线粒体数目偏离正常。
}}


==[[HP:0012103]]==
{{Infobox HPO
| hpoId = HP:0012103
| 名称 = Abnormality of the mitochondrion
| 定义 = An anomaly of the `mitochondrion` (FMA:63835), the membranous cytoplasmic organelle the interior of which is subdivided by cristae. The `mitochondrion` (GO:0005739) is a self replicating organelle that is the site of tissue respiration.
| 中文译名 = 线粒体异常
| 中文定义 = `线粒体` (FMA:63835),即内部被线粒体嵴所分开的膜状细胞质细胞器，的异常。`线粒体`（GO:0005739）为一种自我复制的细胞器,是组织呼吸的部位。
}}


==[[HP:0012113]]==
{{Infobox HPO
| hpoId = HP:0012113
| 名称 = Abnormality of creatine metabolism
| 定义 = An anomaly of the concentration or homeostasis of `creatine`  (CHEBI:16919). Creatine is a derivative of glycine having methyl and amidino groups attached to the nitrogen. Creatine is naturally produced from amino acids, primarily in liver and kidney, and acts as an energy source for cells, primarly for muscle cells.
| 中文译名 = 肌酸代谢异常
| 中文定义 = `肌酸 `（CHEBI:16919）的浓度或体内平衡的异常。肌酸为具有甲基和脒基的甘氨酸连接到氮上的衍生物。肌酸主要是在肝脏和肾脏自然产生的，为肌肉细胞的主要能量来源。
}}


==[[HP:0012116]]==
{{Infobox HPO
| hpoId = HP:0012116
| 名称 = Abnormal albumin level
| 定义 = Deviation from normal concentration of `albumin` (PR:000003918) in the `blood` (FMA:9670).
| 中文译名 = 血清白蛋白水平异常
| 中文定义 = 血中(FMA:9670)的血清白蛋白水平偏离正常范围。
}}


==[[HP:0012117]]==
{{Infobox HPO
| hpoId = HP:0012117
| 名称 = Hyperalbuminemia
| 定义 = Elevation in the concentration of `albumin` (PR:000003918) in the `blood` (FMA:9670).
| 中文译名 = 高白蛋白血症
| 中文定义 = 海拔在`albumin`（PR:000003918）的浓度在`blood`（FMA:9670）。
}}


==[[HP:0012120]]==
{{Infobox HPO
| hpoId = HP:0012120
| 名称 = Methylmalonic aciduria
| 定义 = Increased concentration of `methylmalonic acid` (CHEBI:30860) in the urine.
| 中文译名 = 甲基丙二酸尿症
| 中文定义 = 尿液中甲基丙二酸的浓度增加。
}}


==[[HP:0012127]]==
{{Infobox HPO
| hpoId = HP:0012127
| 名称 = Uraciluria
| 定义 = Increased concentration of `uracil` (CHEBI:17568)  in the urine.
| 中文译名 = 尿嘧啶尿症
| 中文定义 = 尿液中:增加`uracil`（17568 CHEBI）的浓度。
}}


==[[HP:0012153]]==
{{Infobox HPO
| hpoId = HP:0012153
| 名称 = Hypotriglyceridemia
| 定义 = An decrease in the level of `triglycerides` (CHEBI:17855) in the `blood` (FMA:9670).
| 中文译名 = 低甘油三酯血症
| 中文定义 = 在`blood`（FMA:9670）:在&#39;triglycerides`（17855 CHEBI）水平的下降。
}}


==[[HP:0012177]]==
{{Infobox HPO
| hpoId = HP:0012177
| 名称 = Abnormal natural killer cell physiology
| 定义 = A functional anomaly of the `natural killer cell` (CL:0000623).
| 中文译名 = 自然杀伤细胞功能异常
| 中文定义 = 自然杀伤细胞的功能异常（CL:0000623）。
}}


==[[HP:0012178]]==
{{Infobox HPO
| hpoId = HP:0012178
| 名称 = Reduced natural killer cell activity
| 定义 = Reduced ability of the `natural killer cell` (CL:0000623) to function in the  adaptive immune response.
| 中文译名 = 自然杀伤细胞活性降低
| 中文定义 = 在适应性免疫应答中， `自然杀伤细胞`（0000623 CL）的能力降低。
}}


==[[HP:0012184]]==
{{Infobox HPO
| hpoId = HP:0012184
| 名称 = Hyperalphalipoproteinemia
| 定义 = An elevated concentration of `high-density lipoprotein cholesterol` (CHEBI:47775) (HDL) in the `blood` (FMA:9670).
| 中文译名 = 高α脂蛋白血症
| 中文定义 = 浓度升高的`高密度脂蛋白cholesterol`（CHEBI:47775）（HDL）在`blood`（FMA:9670）。
}}


==[[HP:0012187]]==
{{Infobox HPO
| hpoId = HP:0012187
| 名称 = Increased erythrocyte protoporphyrin concentration
| 定义 = An increased concentration of `protoporphyrins` (CHEBI:26361) in erythrocytes.
| 中文译名 = 红细胞原卟啉浓度增高
| 中文定义 = 红细胞:`protoporphyrins`（26361 CHEBI）的浓度增加。
}}


==[[HP:0012202]]==
{{Infobox HPO
| hpoId = HP:0012202
| 名称 = increased serum bile acid concentration
| 定义 = An increase in the concentration of `bile acid` (CHEBI:3098) in the blood.
| 中文译名 = 血清胆汁酸浓度增高
| 中文定义 = 增加了`胆汁acid`（CHEBI:3098）的浓度在血液中。
}}


==[[HP:0012217]]==
{{Infobox HPO
| hpoId = HP:0012217
| 名称 = Increased urinary porphobilinogen
| 定义 = Increased concentration of `porphobilinogen` (CHEBI:17381) in the urine.
| 中文译名 = 尿液胆色素原增高
| 中文定义 = 尿液中:增加`porphobilinogen`（17381 CHEBI）的浓度。
}}

==[[HP:0012236]]==
{{Infobox HPO
| hpoId = HP:0012236
| 名称 = Elevated sweat chloride
| 定义 = An increased concentration of chloride in the sweat.
| 中文译名 = 汗液氯化物浓度升高
| 中文定义 = 氯化物在汗液浓度增加。
}}


==[[HP:0012237]]==
{{Infobox HPO
| hpoId = HP:0012237
| 名称 = Urocanic aciduria
| 定义 = An increased concentration of `urocanic acid` (CHEBI:27248) in the urine.
| 中文译名 = 尿刊酸尿症
| 中文定义 = 在尿常规:尿刊`acid`（27248 CHEBI）的浓度增加。
}}


==[[HP:0012238]]==
{{Infobox HPO
| hpoId = HP:0012238
| 名称 = Hyperchylomicronemia
| 定义 = Increased plasma concentrations of chylomicrons, the large lipid droplet (up to 100 mm in diameter) of reprocessed lipid synthesized in epithelial cells of the small intestine and containing triacylglycerols, cholesterol esters, and several apolipoproteins.
| 中文译名 = 高乳糜微粒血症
| 中文定义 = 乳糜微粒的血浆浓度增加，大的脂滴（100毫米直径）再加工的脂质在小肠中的上皮细胞和含有三酰基甘油，胆甾醇酯，和若干载脂蛋白合成的。
}}


==[[HP:0012239]]==
{{Infobox HPO
| hpoId = HP:0012239
| 名称 = Atransferrinemia
| 定义 = Absence of transferrin, a protein that transprot iron, in the blood.
| 中文译名 = 转铁蛋白缺乏血症
| 中文定义 = 血液中的转铁蛋白，即转运铁的蛋白，缺乏。
}}


==[[HP:0012277]]==
{{Infobox HPO
| hpoId = HP:0012277
| 名称 = Hypoglycinemia
| 定义 = An abnormally reduced concentration of `glycine` (CHEBI:15428) in the `blood` (FMA:9670).
| 中文译名 = 低甘氨酸血症
| 中文定义 = 在`blood`（FMA:9670）:&#39;glycine`（15428 CHEBI）的异常浓度降低。
}}


==[[HP:0012278]]==
{{Infobox HPO
| hpoId = HP:0012278
| 名称 = Abnormality of serine metabolism
| 定义 = An abnormality of a `serine` (CHEBI:17822) metabolism.
| 中文译名 = 丝氨酸代谢异常
| 中文定义 = `丝氨酸`（CHEBI:17822）的代谢异常。
}}


==[[HP:0012279]]==
{{Infobox HPO
| hpoId = HP:0012279
| 名称 = Hyposerinemia
| 定义 = Reduced concentration of `serine` (CHEBI:17822) in the blood.
| 中文译名 = 低丝氨酸血症
| 中文定义 = 血液中的:减少`serine`（17822 CHEBI）的浓度。
}}


==[[HP:0012280]]==
{{Infobox HPO
| hpoId = HP:0012280
| 名称 = Hepatic amyloidosis
| 定义 = A form of `amyloidosis` (HP:0011034) that affects the liver.
| 中文译名 = 肝淀粉样变性
| 中文定义 = 一种影响肝脏的“淀粉样病变”形式。
}}


==[[HP:0012301]]==
{{Infobox HPO
| hpoId = HP:0012301
| 名称 = Type II transferrin isoform profile
| 定义 = Abnormal transferrin isoform profile consistent with a type II congenital disorder of glycosylation.
| 中文译名 = II型转铁蛋白异构体谱
| 中文定义 = 异常转异构体轮廓与糖基化的II型先天性紊乱一致。
}}


==[[HP:0012309]]==
{{Infobox HPO
| hpoId = HP:0012309
| 名称 = Cutaneous amyloidosis
| 定义 = The presence of `amyloid deposition` (MPATH:34) in the superficial dermis.
| 中文译名 = 皮肤淀粉样变
| 中文定义 = 出现真皮浅层中的`淀粉样堆积`(MPATH:34)。
}}


==[[HP:0012321]]==
{{Infobox HPO
| hpoId = HP:0012321
| 名称 = D-2-hydroxyglutaric aciduria
| 定义 = An increased concentration of `2-hydroxyglutaric acid` (CHEBI:17084) in the `urine` (FMA:12274).
| 中文译名 = D-2-羟基戊二酸尿症
| 中文定义 = 尿中D-2-羟基戊二酸浓度增加。
}}


==[[HP:0012335]]==
{{Infobox HPO
| hpoId = HP:0012335
| 名称 = Abnormality of folate metabolism
| 定义 = An abnormality of the metabolism of `folic acid` (CHEBI:27470), which is also known as vitamin B9.
| 中文译名 = 叶酸代谢异常
| 中文定义 = `叶酸`（CHEBI:27470）又称为维生素B9的代谢异常。
}}


==[[HP:0012336]]==
{{Infobox HPO
| hpoId = HP:0012336
| 名称 = Reduced cerebrospinal fluid 5-methyltetrahydrofolate concentration
| 定义 = A decreased concentration of `5-methyltetrahydrofolate` (CHEBI:20612) in the `cerebrospinal fluid` (FMA:20935).
| 中文译名 = 脑脊液5-甲基四氢叶酸浓度降低
| 中文定义 = 在&#39;脑fluid`（FMA:20935）的`5 methyltetrahydrofolate`（20612 CHEBI）降低浓度。
}}


==[[HP:0012337]]==
{{Infobox HPO
| hpoId = HP:0012337
| 名称 = Abnormal homeostasis
| 定义 = An anomaly in the processes involved in the maintenance of an internal equilibrium.
| 中文译名 = 内稳态平衡的失常
| 中文定义 = 涉及体内平衡的维持过程中发生的异常。
}}


==[[HP:0012338]]==
{{Infobox HPO
| hpoId = HP:0012338
| 名称 = Abnormal energy expenditure
| 定义 = Any anomaly in the utilization of energy (calories).
| 中文译名 = 能量消耗异常
| 中文定义 = 能量（卡路里）利用的任何异常。
}}


==[[HP:0012339]]==
{{Infobox HPO
| hpoId = HP:0012339
| 名称 = Increased resting energy expenditure
| 定义 = An increase in the number of calories used per unit time.
| 中文译名 = 静息能量消耗增加
| 中文定义 = 增加每单位时间使用的卡路里数。
}}


==[[HP:0012340]]==
{{Infobox HPO
| hpoId = HP:0012340
| 名称 = Decreased resting energy expenditure
| 定义 = An reduction in the number of calories used per unit time.
| 中文译名 = 静息能量消耗降低
| 中文定义 = 在每单位时间使用的卡路里数的减少。
}}


==[[HP:0012343]]==
{{Infobox HPO
| hpoId = HP:0012343
| 名称 = Decreased serum ferritin
| 定义 = Abnormally reduced concentration of ferritin, a ubiquitous intracellular protein that stores iron, in the blood.
| 中文译名 = 血清铁蛋白降低
| 中文定义 = 异常降低浓度铁蛋白，其存储铁一个无处不在的细胞内的蛋白质，在血液中。
}}


==[[HP:0012345]]==
{{Infobox HPO
| hpoId = HP:0012345
| 名称 = Abnormal glycosylation
| 定义 = An anomaly of a `glycosylation` (GO:0070085) process, i.e., a process involved in the covalent attachment of a glycosyl residue to a substrate molecule.
| 中文译名 = 糖基化异常
| 中文定义 = 异常化的糖基化过程(GO:0070085)，即糖化残基和底物分子的共联过程。
}}


==[[HP:0012346]]==
{{Infobox HPO
| hpoId = HP:0012346
| 名称 = Abnormal protein glycosylation
| 定义 = An anomaly of a `protein glycosylation` (GO:0006486) process, i.e., of a protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
| 中文译名 = 蛋白质糖基化异常
| 中文定义 = 异常的`蛋白糖基化`（GO:0006486），即蛋白修饰过程，其可导致碳水化合物或碳水化合物衍生物单元位添加到蛋白质氨基酸分子上，例如加入聚糖链到蛋白质上。
}}


==[[HP:0012347]]==
{{Infobox HPO
| hpoId = HP:0012347
| 名称 = Abnormal protein N-linked glycosylation
| 定义 = An anomaly of `protein N-linked glycosylation` (GO:0006487), i.e., an abnormality of the protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via a nitrogen atom in an amino acid residue in a protein.
| 中文译名 = 蛋白质N-联糖基化异常
| 中文定义 = 蛋白质N-联糖基化（GO:0006487）的一种异常，即蛋白质糖基化过程中的一种异常，其中一个碳水化合物或碳水化合物衍生物单体通过在蛋白质上的氨基酸中的氮原子被加入蛋白质上。
}}


==[[HP:0012348]]==
{{Infobox HPO
| hpoId = HP:0012348
| 名称 = Decreased galactosylation of N-linked protein glycosylation
| 定义 = A reduction in the amount of galactose residues of N-glycans.
| 中文译名 = N-联蛋白糖基的半乳糖基化降低
| 中文定义 = 在N-聚糖的半乳糖残基的量的减少。
}}

==[[HP:0012349]]==
{{Infobox HPO
| hpoId = HP:0012349
| 名称 = Abnormal sialylation of N-linked protein glycosylation
| 定义 = An anomaly of the addition of sialic acids to N-linked glycans.
| 中文译名 = N-联蛋白糖基的唾液酸化异常
| 中文定义 = 唾液酸添加到N联聚糖上的异常。
}}


==[[HP:0012350]]==
{{Infobox HPO
| hpoId = HP:0012350
| 名称 = Decreased sialylation of N-linked protein glycosylation
| 定义 = Decreased addition of sialic acids to N-linked glycans.
| 中文译名 = N-联蛋白糖基的唾液酸化降低
| 中文定义 = 降低加入唾液酸到N联聚糖。
}}


==[[HP:0012351]]==
{{Infobox HPO
| hpoId = HP:0012351
| 名称 = Increased sialylation of N-linked protein glycosylation
| 定义 = Increased addition of sialic acids to N-linked glycans.
| 中文译名 = N-联蛋白糖基的唾液酸化增高
| 中文定义 = 增加另外的唾液酸到N联聚糖。
}}


==[[HP:0012352]]==
{{Infobox HPO
| hpoId = HP:0012352
| 名称 = Abnormal fucosylation of protein N-linked glycosylation
| 定义 = An anomaly of the addition of fucose sugar units to N-linked glycans.
| 中文译名 = 蛋白质的N-联糖基的岩藻糖基化异常
| 中文定义 = 在N-联聚糖上加入岩藻糖单位的异常。
}}


==[[HP:0012353]]==
{{Infobox HPO
| hpoId = HP:0012353
| 名称 = Decreased fucosylation of N-linked protein glycosylation
| 定义 = Decreased addition of fucose sugar units to N-linked glycans.
| 中文译名 = N-联蛋白糖基的岩藻糖基化降低
| 中文定义 = 降低加入岩藻糖单位的N-连接的聚糖。
}}

==[[HP:0012354]]==
{{Infobox HPO
| hpoId = HP:0012354
| 名称 = Increased fucosylation of N-linked protein glycosylation
| 定义 = Increased addition of fucose sugar units to N-linked glycans.
| 中文译名 = N-联蛋白糖基的岩藻糖基化增高
| 中文定义 = 增加另外岩藻糖单元与N-连接的聚糖。
}}


==[[HP:0012355]]==
{{Infobox HPO
| hpoId = HP:0012355
| 名称 = Abnormal mannosylation of N-linked protein glycosylation
| 定义 = An anomaly of the addition of mannose to N-linked glycans.
| 中文译名 = N-联蛋白糖基的甘露糖基化异常
| 中文定义 = N-联聚糖上加入甘露糖的异常。
}}


==[[HP:0012356]]==
{{Infobox HPO
| hpoId = HP:0012356
| 名称 = Decreased mannosylation of N-linked protein glycosylation
| 定义 = Reduced addition of mannose to N-linked glycans.
| 中文译名 = N-联蛋白糖基的甘露糖基化降低
| 中文定义 = 减压除甘露糖与N-连接的聚糖。
}}

==[[HP:0012357]]==
{{Infobox HPO
| hpoId = HP:0012357
| 名称 = Increased mannosylation of N-linked protein glycosylation
| 定义 = Increased addition of mannose to N-linked glycans.
| 中文译名 = N-联蛋白糖基的甘露糖基化增高
| 中文定义 = 增加除甘露糖与N-连接的聚糖。
}}


==[[HP:0012358]]==
{{Infobox HPO
| hpoId = HP:0012358
| 名称 = Abnormal protein O-linked glycosylation
| 定义 = An anomaly of `protein O-linked glycosylation` (GO:0006493), i.e., of the process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of a serine or threonine residue.
| 中文译名 = 蛋白质O-联糖基化异常
| 中文定义 = 异常的`蛋白质O-联糖基化`（GO:0006493），即一种碳水化合物或碳水化合物衍生物单位经由丝氨酸或苏氨酸残基的羟基基团添加到蛋白质上的过程。
}}


==[[HP:0012359]]==
{{Infobox HPO
| hpoId = HP:0012359
| 名称 = Abnormal fucosylation of O-linked protein glycosylation
| 定义 = An anomaly of the addition of fucose sugar units to O-linked glycans.
| 中文译名 = O联蛋白糖基的岩藻糖基化异常
| 中文定义 = 在O-联聚糖上加入岩藻糖单位的异常。
}}


==[[HP:0012360]]==
{{Infobox HPO
| hpoId = HP:0012360
| 名称 = Decreased fucosylation of O-linked protein glycosylation
| 定义 = A reduction of the addition of fucose sugar units to O-linked glycans.
| 中文译名 = O-联蛋白糖基的岩藻糖基化降低
| 中文定义 = 的减少增加了岩藻糖单位O连接聚糖。
}}


==[[HP:0012361]]==
{{Infobox HPO
| hpoId = HP:0012361
| 名称 = Increased fucosylation of O-linked protein glycosylation
| 定义 = Increased addition of fucose sugar units to O-linked glycans.
| 中文译名 = O-联蛋白糖基的岩藻糖基化增高
| 中文定义 = 除了增加的岩藻糖单位O连接聚糖。
}}


==[[HP:0012362]]==
{{Infobox HPO
| hpoId = HP:0012362
| 名称 = Abnormal sialylation of O-linked protein glycosylation
| 定义 = An anomaly of the addition of sialic acids to O-linked glycans.
| 中文译名 = O-联蛋白糖基的唾液酸化异常
| 中文定义 = 唾液酸添加到O联聚糖的一种异常。
}}


==[[HP:0012363]]==
{{Infobox HPO
| hpoId = HP:0012363
| 名称 = Decreased sialylation of O-linked protein glycosylation
| 定义 = An reduced addition of sialic acids to O-linked glycans.
| 中文译名 = O联蛋白糖基的唾液酸化降低
| 中文定义 = 一个减少加入唾液酸到O-连接的聚糖。
}}


==[[HP:0012364]]==
{{Infobox HPO
| hpoId = HP:0012364
| 名称 = Decreased urinary potassium
| 定义 = A decreased concentration of `potassium(1+)` (CHEBI:29103) in the `urine` (FMA:12274).
| 中文译名 = 尿钾降低
| 中文定义 = 尿中钾离子的浓度降低。
}}


==[[HP:0012365]]==
{{Infobox HPO
| hpoId = HP:0012365
| 名称 = Hypophosphaturia
| 定义 = An abnormally decreased `phosphate` (CHEBI:18367) concentration in the urine.
| 中文译名 = 低磷酸盐尿
| 中文定义 = 尿液中异常降低磷酸盐浓度。
}}


==[[HP:0012379]]==
{{Infobox HPO
| hpoId = HP:0012379
| 名称 = Abnormal enzyme/coenzyme activity
| 定义 = An altered ability of any enzyme or their cofactors to act as catalysts.
| 中文译名 = 酶/辅酶活性异常
| 中文定义 = 作为催化剂的任何酶或辅因子的作用能力改变。
}}


==[[HP:0012380]]==
{{Infobox HPO
| hpoId = HP:0012380
| 名称 = Reduced carnitine O-palmitoyltransferase activity
| 定义 = Reduced `carnitine O-palmitoyltransferase activity` (GO:0004095), i.e., reduced activity of the reaction: palmitoyl-CoA + L-carnitine = CoA + L-palmitoylcarnitine.
| 中文译名 = 肉毒碱棕榈酰转移酶活性降低
| 中文定义 = 减少`肉碱O型棕榈activity`（GO:0004095），反应即减少活动:棕榈酰辅酶A +左旋肉碱=辅酶A + L-palmitoylcarnitine。
}}


==[[HP:0012398]]==
{{Infobox HPO
| hpoId = HP:0012398
| 名称 = Peripheral edema
| 定义 = An abnormal accumulation of the accumulation of interstitial fluid in the soft tissues of the limbs.
| 中文译名 = 周围性水肿
| 中文定义 = 组织液中的肢体的软组织中积累的异常积累。
}}


==[[HP:0012400]]==
{{Infobox HPO
| hpoId = HP:0012400
| 名称 = Abnormal aldolase level
| 定义 = An abnormal concentration of aldolase in the serum. Aldolase is an enzyme responsible for converting fructose 1,6-bisphosphate into the triose phosphates dihydroxyacetone phosphate and glyceraldehyde 3-phosphate.
| 中文译名 = 醛缩酶水平异常
| 中文定义 = 血清中醛缩酶的浓度异常。醛缩酶是负责将果糖-1,6-双磷酸入转化为丙糖磷酸酯二羟丙酮磷酸和甘油醛-3-磷酸的酶。
}}


==[[HP:0012401]]==
{{Infobox HPO
| hpoId = HP:0012401
| 名称 = Abnormal urine alpha-ketoglutarate concentration
| 定义 = A deviation from normal of the concentration of  `2-oxoglutaric acid` (CHEBI:30915) in the urine.
| 中文译名 = 尿α-酮戊二酸盐浓度异常
| 中文定义 = 尿液中α-酮戊二酸盐的浓度异常。
}}


==[[HP:0012402]]==
{{Infobox HPO
| hpoId = HP:0012402
| 名称 = Increased urine alpha-ketoglutarate concentration
| 定义 = A greater than normal concentration of  `2-oxoglutaric acid` (CHEBI:30915) in the urine.
| 中文译名 = 尿α-酮戊二酸浓度增高
| 中文定义 = 尿液中α-酮戊二酸浓度高于正常范围。
}}

==[[HP:0012403]]==
{{Infobox HPO
| hpoId = HP:0012403
| 名称 = Decreased urine alpha-ketoglutarate concentration
| 定义 = A lower than normal concentration of  `2-oxoglutaric acid` (CHEBI:30915) in the urine.
| 中文译名 = 尿α-酮戊二酸盐浓度降低
| 中文定义 = 尿液中α-酮戊二酸盐浓度低于正常。
}}


==[[HP:0012404]]==
{{Infobox HPO
| hpoId = HP:0012404
| 名称 = Abnormal urine citrate concentration
| 定义 = A deviation from normal of the concentration of  `citrate(3-)` (CHEBI:16947) in the urine.
| 中文译名 = 尿柠檬酸盐浓度异常
| 中文定义 = 尿液中三价柠檬酸根(3-)浓度异常。
}}


==[[HP:0012405]]==
{{Infobox HPO
| hpoId = HP:0012405
| 名称 = Hypocitraturia
| 定义 = A lower than normal concentration of `citrate(3-)` (CHEBI:16947) in the urine.
| 中文译名 = 低枸橼酸尿
| 中文定义 = 尿液中柠檬酸盐的浓度低于正常。
}}


==[[HP:0012406]]==
{{Infobox HPO
| hpoId = HP:0012406
| 名称 = Hypercitraturia
| 定义 = A greater than normal concentration of `citrate(3-)` (CHEBI:16947) in the urine.
| 中文译名 = 高枸橼酸尿
| 中文定义 = 尿液中柠檬酸浓度超出正常范围。
}}


==[[HP:0012461]]==
{{Infobox HPO
| hpoId = HP:0012461
| 名称 = Bacteriuria
| 定义 = The presence of bacteria in the urine.
| 中文译名 = 菌尿
| 中文定义 = 尿液中存在细菌。
}}


==[[HP:0012463]]==
{{Infobox HPO
| hpoId = HP:0012463
| 名称 = Elevated transferrin saturation
| 定义 = An above normal level of saturation of serum transferrin with iron.
| 中文译名 = 转铁蛋白饱和度升高
| 中文定义 = 血清转铁蛋白与铁的饱和度高于正常水平。
}}


==[[HP:0012464]]==
{{Infobox HPO
| hpoId = HP:0012464
| 名称 = Decreased transferrin saturation
| 定义 = A below normal level of saturation of serum transferrin with iron.
| 中文译名 = 转铁蛋白饱和度降低
| 中文定义 = ，低于血清转​​铁饱和的正常水平。
}}


==[[HP:0012465]]==
{{Infobox HPO
| hpoId = HP:0012465
| 名称 = Elevated hepatic iron concentration
| 定义 = An increased level of iron in liver tissues.
| 中文译名 = 肝内铁浓度升高
| 中文定义 = 铁在肝组织的增加的水平。
}}


==[[HP:0012466]]==
{{Infobox HPO
| hpoId = HP:0012466
| 名称 = Chronic respiratory acidosis
| 定义 = Longstanding impairment in ventilation such that the partial pressure of carbon dioxide (PaCO2) is elevated above the upper limit of the reference range (more than 45 mm Hg), with a normal or near-normal pH secondary to renal compensation and an elevated serum bicarbonate levels (more than30 mEq/L).
| 中文译名 = 慢性呼吸性酸中毒
| 中文定义 = 长期的通气损害，使二氧化碳的分压（PaCO2）升高超过参考范围（大于45毫米汞柱）的正常上限，继发于肾补偿和血清碳酸氢盐水平（高于30毫当量/升），pH值正常或接近正常。
}}


==[[HP:0012467]]==
{{Infobox HPO
| hpoId = HP:0012467
| 名称 = Acute respiratory acidosis
| 定义 = Sudden onset of impairment in ventilation such that the removal of carbon dioxide by the respiratory system is less than the production of carbon dioxide in the tissues, leading to an elevation of the partial pressure of carbon dioxide (PaCO2) above the normal limits (more than 45 mm Hg) with an accompanying acidemia (pH less than 7.35).
| 中文译名 = 急性呼吸性酸中毒
| 中文定义 = 突然发作的通气障碍，使呼吸系统移除的二氧化碳少于组织中产生的二氧化碳在，导致二氧化碳（PaCO2的）分压高于正常值范围（超过45毫米汞柱），并伴发血症（pH值小于7.35）。
}}


==[[HP:0012468]]==
{{Infobox HPO
| hpoId = HP:0012468
| 名称 = Chronic acidosis
| 定义 = Longstanding abnormal acid accumulation or depletion of base.
| 中文译名 = 慢性酸中毒
| 中文定义 = 长期不正常的酸堆积或碱消耗。
}}


==[[HP:0012509]]==
{{Infobox HPO
| hpoId = HP:0012509
| 名称 = Reduced thyroxin-binding globulin
| 定义 = An abnormally decreased amount of thyroxin-binding globulin (TBG) in blood. TBG is responsible for carrying the thyroid hormones thyroxine (T4) and 3,5,3&#39;-triiodothyronine (T3) in the bloodstream.
| 中文译名 = 甲状腺素结合球蛋白降低
| 中文定义 = 一个异常降低的数额甲状腺素结合球蛋白（TBG）的血液。 TBG负责执行甲状腺激素甲状腺素（T4）和3,5,3&#39;碘甲状腺原氨酸（T3）在血流中。
}}

==[[HP:0012517]]==
{{Infobox HPO
| hpoId = HP:0012517
| 名称 = Reduced catalase activity
| 定义 = An abnormally decreased amount of `catalase activity` (GO:0004096).
| 中文译名 = 过氧化氢酶活性降低
| 中文定义 = 一个异常降低的数额`过氧化氢酶activity`的（GO:0004096）。
}}


==[[HP:0012537]]==
{{Infobox HPO
| hpoId = HP:0012537
| 名称 = Food intolerance
| 定义 = A detrimental reaction to a food, beverage, food additive, or compound found in foods that produces symptoms in one or more body organs and systems that is not mediated by an immune reaction.
| 中文译名 = 食物不耐受
| 中文定义 = 甲有害反应到食品，饮料，食品添加剂，或化合物中产生的症状中，而并非由免疫反应介导的一个或多个身体器官和系统食品中发现。
}}


==[[HP:0012538]]==
{{Infobox HPO
| hpoId = HP:0012538
| 名称 = Gluten intolerance
| 定义 = A detrimental reaction to the presence of gluten in food, which may include abdominal pain, fatigue, headaches and paresthesia, or celiac disease.
| 中文译名 = 麸质不耐受
| 中文定义 = 甲不利反应，以面筋的食物中存在，其可以包括腹部疼痛，疲劳，头痛和感觉异常，或腹腔疾病。
}}


==[[HP:0012543]]==
{{Infobox HPO
| hpoId = HP:0012543
| 名称 = Hemosiderinuria
| 定义 = The presence of hemosiderin in the urine.
| 中文译名 = 含铁血黄素尿症
| 中文定义 = 尿液中存在含铁血黄素。
}}


==[[HP:0012544]]==
{{Infobox HPO
| hpoId = HP:0012544
| 名称 = Elevated aldolase level
| 定义 = An increased concentration of  fructose 1,6-bisphosphate aldolase in the serum.
| 中文译名 = 醛缩酶水平升高
| 中文定义 = 的血清中果糖-1,6-双磷酸醛缩酶的浓度增加。
}}


==[[HP:0012545]]==
{{Infobox HPO
| hpoId = HP:0012545
| 名称 = Reduced aldolase level
| 定义 = An decreased concentration of  fructose 1,6-bisphosphate aldolase in the serum.
| 中文译名 = 醛缩酶水平降低
| 中文定义 = 一个降低浓度的血清中果糖-1,6-双磷酸醛缩酶。
}}


==[[HP:0012556]]==
{{Infobox HPO
| hpoId = HP:0012556
| 名称 = Hyperbetaalaninemia
| 定义 = Increased concentration of `beta-alanine` (CHEBI:16958) in the blood.
| 中文译名 = 高β丙氨酸血症
| 中文定义 = 血液中的:增加`的β-alanine`（16958 CHEBI）的浓度。
}}


==[[HP:0012568]]==
{{Infobox HPO
| hpoId = HP:0012568
| 名称 = Lower eyelid edema
| 定义 = Edema in the region of the `Lower eyelid` (FMA:54442).
| 中文译名 = 下眼睑浮肿
| 中文定义 = 下眼睑区域浮肿
}}


==[[HP:0012587]]==
{{Infobox HPO
| hpoId = HP:0012587
| 名称 = Macroscopic hematuria
| 定义 = Hematuria that is visible upon inspection of the urine.
| 中文译名 = 肉眼血尿
| 中文定义 = 尿液中含有一定量的红细胞时称为血尿，当肉眼就可以看到尿液为红色时，即为肉眼血尿。
}}


==[[HP:0012591]]==
{{Infobox HPO
| hpoId = HP:0012591
| 名称 = Abnormal urinary electrolyte concentration
| 定义 = #####
| 中文译名 = 尿电解质浓度异常
| 中文定义 = #####
}}


==[[HP:0012592]]==
{{Infobox HPO
| hpoId = HP:0012592
| 名称 = Albuminuria
| 定义 = Increased concentration of albumin in the urine.
| 中文译名 = 蛋白尿
| 中文定义 = 尿中白蛋白的浓度增加。
}}


==[[HP:0012593]]==
{{Infobox HPO
| hpoId = HP:0012593
| 名称 = Nephrotic range proteinuria
| 定义 = Severely increased amount of excretion of protein in the urine, defined as 3.5 grams per day or more in adults and 40 mg per meter-squared body surface area per hour in children.
| 中文译名 = 肾性蛋白尿排泄增高
| 中文定义 = 尿液中蛋白质的排泄量重度增加，成人达到3.5克/天或更多，儿童每米平方体表面积40毫克/小时。
}}

==[[HP:0012594]]==
{{Infobox HPO
| hpoId = HP:0012594
| 名称 = Microalbuminuria
| 定义 = The presence of mildly increased concentrations of albumin in the urine (in adults, 30-150 mg per day).
| 中文译名 = 微量白蛋白尿
| 中文定义 = 尿液中白蛋白浓度轻度增加（成人每天30-150毫克）。
}}


==[[HP:0012595]]==
{{Infobox HPO
| hpoId = HP:0012595
| 名称 = Mild proteinuria
| 定义 = Mildly increased levels of protein in the urine (150-500 mg per day in adults).
| 中文译名 = 轻度蛋白尿
| 中文定义 = 尿中蛋白质水平轻度增加（成人每天150-500毫克）。
}}


==[[HP:0012596]]==
{{Infobox HPO
| hpoId = HP:0012596
| 名称 = Moderate proteinuria
| 定义 = Moderately increased levels of protein in the urine (500-1000 mg per day in adults).
| 中文译名 = 中度蛋白尿
| 中文定义 = 尿中蛋白质水平中度增加（成人每天500-1000毫克）。
}}


==[[HP:0012597]]==
{{Infobox HPO
| hpoId = HP:0012597
| 名称 = Heavy proteinuria
| 定义 = Severely increased levels of protein in the urine (1000-3000 mg per day in adults).
| 中文译名 = 严重蛋白尿
| 中文定义 = 尿液中蛋白质水平大量增加（成人每天正常值为1000-3000毫克）。
}}


==[[HP:0012598]]==
{{Infobox HPO
| hpoId = HP:0012598
| 名称 = Abnormal urine potassium concentration
| 定义 = An abnormal concentration of `potassium(1+)` (CHEBI:29103) in the `urine` (FMA:12274).
| 中文译名 = 尿钾浓度异常
| 中文定义 = 尿液中钾离子的浓度异常。
}}


==[[HP:0012599]]==
{{Infobox HPO
| hpoId = HP:0012599
| 名称 = Abnormal urine phosphate concentration
| 定义 = An abnormal `phosphate` (CHEBI:18367) concentration in the urine.
| 中文译名 = 尿磷酸盐浓度异常
| 中文定义 = 尿液中磷酸盐的浓度异常。
}}


==[[HP:0012600]]==
{{Infobox HPO
| hpoId = HP:0012600
| 名称 = Abnormal urine chloride concentration
| 定义 = An abnormal concentration of `chloride` (CHEBI:17996) in the `urine` (FMA:12274).
| 中文译名 = 尿液中氯离子浓度异常
| 中文定义 = 尿液中氯离子浓度的超出正常范围。
}}


==[[HP:0012601]]==
{{Infobox HPO
| hpoId = HP:0012601
| 名称 = Hypochloriduria
| 定义 = An decreased concentration of `chloride` (CHEBI:17996) in the `urine` (FMA:12274).
| 中文译名 = 低氯化物尿
| 中文定义 = 尿液中氯化物的浓度降低。
}}


==[[HP:0012602]]==
{{Infobox HPO
| hpoId = HP:0012602
| 名称 = Renal chloride wasting
| 定义 = High urine chloride in the presence of hypochloridemia.
| 中文译名 = 肾源性氯化物丢失
| 中文定义 = 尿液中氯化物浓度高，发生低氯血症。
}}


==[[HP:0012603]]==
{{Infobox HPO
| hpoId = HP:0012603
| 名称 = Abnormal urine sodium concentration
| 定义 = An abnormal concentration of sodium in the `urine` (FMA:12274).
| 中文译名 = 尿钠浓度异常
| 中文定义 = 尿液中钠离子的浓度异常。
}}


==[[HP:0012604]]==
{{Infobox HPO
| hpoId = HP:0012604
| 名称 = Hyponatriuria
| 定义 = An abnormally decreased sodium concentration in the urine.
| 中文译名 = 低钠尿
| 中文定义 = 尿液中纳离子浓度的降低。
}}


==[[HP:0012605]]==
{{Infobox HPO
| hpoId = HP:0012605
| 名称 = Hypernatriuria
| 定义 = An increased concentration of `sodium(1+)` (CHEBI:29101) in the `urine` (FMA:12274).
| 中文译名 = 高钠尿症
| 中文定义 = 尿液中钠离子浓度增加。
}}


==[[HP:0012606]]==
{{Infobox HPO
| hpoId = HP:0012606
| 名称 = Renal sodium wasting
| 定义 = An abnormally increased sodium concentration in the urine in the presence of hyponatremia.
| 中文译名 = 肾源性钠流失
| 中文定义 = 尿液中钠浓度异常增加，而有低钠血症。
}}


==[[HP:0012607]]==
{{Infobox HPO
| hpoId = HP:0012607
| 名称 = Abnormal urine magnesium concentration
| 定义 = An abnormal concentration of magnesium the `urine` (FMA:12274).
| 中文译名 = 尿中镁离子浓度异常
| 中文定义 = 尿液中镁的浓度异常。
}}

==[[HP:0012608]]==
{{Infobox HPO
| hpoId = HP:0012608
| 名称 = Hypermagnesiuria
| 定义 = An increased concentration of magnesium the `urine` (FMA:12274).
| 中文译名 = 高镁尿症
| 中文定义 = 尿液中镁的浓度增加。
}}


==[[HP:0012609]]==
{{Infobox HPO
| hpoId = HP:0012609
| 名称 = Hypomagnesiuria
| 定义 = An decreased concentration of magnesium the `urine` (FMA:12274).
| 中文译名 = 低镁血症
| 中文定义 = 尿液中镁的浓度降低。
}}


==[[HP:0012610]]==
{{Infobox HPO
| hpoId = HP:0012610
| 名称 = Abnormality of urinary uric acid concentration
| 定义 = Abnormal concentration of `urate` (CHEBI:46819) in the urine.
| 中文译名 = 尿中尿酸浓度异常
| 中文定义 = 尿液中尿酸盐浓度异常。
}}


==[[HP:0012611]]==
{{Infobox HPO
| hpoId = HP:0012611
| 名称 = Increased urinary urate
| 定义 = Elevanted concentration of `urate` (CHEBI:46819) in the urine.
| 中文译名 = 尿中尿酸盐增高
| 中文定义 = 尿液中尿酸盐浓度增加。
}}

==[[HP:0012612]]==
{{Infobox HPO
| hpoId = HP:0012612
| 名称 = Abnormal urinary sulfate concentration
| 定义 = Abnormal concentration of `sulfate` (CHEBI:16189) in the urine.
| 中文译名 = 尿中硫酸盐浓度异常
| 中文定义 = 尿液中硫酸盐浓度异常。
}}

==[[HP:0012613]]==
{{Infobox HPO
| hpoId = HP:0012613
| 名称 = Increased urinary sulfate
| 定义 = Elevated concentration of `sulfate` (CHEBI:16189) in the urine.
| 中文译名 = 尿中硫酸盐增高
| 中文定义 = 尿液中硫酸盐浓度增加。
}}

==[[HP:0012614]]==
{{Infobox HPO
| hpoId = HP:0012614
| 名称 = Abnormal urine cytology
| 定义 = An anomalous finding in the examination of the urine for cells.
| 中文译名 = 尿液细胞学异常
| 中文定义 = 尿液镜检时所发现的细胞异常。
}}


==[[HP:0012615]]==
{{Infobox HPO
| hpoId = HP:0012615
| 名称 = Cylindruria
| 定义 = The presence of renal casts (cylindrical structures produced by the kidney in certain disease states) in the urine.
| 中文译名 = 管型尿
| 中文定义 = 尿中存在管型（在某些疾病状态由肾脏产生的圆柱结构）。
}}


==[[HP:0012616]]==
{{Infobox HPO
| hpoId = HP:0012616
| 名称 = Leukocyte cylindruria
| 定义 = Presence of leukocyte casts (cylindrical structures produced by the kidney in certain disease states) in the urine.
| 中文译名 = 白细胞管型尿
| 中文定义 = 尿液中存在白细胞管型（在某些肾脏疾病中产生的圆柱形结构）。
}}


==[[HP:0012617]]==
{{Infobox HPO
| hpoId = HP:0012617
| 名称 = Erythrocyte cylindruria
| 定义 = Presence of erythrocyte casts (cylindrical structures produced by the kidney in certain disease states) in the urine.
| 中文译名 = 红细胞管型尿
| 中文定义 = 尿中存在红细胞管型（在某些肾脏疾病尿中所见的管形结构）。
}}


==[[HP:0012637]]==
{{Infobox HPO
| hpoId = HP:0012637
| 名称 = Renal calcium wasting
| 定义 = High urine calcium in the presence of hypocalcemia.
| 中文译名 = 肾源性钙流失
| 中文定义 = 尿液钙浓度高，发生低钙血症。
}}


==[[HP:0012676]]==
{{Infobox HPO
| hpoId = HP:0012676
| 名称 = Copper accumulation in brain
| 定义 = An anomalous build up of copper (Cu) in the `brain` (FMA:50801).
| 中文译名 = 脑中铜堆积
| 中文定义 = 大脑（FMA:50801）内铜（Cu）的异常积聚。
}}

==[[HP:0012724]]==
{{Infobox HPO
| hpoId = HP:0012724
| 名称 = Upper eyelid edema
| 定义 = Edema in the region of the upper eyelid.
| 中文译名 = 上眼睑水肿
| 中文定义 = 上眼睑区域水肿。
}}


==[[HP:0012726]]==
{{Infobox HPO
| hpoId = HP:0012726
| 名称 = Episodic hypokalemia
| 定义 = An abnormally decreased `potassium` (CHEBI:29103) concentration in the blood occurring periodically with a return to normal between the episodes.
| 中文译名 = 阵发性低钾血症
| 中文定义 = 一个异常降低`potassium`（CHEBI:29103）的浓度在血液中与返回到正常的发作之间周期性出现。
}}


==[[HP:0012734]]==
{{Infobox HPO
| hpoId = HP:0012734
| 名称 = Ketotic hypoglycemia
| 定义 = Low blood glucose is accompanied by elevated levels of ketone bodies in the body.
| 中文译名 = 酮症性低血糖症
| 中文定义 = 低血糖是伴随着在主体酮体水平升高。
}}


==[[HP:0025020]]==
{{Infobox HPO
| hpoId = HP:0025020
| 名称 = Elevated prostate-specific antigen level
| 定义 = An increased concentration of prostate specific antigen (PSA) in the circulation.
| 中文译名 = 前列腺特异抗原水平升高
| 中文定义 = #####
}}


==[[HP:0025021]]==
{{Infobox HPO
| hpoId = HP:0025021
| 名称 = Abnormal erythrocyte sedimentation rate
| 定义 = A deviation from normal range of the erythrocyte sedimentation rate (ESR), a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. An elevation may indicate inflammation or may be caused by any condition that elevates fibrinogen. A decreased ESR may be seen in polycythemia or in certain blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling.
| 中文译名 = 红细胞沉降率异常
| 中文定义 = #####
}}


==[[HP:0025022]]==
{{Infobox HPO
| hpoId = HP:0025022
| 名称 = Decreased erythrocyte sedimentation rate
| 定义 = A reduced erythrocyte sedimentation rate (ESR). The ESR is a test that measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The ESR is a nonspecific finding. A decreased ESR may be seen in polycythemia or in certain blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling.
| 中文译名 = 红细胞沉降率下降
| 中文定义 = #####
}}


==[[HP:0030059]]==
{{Infobox HPO
| hpoId = HP:0030059
| 名称 = Mitochondrial depletion
| 定义 = An abnormal reduction in mitochondrial DNA content of cells.
| 中文译名 = 线粒体DNA耗竭
| 中文定义 = #####
}}


==[[HP:0030088]]==
{{Infobox HPO
| hpoId = HP:0030088
| 名称 = Increased serum testosterone level
| 定义 = An elevated circulating testosterone level in the blood.
| 中文译名 = 血清睾酮水平增高
| 中文定义 = #####
}}

==[[HP:0030156]]==
{{Infobox HPO
| hpoId = HP:0030156
| 名称 = Bence Jones Proteinuria
| 定义 = The presence of free monoclonal immunoglobulin light chains in the urine.
| 中文译名 = 本氏蛋白尿
| 中文定义 = #####
}}

==[[HP:0030234]]==
{{Infobox HPO
| hpoId = HP:0030234
| 名称 = Highly elevated creatine phosphokinase
| 定义 = An increased CPK level between 4X and 50X above the upper normal level.
| 中文译名 = 肌酸磷酸激酶明显上升
| 中文定义 = #####
}}


==[[HP:0030235]]==
{{Infobox HPO
| hpoId = HP:0030235
| 名称 = Extremely elevated creatine phosphokinase
| 定义 = An increased CPK level more than 50X above the upper normal level.
| 中文译名 = 肌酸磷酸激酶极度上升
| 中文定义 = #####
}}


==[[HP:0030253]]==
{{Infobox HPO
| hpoId = HP:0030253
| 名称 = Defective T cell proliferation
| 定义 = A reduced ability of a T cell population to expand by cell division following T cell activation.
| 中文译名 = T 细胞增殖缺陷
| 中文定义 = #####
}}


==[[HP:0030270]]==
{{Infobox HPO
| hpoId = HP:0030270
| 名称 = Elevated red cell adenosine deaminase activity
| 定义 = Increase in the activity of adenosine deaminase (ADA), an enzyme involved in purine metabolism, within erythrocytes. ADA is involved in the catabolism of adenosine.
| 中文译名 = 红细胞腺苷脱氨酶活性增高
| 中文定义 = #####
}}

==[[HP:0030272]]==
{{Infobox HPO
| hpoId = HP:0030272
| 名称 = Abnormal erythrocyte enzyme activity
| 定义 = An altered ability of any enzyme to act as catalysts within erythrocytes. This term includes changes due to altered levels of an enzyme.
| 中文译名 = 红细胞酶活性异常
| 中文定义 = #####
}}


==[[HP:0030273]]==
{{Infobox HPO
| hpoId = HP:0030273
| 名称 = Reduced red cell adenosine deaminase activity
| 定义 = Decrease in the activity of adenosine deaminase (ADA), an enzyme involved in purine metabolism, within erythrocytes. ADA is involved in the catabolism of adenosine.
| 中文译名 = 红细胞腺苷脱氨酶活性降低
| 中文定义 = #####
}}


==[[HP:0030361]]==
{{Infobox HPO
| hpoId = HP:0030361
| 名称 = Abnormality of eicosanoid metabolism
| 定义 = An anomaly of the metabolism of an icosanoid (also know as eicosanoids). These are signaling molecules derived from oxidation of 20-carbon fatty acids. Most are produced from arachidonic acid, a 20-carbon polyunsaturated fatty acid (5,8,11,14-eicosatetraenoic acid).
| 中文译名 = 类花生酸代谢异常
| 中文定义 = #####
}}


==[[HP:0030362]]==
{{Infobox HPO
| hpoId = HP:0030362
| 名称 = Reduced muscle carnitine level
| 定义 = A reduction in the level of carnitine in muscle tissue.
| 中文译名 = 肌肉肉碱水平降低
| 中文定义 = #####
}}


==[[HP:0030389]]==
{{Infobox HPO
| hpoId = HP:0030389
| 名称 = Abnormality of thromboxane metabolism
| 定义 = An anomaly of the metabolism of thromboxane (CHEBI:26995). Thromboxanes are derived from prostaglandin precursors in platelets, and stimulate aggregation of platelets and constriction of blood vessels.
| 中文译名 = 血栓烷代谢异常
| 中文定义 = #####
}}


==[[HP:0030390]]==
{{Infobox HPO
| hpoId = HP:0030390
| 名称 = Abnormality of leukotriene metabolism
| 定义 = An anomaly of the metabolism of leukotriene (CHEBI:25029).
| 中文译名 = 白三烯代谢异常
| 中文定义 = #####
}}


==[[HP:0030774]]==
{{Infobox HPO
| hpoId = HP:0030774
| 名称 = Mitochondrial swelling
| 定义 = The mitochondrial matrix refers to the substance occupying the space enclosed by the inner membrane of a mitochondrion, which contains enzymes, DNA, granules, and inclusions of protein crystals, glycogen, and lipid. Mitochondrial swelling refers to an increase in size of the mitochondrial matrix. This phenomenon is thought to be related to a permeabilized inner membrane that originates a large swelling in the mitochondrial matrix. Mitochondrial swelling may distend the outer membrane until it ruptures.
| 中文译名 = 线粒体肿胀
| 中文定义 = #####
}}


==[[HP:0030781]]==
{{Infobox HPO
| hpoId = HP:0030781
| 名称 = Increased circulating free fatty acid level
| 定义 = A higher than normal levels of the fatty acids which can occur in plasma as a result of lipolysis in adipose tissue or when plasma triacyglycerols are taken into tissues.
| 中文译名 = 循环系统内游离脂肪酸水平增高
| 中文定义 = #####
}}

==[[HP:0030794]]==
{{Infobox HPO
| hpoId = HP:0030794
| 名称 = Abnormal C-peptide level
| 定义 = An anomolous circulating concentration of the connecting (C) peptide, which links the insulin A and B chains in proinsulin, providing thereby a means to promote their efficient folding and assembly in the endoplasmic reticulum during insulin biosynthesis. After cleavage of proinsulin, C-peptide is stored with insulin in the soluble phase of the secretory granules and is subsequently released in equimolar amounts with insulin, providing a useful independent indicator of insulin secretion.
| 中文译名 = C-肽水平异常
| 中文定义 = #####
}}


==[[HP:0030795]]==
{{Infobox HPO
| hpoId = HP:0030795
| 名称 = Reduced C-peptide level
| 定义 = A decreased concentration of C-peptide in the circulation. Since C-peptide is secreted in equimolar amounts to insulin, this feature correlates with reduced insulin secretion.
| 中文译名 = C-肽水平降低
| 中文定义 = #####
}}


==[[HP:0030796]]==
{{Infobox HPO
| hpoId = HP:0030796
| 名称 = Increased C-peptide level
| 定义 = An elevated concentration of C-peptide in the circulation. Since C-peptide is secreted in equimolar amounts to insulin, this feature correlates with increased insulin secretion.
| 中文译名 = C-肽水平增高
| 中文定义 = #####
}}

==[[HP:0030843]]==
{{Infobox HPO
| hpoId = HP:0030843
| 名称 = Cardiac amyloidosis
| 定义 = Extracellular deposition in cardiac tissue of a proteinaceous material that, when stained with Congo red, demonstrates apple-green birefringence under polarized light and that has a distinct color when stained with sulfated Alcian blue. Viewed with electron microscopy, the amyloid deposits are seen to be composed of a beta-sheet fibrillar material. These nonbranching fibrils have a diameter of 7.5 to 10 nm and are the result of protein misfolding.
| 中文译名 = 心脏淀粉样变性
| 中文定义 = #####
}}


==[[HP:0040012]]==
{{Infobox HPO
| hpoId = HP:0040012
| 名称 = Chromsome breakage
| 定义 = #####
| 中文译名 = 染色体断裂
| 中文定义 = #####
}}


==[[HP:0040013]]==
{{Infobox HPO
| hpoId = HP:0040013
| 名称 = Decreased mitochondrial number
| 定义 = #####
| 中文译名 = 线粒体数量减少
| 中文定义 = #####
}}


==[[HP:0040014]]==
{{Infobox HPO
| hpoId = HP:0040014
| 名称 = Increased mitochondrial number
| 定义 = #####
| 中文译名 = 线粒体数目增加
| 中文定义 = #####
}}


==[[HP:0040015]]==
{{Infobox HPO
| hpoId = HP:0040015
| 名称 = Increased activity of mitochondrial respiratory chain
| 定义 = #####
| 中文译名 = 线粒体呼吸链活性增高
| 中文定义 = #####
}}

==[[HP:0040049]]==
{{Infobox HPO
| hpoId = HP:0040049
| 名称 = #####
| 定义 = #####
| 中文译名 = 黄斑水肿
| 中文定义 = #####
}}


==[[HP:0040077]]==
{{Infobox HPO
| hpoId = HP:0040077
| 名称 = Abnormal concentration of calcium in blood
| 定义 = #####
| 中文译名 = 血液钙浓度异常
| 中文定义 = #####
}}


==[[HP:0040081]]==
{{Infobox HPO
| hpoId = HP:0040081
| 名称 = Abnormal levels of creatine kinase in blood
| 定义 = #####
| 中文译名 = 血液肌酸激酶水平异常
| 中文定义 = #####
}}


==[[HP:0040087]]==
{{Infobox HPO
| hpoId = HP:0040087
| 名称 = Abnormality of folate in blood
| 定义 = #####
| 中文译名 = 血液叶酸异常
| 中文定义 = #####
}}


==[[HP:0040126]]==
{{Infobox HPO
| hpoId = HP:0040126
| 名称 = Abnormal serum cobalamin
| 定义 = #####
| 中文译名 = 血清钴胺素异常
| 中文定义 = #####
}}


==[[HP:0040127]]==
{{Infobox HPO
| hpoId = HP:0040127
| 名称 = Abnormal sweat homeostasis
| 定义 = An abnormality of the composition of sweat or the levels of its components.
| 中文译名 = 汗液稳态异常
| 中文定义 = #####
}}


==[[HP:0040128]]==
{{Infobox HPO
| hpoId = HP:0040128
| 名称 = Abnormal sweat electrolytes
| 定义 = #####
| 中文译名 = 汗液电解质异常
| 中文定义 = #####
}}


==[[HP:0040130]]==
{{Infobox HPO
| hpoId = HP:0040130
| 名称 = Abnormal serum iron
| 定义 = #####
| 中文译名 = 血清铁异常
| 中文定义 = #####
}}


==[[HP:0040133]]==
{{Infobox HPO
| hpoId = HP:0040133
| 名称 = Abnormal serum ferritin
| 定义 = #####
| 中文译名 = 血清铁蛋白异常
| 中文定义 = #####
}}


==[[HP:0040134]]==
{{Infobox HPO
| hpoId = HP:0040134
| 名称 = Abnormal hepatic iron concentration
| 定义 = #####
| 中文译名 = 肝脏铁浓度异常
| 中文定义 = #####
}}


==[[HP:0040135]]==
{{Infobox HPO
| hpoId = HP:0040135
| 名称 = Abnormal transferrin saturation
| 定义 = #####
| 中文译名 = 运铁蛋白饱和度异常
| 中文定义 = #####
}}


==[[HP:0040139]]==
{{Infobox HPO
| hpoId = HP:0040139
| 名称 = Lipogranulomatosis
| 定义 = Yellow nodules of lipoid material are deposited in the skin and mucosae. This gives rise to granulomatous reactions.
| 中文译名 = 皮下脂肪肉芽肿病
| 中文定义 = #####
}}


==[[HP:0040142]]==
{{Infobox HPO
| hpoId = HP:0040142
| 名称 = #####
| 定义 = #####
| 中文译名 = 5-羟脯氨酸酶缺乏症
| 中文定义 = #####
}}


==[[HP:0040144]]==
{{Infobox HPO
| hpoId = HP:0040144
| 名称 = #####
| 定义 = #####
| 中文译名 = L-2-羟基戊二酸尿症
| 中文定义 = #####
}}


==[[HP:0040145]]==
{{Infobox HPO
| hpoId = HP:0040145
| 名称 = Dicarboxylic acidemia
| 定义 = #####
| 中文译名 = 二羧酸血症
| 中文定义 = #####
}}


==[[HP:0040146]]==
{{Infobox HPO
| hpoId = HP:0040146
| 名称 = D-2-hydroxyglutaric acidemia
| 定义 = #####
| 中文译名 = D-2-羟基戊二酸血症
| 中文定义 = #####
}}


==[[HP:0040147]]==
{{Infobox HPO
| hpoId = HP:0040147
| 名称 = #####
| 定义 = #####
| 中文译名 = L-2-羟基戊二酸血症
| 中文定义 = #####
}}


==[[HP:0040155]]==
{{Infobox HPO
| hpoId = HP:0040155
| 名称 = Elevated urinary 3-hydroxybutyric acid
| 定义 = An increased amount of 3-hydroxybutyric acid in the urine.
| 中文译名 = 尿3-羟基丁酸水平升高
| 中文定义 = #####
}}


==[[HP:0040156]]==
{{Infobox HPO
| hpoId = HP:0040156
| 名称 = Elevated urinary carboxylic acid
| 定义 = An increased amount of carboxylic acid in the urine.
| 中文译名 = 尿羧酸水平升高
| 中文定义 = #####
}}


==[[HP:0040171]]==
{{Infobox HPO
| hpoId = HP:0040171
| 名称 = #####
| 定义 = #####
| 中文译名 = 血清睾酮水平降低
| 中文定义 = #####
}}


==[[HP:0040175]]==
{{Infobox HPO
| hpoId = HP:0040175
| 名称 = #####
| 定义 = #####
| 中文译名 = 血小板活化因子乙酰水解酶缺乏
| 中文定义 = #####
}}


==[[HP:0040176]]==
{{Infobox HPO
| hpoId = HP:0040176
| 名称 = Abnormal level of phospholipids
| 定义 = #####
| 中文译名 = 磷脂水平异常
| 中文定义 = #####
}}


==[[HP:0040177]]==
{{Infobox HPO
| hpoId = HP:0040177
| 名称 = Abnormal level of platelet-activating factor
| 定义 = #####
| 中文译名 = 血小板活化因子水平异常
| 中文定义 = #####
}}


==[[HP:0040178]]==
{{Infobox HPO
| hpoId = HP:0040178
| 名称 = #####
| 定义 = #####
| 中文译名 = 血小板活化因子水平升高
| 中文定义 = #####
}}


==[[HP:0040179]]==
{{Infobox HPO
| hpoId = HP:0040179
| 名称 = Decreased level of platelet-activating factor
| 定义 = #####
| 中文译名 = 血小板活化因子水平降低
| 中文定义 = #####
}}


==[[HP:0040203]]==
{{Infobox HPO
| hpoId = HP:0040203
| 名称 = Abnormal CSF neopterin level
| 定义 = Abnormal concentration of neopterin in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液新喋呤水平异常
| 中文定义 = #####
}}


==[[HP:0040204]]==
{{Infobox HPO
| hpoId = HP:0040204
| 名称 = Elevated CSF neopterin level
| 定义 = Increased concentration of neopterin in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液新喋呤水平升高
| 中文定义 = #####
}}


==[[HP:0040205]]==
{{Infobox HPO
| hpoId = HP:0040205
| 名称 = Decreased CSF neopterin level
| 定义 = Decreased concentration of dopamine in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液新喋呤水平降低
| 中文定义 = #####
}}


==[[HP:0040206]]==
{{Infobox HPO
| hpoId = HP:0040206
| 名称 = Abnormal level of neopterin
| 定义 = The presence of an abnormal concentration of neopterin.
| 中文译名 = 新喋呤水平异常
| 中文定义 = #####
}}


==[[HP:0040207]]==
{{Infobox HPO
| hpoId = HP:0040207
| 名称 = Abnormal CSF biopterin level
| 定义 = Abnormal concentration of biopterin in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液生物喋呤水平异常
| 中文定义 = #####
}}


==[[HP:0040208]]==
{{Infobox HPO
| hpoId = HP:0040208
| 名称 = Elevated CSF biopterin level
| 定义 = Increased concentration of biopterin in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液生物喋呤水平升高
| 中文定义 = #####
}}


==[[HP:0040209]]==
{{Infobox HPO
| hpoId = HP:0040209
| 名称 = Decreased CSF biopterin level
| 定义 = Decreased concentration of biopterin in the cerebrospinal fluid (CSF).
| 中文译名 = 脑脊液生物喋呤水平降低
| 中文定义 = #####
}}


==[[HP:0040210]]==
{{Infobox HPO
| hpoId = HP:0040210
| 名称 = Abnormal level of biopterin
| 定义 = The presence of an abnormal concentration of biopterin.
| 中文译名 = 生物喋呤水平异常
| 中文定义 = #####
}}


==[[HP:0040270]]==
{{Infobox HPO
| hpoId = HP:0040270
| 名称 = Decreased glucose tolerance
| 定义 = An abnormal resistance to glucose, i.e., a reduction in the ability to maintain glucose levels in the blood stream within normal limits following oral or intravenous administration of glucose.
| 中文译名 = 葡萄糖耐量下降
| 中文定义 = #####
}}


==[[HP:0045011]]==
{{Infobox HPO
| hpoId = HP:0045011
| 名称 = Decreased urine bicarbonate concentration
| 定义 = #####
| 中文译名 = 尿中碳酸氢盐浓度降低
| 中文定义 = #####
}}

==[[HP:0045012]]==
{{Infobox HPO
| hpoId = HP:0045012
| 名称 = Decreased urinary catecholamine concentration
| 定义 = #####
| 中文译名 = 尿中儿茶酚胺浓度降低
| 中文定义 = #####
}}

==[[HP:0045013]]==
{{Infobox HPO
| hpoId = HP:0045013
| 名称 = Decreased urinary glucose concentration
| 定义 = #####
| 中文译名 = 尿葡萄糖浓度降低
| 中文定义 = #####
}}

==[[HP:0045014]]==
{{Infobox HPO
| hpoId = HP:0045014
| 名称 = Hypolipidemia
| 定义 = #####
| 中文译名 = 低脂血症
| 中文定义 = #####
}}


==[[HP:0045016]]==
{{Infobox HPO
| hpoId = HP:0045016
| 名称 = #####
| 定义 = #####
| 中文译名 = 血清长链脂肪酸增高
| 中文定义 = #####
}}

==[[HP:0045034]]==
{{Infobox HPO
| hpoId = HP:0045034
| 名称 = Elevated urinary aminoisobutyric acid
| 定义 = An increased amount of 3-aminoisobutyric acid in the urine.
| 中文译名 = 尿氨基异丁酸增高
| 中文定义 = #####
}}

==[[HP:0045035]]==
{{Infobox HPO
| hpoId = HP:0045035
| 名称 = Decreased urinary copper concentration
| 定义 = #####
| 中文译名 = 尿铜浓度降低
| 中文定义 = #####
}}


==[[HP:0045036]]==
{{Infobox HPO
| hpoId = HP:0045036
| 名称 = Abnormal urinary copper concentration
| 定义 = #####
| 中文译名 = 尿铜浓度异常
| 中文定义 = #####
}}


==[[HP:0045040]]==
{{Infobox HPO
| hpoId = HP:0045040
| 名称 = Abnormal lactate dehydrogenase activity
| 定义 = #####
| 中文译名 = 乳酸脱氢酶活性异常
| 中文定义 = #####
}}


==[[HP:0045041]]==
{{Infobox HPO
| hpoId = HP:0045041
| 名称 = #####
| 定义 = #####
| 中文译名 = 乳酸脱氢酶B缺陷
| 中文定义 = #####
}}


==[[HP:0045045]]==
{{Infobox HPO
| hpoId = HP:0045045
| 名称 = #####
| 定义 = #####
| 中文译名 = 血浆酰基肉碱水平升高
| 中文定义 = #####
}}


==[[HP:0045046]]==
{{Infobox HPO
| hpoId = HP:0045046
| 名称 = #####
| 定义 = #####
| 中文译名 = 酸性不稳定亚基水平降低
| 中文定义 = #####
}}

==[[HP:0045056]]==
{{Infobox HPO
| hpoId = HP:0045056
| 名称 = Abnormal levels of alpha-fetoprotein
| 定义 = #####
| 中文译名 = 甲胎蛋白水平异常
| 中文定义 = #####
}}


==[[HP:0045057]]==
{{Infobox HPO
| hpoId = HP:0045057
| 名称 = #####
| 定义 = #####
| 中文译名 = 甲胎蛋白水平下降
| 中文定义 = #####
}}


==[[HP:0045061]]==
{{Infobox HPO
| hpoId = HP:0045061
| 名称 = #####
| 定义 = #####
| 中文译名 = 肝脏中肉碱水平降低
| 中文定义 = #####
}}

==[[HP:0045063]]==
{{Infobox HPO
| hpoId = HP:0045063
| 名称 = Increased PIVKA-II
| 定义 = Des-gamma carboxyprothrombin (DCP) or pro-thrombin induced by vitamin K absence-II (PIVKA-II) is an abnormal prothrombin protein that is increased in the serum of patients with HCC. Generation of DCP is thought to be a result of an acquired defect in the post- translational carboxylation of the prothrombin precursor in malignant cells.
| 中文译名 = PIVKA-II增高（异常凝血酶原）
| 中文定义 = #####
}}

==[[HP:0100292]]==
{{Infobox HPO
| hpoId = HP:0100292
| 名称 = Amyloidosis of peripheral nerves
| 定义 = The presence of `amyloid deposition` (MPATH:34) in the nerves of the `peripheral nervous system` (FMA:9903).
| 中文译名 = 外周神经淀粉样变性
| 中文定义 = 周围神经系统（FMA:9903）出现`淀粉样蛋白沉积`（mpath:34）。
}}

==[[HP:0100493]]==
{{Infobox HPO
| hpoId = HP:0100493
| 名称 = Hypoammonemia
| 定义 = A decreased concentration of `ammonia` (CHEBI:16134) in the `blood` (FMA:9670).
| 中文译名 = 低血氨
| 中文定义 = 在`blood`:`ammonia`（16134 CHEBI）的浓度降低（FMA:9670）。
}}


==[[HP:0100496]]==
{{Infobox HPO
| hpoId = HP:0100496
| 名称 = Abnormality of the vitamin B3 metabolism
| 定义 = #####
| 中文译名 = 维生素B3代谢异常
| 中文定义 = #####
}}


==[[HP:0100497]]==
{{Infobox HPO
| hpoId = HP:0100497
| 名称 = Vitamin B3 deficiency
| 定义 = #####
| 中文译名 = 维生素B3缺乏症
| 中文定义 = #####
}}


==[[HP:0100502]]==
{{Infobox HPO
| hpoId = HP:0100502
| 名称 = Vitamin B12 deficiency
| 定义 = #####
| 中文译名 = 维生素B12缺乏症
| 中文定义 = #####
}}


==[[HP:0100503]]==
{{Infobox HPO
| hpoId = HP:0100503
| 名称 = Vitamin B1 deficiency
| 定义 = #####
| 中文译名 = 维生素B1缺乏症
| 中文定义 = #####
}}


==[[HP:0100504]]==
{{Infobox HPO
| hpoId = HP:0100504
| 名称 = Vitamin B2 deficiency
| 定义 = #####
| 中文译名 = 维生素B2缺乏症
| 中文定义 = #####
}}


==[[HP:0100505]]==
{{Infobox HPO
| hpoId = HP:0100505
| 名称 = Vitamin B5 deficiency
| 定义 = #####
| 中文译名 = 维生素B5缺乏症
| 中文定义 = #####
}}


==[[HP:0100506]]==
{{Infobox HPO
| hpoId = HP:0100506
| 名称 = Vitamin B8 deficiency
| 定义 = #####
| 中文译名 = 维生素B8缺乏症
| 中文定义 = #####
}}


==[[HP:0100507]]==
{{Infobox HPO
| hpoId = HP:0100507
| 名称 = Folate deficiency
| 定义 = A reduced concentration of `folic acid` (CHEBI:27470), which is also known as vitamin B9.
| 中文译名 = 叶酸缺乏症
| 中文定义 = 的`叶酸acid`减小的浓度（CHEBI:27470），其也被称为维生素B9中。
}}

==[[HP:0100508]]==
{{Infobox HPO
| hpoId = HP:0100508
| 名称 = Abnormality of vitamin metabolism
| 定义 = #####
| 中文译名 = 维生素代谢异常
| 中文定义 = #####
}}


==[[HP:0100509]]==
{{Infobox HPO
| hpoId = HP:0100509
| 名称 = Abnormality of vitamin C metabolism
| 定义 = #####
| 中文译名 = 维生素C代谢异常
| 中文定义 = #####
}}


==[[HP:0100510]]==
{{Infobox HPO
| hpoId = HP:0100510
| 名称 = Vitamin C deficiency
| 定义 = #####
| 中文译名 = 维生素C缺乏症
| 中文定义 = #####
}}


==[[HP:0100511]]==
{{Infobox HPO
| hpoId = HP:0100511
| 名称 = Abnormality of vitamin D metabolism
| 定义 = #####
| 中文译名 = 维生素D代谢异常
| 中文定义 = #####
}}


==[[HP:0100512]]==
{{Infobox HPO
| hpoId = HP:0100512
| 名称 = Vitamin D deficiency
| 定义 = #####
| 中文译名 = 维生素D缺乏症
| 中文定义 = #####
}}


==[[HP:0100513]]==
{{Infobox HPO
| hpoId = HP:0100513
| 名称 = Vitamin E deficiency
| 定义 = #####
| 中文译名 = 维生素E缺乏症
| 中文定义 = #####
}}


==[[HP:0100514]]==
{{Infobox HPO
| hpoId = HP:0100514
| 名称 = Abnormality of vitamin E metabolism
| 定义 = #####
| 中文译名 = 维生素E代谢异常
| 中文定义 = #####
}}


==[[HP:0100529]]==
{{Infobox HPO
| hpoId = HP:0100529
| 名称 = Abnormality of phosphate homeostasis
| 定义 = An abnormality of `phosphate` (CHEBI:26020) homeostasis or concentration in the body.
| 中文译名 = 磷酸盐稳态平衡异常
| 中文定义 = 体内`磷酸盐`异常（CHEBI:26020）的平衡或浓度异常。
}}


==[[HP:0100530]]==
{{Infobox HPO
| hpoId = HP:0100530
| 名称 = Abnormality of calcium-phosphate metabolism
| 定义 = #####
| 中文译名 = 磷酸钙代谢异常
| 中文定义 = #####
}}


==[[HP:0100539]]==
{{Infobox HPO
| hpoId = HP:0100539
| 名称 = Periorbital edema
| 定义 = Edema affecting the region situated around the orbit of the eye.
| 中文译名 = 眶周水肿
| 中文定义 = 水肿影响位于眼部周围的轨道的区域。
}}


==[[HP:0100540]]==
{{Infobox HPO
| hpoId = HP:0100540
| 名称 = Palpebral edema
| 定义 = Edema in the region of the `eyelids` (FMA:75178).
| 中文译名 = 眼睑水肿
| 中文定义 = 眼睑区域水肿
}}


==[[HP:0100586]]==
{{Infobox HPO
| hpoId = HP:0100586
| 名称 = Aseptic leukocyturia
| 定义 = Leukocyturia without bacterial growth upon urine culture.
| 中文译名 = 无菌性白细胞尿
| 中文定义 = 尿存在白细胞，但尿培养无细菌生长。
}}


==[[HP:0100598]]==
{{Infobox HPO
| hpoId = HP:0100598
| 名称 = Pulmonary edema
| 定义 = Fluid accumulation in the lungs.
| 中文译名 = 肺水肿
| 中文定义 = 液体积聚在肺中。
}}


==[[HP:0100610]]==
{{Infobox HPO
| hpoId = HP:0100610
| 名称 = Maternal hyperphenylalaninemia
| 定义 = Leading to  hyperphenylalaninemia , maternal Of phenylketonuria  with inadequate control during pregnancy  ,  resulting in fetal microcephaly, mental retardation, congenital heart disease, intrauterine growth retardation haphenylketonuria  pregnancy.
| 中文译名 = 母体高苯丙氨酸血症
| 中文定义 = 苯丙酮尿症孕妇孕期饮食控制不佳导致高苯丙氨酸血症,从而导致胎儿小头畸形，精神发育迟缓，宫内发育迟缓等。
}}


==[[HP:0100651]]==
{{Infobox HPO
| hpoId = HP:0100651
| 名称 = Type I diabetes mellitus
| 定义 = A chronic condition in which the pancreas produces little or no insulin. Type I diabetes mellitus is manifested by the sudden onset of severe hyperglycemia with rapid progression to diabetic ketoacidosis unless treated with insulin.
| 中文译名 = 1型糖尿病
| 中文定义 = 一种胰腺不产生或产生很少胰岛素的慢性病症。1型糖尿病发病突然，特点是严重的高血糖，若不使用胰岛素治疗，即迅速发展为糖尿病酮症酸中毒
}}


==[[HP:0100665]]==
{{Infobox HPO
| hpoId = HP:0100665
| 名称 = Angioedema
| 定义 = Rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues of the skin of the face, normally around the mouth, and the mucosa of the mouth and/or throat, as well as the tongue during a period of minutes to several hours. The swelling can also occur elsewhere, typically in the hands. Angioedema is similar to urticaria, but the swelling is subcutaneous rather than on the epidermis.
| 中文译名 = 血管性水肿
| 中文定义 = 面部皮肤的真皮、皮下组织、粘膜和粘膜下组织的迅速肿胀（水肿），通常在几分钟到几个小时即可涉及口周、口腔和/或喉的粘膜以及舌头。肿胀也可能发生在其他地方，典型的是手部。血管性水肿类似于荨麻疹，但肿胀部位主要在皮下组织而非表皮。
}}


==[[HP:0100748]]==
{{Infobox HPO
| hpoId = HP:0100748
| 名称 = Muscular edema
| 定义 = #####
| 中文译名 = 肌内水肿
| 中文定义 = #####
}}


==[[HP:0100758]]==
{{Infobox HPO
| hpoId = HP:0100758
| 名称 = Gangrene
| 定义 = A serious and potentially life-threatening condition that arises when a considerable mass of body tissue dies (necrosis).
| 中文译名 = 坏疽
| 中文定义 = 一个严重和潜在威胁生命的条件出现时，有相当质量体组织死亡（坏死）。
}}


==[[HP:0100831]]==
{{Infobox HPO
| hpoId = HP:0100831
| 名称 = Abnormality of vitamin K metabolism
| 定义 = Vitamin K is a fat-soluble vitamin with a role in promoting the coagulation cascade.
| 中文译名 = 维生素K代谢异常
| 中文定义 = 维生素K是一种脂溶性维生素，具有促进凝血级联反应的作用。。
}}


==[[HP:0100950]]==
{{Infobox HPO
| hpoId = HP:0100950
| 名称 = Long chain 3 hydroxyacyl coA dehydrogenase deficiency
| 定义 = #####
| 中文译名 = 长链3羟辅酶A脱氢酶缺乏症
| 中文定义 = #####
}}


==[[HP:0200024]]==
{{Infobox HPO
| hpoId = HP:0200024
| 名称 = Premature chromatid separation
| 定义 = The presence of `premature` (PATO:0000694) `sister chromatid segregation` (GO:0000819).
| 中文译名 = 未成熟染色单体的分离
| 中文定义 = 的`premature`的存在（PATO:0000694）`姐妹染色单体segregation`（GO:0000819）。
}}


==[[HP:0200114]]==
{{Infobox HPO
| hpoId = HP:0200114
| 名称 = Metabolic alkalosis
| 定义 = #####
| 中文译名 = 代谢性碱中毒
| 中文定义 = #####
}}


==[[HP:0200118]]==
{{Infobox HPO
| hpoId = HP:0200118
| 名称 = Malabsorption of Vitamin B12
| 定义 = #####
| 中文译名 = 维生素B12吸收不良
| 中文定义 = #####
}}


==[[HP:0200125]]==
{{Infobox HPO
| hpoId = HP:0200125
| 名称 = Mitochondrial respiratory chain defects
| 定义 = #####
| 中文译名 = 线粒体呼吸链缺陷
| 中文定义 = #####
}}


==[[HP:0200126]]==
{{Infobox HPO
| hpoId = HP:0200126
| 名称 = Amyolid cardiomyopathy
| 定义 = Amyloid cardiomyopathy is a disease of cardiac muscle dysfunction, with amyloid protein deposited in cardiac tissue.
| 中文译名 = 淀粉样心肌病
| 中文定义 = 淀粉样变心肌病是一种心肌功能紊乱的疾病，在心肌组织内沉积有淀粉样蛋白质。
}}


==[[HP:0200150]]==
{{Infobox HPO
| hpoId = HP:0200150
| 名称 = increased serum bile acid concentration during pregnancy
| 定义 = #####
| 中文译名 = 孕期血清胆汁酸浓度增高
| 中文定义 = #####
}}